id	sid	tid	token	lemma	pos
dpc-2082	1	1	dermatology	dermatology	NOUN
dpc-2082	1	2	:	:	PUNCT
dpc-2082	1	3	practical	practical	ADJ
dpc-2082	1	4	and	and	CCONJ
dpc-2082	1	5	conceptual	conceptual	ADJ
dpc-2082	1	6	original	original	ADJ
dpc-2082	1	7	article	article	NOUN
dpc-2082	1	8	|	|	ADV
dpc-2082	1	9	dermatol	dermatol	ADJ
dpc-2082	1	10	pract	pract	NOUN
dpc-2082	1	11	concept	concept	NOUN
dpc-2082	1	12	.	.	PUNCT
dpc-2082	2	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	2	2	1	1	NUM
dpc-2082	2	3	diagnostic	diagnostic	ADJ
dpc-2082	2	4	role	role	NOUN
dpc-2082	2	5	of	of	ADP
dpc-2082	2	6	direct	direct	ADJ
dpc-2082	2	7	immunofluorescence	immunofluorescence	NOUN
dpc-2082	2	8	assay	assay	NOUN
dpc-2082	2	9	in	in	ADP
dpc-2082	2	10	determining	determine	VERB
dpc-2082	2	11	the	the	DET
dpc-2082	2	12	etiology	etiology	NOUN
dpc-2082	2	13	of	of	ADP
dpc-2082	2	14	erythroderma	erythroderma	NOUN
dpc-2082	2	15	:	:	PUNCT
dpc-2082	2	16	experience	experience	NOUN
dpc-2082	2	17	in	in	ADP
dpc-2082	2	18	a	a	DET
dpc-2082	2	19	tertiary	tertiary	ADJ
dpc-2082	2	20	referral	referral	NOUN
dpc-2082	2	21	hospital	hospital	NOUN
dpc-2082	2	22	ecem	ecem	PROPN
dpc-2082	2	23	bostan	bostan	PROPN
dpc-2082	2	24	md1	md1	NOUN
dpc-2082	2	25	,	,	PUNCT
dpc-2082	2	26	ozay	ozay	ADV
dpc-2082	2	27	gokoz2	gokoz2	NOUN
dpc-2082	2	28	,	,	PUNCT
dpc-2082	2	29	sibel	sibel	NOUN
dpc-2082	2	30	dogan1	dogan1	NOUN
dpc-2082	2	31	,	,	PUNCT
dpc-2082	2	32	duygu	duygu	NOUN
dpc-2082	2	33	gulseren1	gulseren1	NOUN
dpc-2082	2	34	,	,	PUNCT
dpc-2082	2	35	neslihan	neslihan	NOUN
dpc-2082	2	36	akdogan1	akdogan1	PROPN
dpc-2082	2	37	,	,	PUNCT
dpc-2082	2	38	basak	basak	PROPN
dpc-2082	2	39	yalici	yalici	PROPN
dpc-2082	2	40	-	-	PUNCT
dpc-2082	2	41	armagan1	armagan1	PROPN
dpc-2082	2	42	,	,	PUNCT
dpc-2082	2	43	sibel	sibel	PROPN
dpc-2082	2	44	ersoy	ersoy	NOUN
dpc-2082	2	45	-	-	PUNCT
dpc-2082	2	46	evans1	evans1	NOUN
dpc-2082	2	47	,	,	PUNCT
dpc-2082	2	48	gonca	gonca	PROPN
dpc-2082	2	49	elcin1	elcin1	PROPN
dpc-2082	2	50	,	,	PUNCT
dpc-2082	2	51	aysen	aysen	PROPN
dpc-2082	2	52	karaduman1	karaduman1	PROPN
dpc-2082	2	53	1	1	NUM
dpc-2082	2	54	department	department	NOUN
dpc-2082	2	55	of	of	ADP
dpc-2082	2	56	dermatology	dermatology	NOUN
dpc-2082	2	57	and	and	CCONJ
dpc-2082	2	58	venereology	venereology	NOUN
dpc-2082	2	59	,	,	PUNCT
dpc-2082	2	60	hacettepe	hacettepe	PROPN
dpc-2082	2	61	university	university	NOUN
dpc-2082	2	62	,	,	PUNCT
dpc-2082	2	63	faculty	faculty	NOUN
dpc-2082	2	64	of	of	ADP
dpc-2082	2	65	medicine	medicine	NOUN
dpc-2082	2	66	,	,	PUNCT
dpc-2082	2	67	ankara	ankara	PROPN
dpc-2082	2	68	,	,	PUNCT
dpc-2082	2	69	turkey	turkey	PROPN
dpc-2082	2	70	2	2	NUM
dpc-2082	2	71	department	department	NOUN
dpc-2082	2	72	of	of	ADP
dpc-2082	2	73	pathology	pathology	PROPN
dpc-2082	2	74	,	,	PUNCT
dpc-2082	2	75	hacettepe	hacettepe	PROPN
dpc-2082	2	76	university	university	NOUN
dpc-2082	2	77	,	,	PUNCT
dpc-2082	2	78	faculty	faculty	NOUN
dpc-2082	2	79	of	of	ADP
dpc-2082	2	80	medicine	medicine	NOUN
dpc-2082	2	81	,	,	PUNCT
dpc-2082	2	82	ankara	ankara	PROPN
dpc-2082	2	83	,	,	PUNCT
dpc-2082	2	84	turkey	turkey	PROPN
dpc-2082	2	85	key	key	ADJ
dpc-2082	2	86	words	word	NOUN
dpc-2082	2	87	:	:	PUNCT
dpc-2082	2	88	erythroderma	erythroderma	NOUN
dpc-2082	2	89	,	,	PUNCT
dpc-2082	2	90	fluorescent	fluorescent	ADJ
dpc-2082	2	91	antibody	antibody	NOUN
dpc-2082	2	92	technique	technique	NOUN
dpc-2082	2	93	,	,	PUNCT
dpc-2082	2	94	immunobullous	immunobullous	ADJ
dpc-2082	2	95	diseases	disease	NOUN
dpc-2082	2	96	,	,	PUNCT
dpc-2082	2	97	pathology	pathology	NOUN
dpc-2082	2	98	citation	citation	NOUN
dpc-2082	2	99	:	:	PUNCT
dpc-2082	2	100	bostan	bostan	PROPN
dpc-2082	2	101	e	e	NOUN
dpc-2082	2	102	,	,	PUNCT
dpc-2082	2	103	gokoz	gokoz	PROPN
dpc-2082	2	104	o	o	NOUN
dpc-2082	2	105	,	,	PUNCT
dpc-2082	2	106	dogan	dogan	PROPN
dpc-2082	2	107	s	s	PROPN
dpc-2082	2	108	,	,	PUNCT
dpc-2082	2	109	et	et	PROPN
dpc-2082	2	110	al	al	PROPN
dpc-2082	2	111	.	.	PUNCT
dpc-2082	3	1	diagnostic	diagnostic	ADJ
dpc-2082	3	2	role	role	NOUN
dpc-2082	3	3	of	of	ADP
dpc-2082	3	4	direct	direct	ADJ
dpc-2082	3	5	immunofluorescence	immunofluorescence	NOUN
dpc-2082	3	6	assay	assay	NOUN
dpc-2082	3	7	in	in	ADP
dpc-2082	3	8	determining	determine	VERB
dpc-2082	3	9	the	the	DET
dpc-2082	3	10	etiology	etiology	NOUN
dpc-2082	3	11	of	of	ADP
dpc-2082	3	12	erythroderma	erythroderma	NOUN
dpc-2082	3	13	:	:	PUNCT
dpc-2082	3	14	experience	experience	NOUN
dpc-2082	3	15	in	in	ADP
dpc-2082	3	16	a	a	DET
dpc-2082	3	17	tertiary	tertiary	ADJ
dpc-2082	3	18	referral	referral	NOUN
dpc-2082	3	19	hospital	hospital	NOUN
dpc-2082	3	20	.	.	PUNCT
dpc-2082	4	1	dermatol	dermatol	NOUN
dpc-2082	4	2	pract	pract	PROPN
dpc-2082	4	3	concept	concept	NOUN
dpc-2082	4	4	.	.	PUNCT
dpc-2082	5	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	5	2	.	.	PUNCT
dpc-2082	5	3	doi	doi	PROPN
dpc-2082	5	4	:	:	PUNCT
dpc-2082	5	5	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-2082	5	6	dpc.1204a160	dpc.1204a160	NOUN
dpc-2082	5	7	accepted	accept	VERB
dpc-2082	5	8	:	:	PUNCT
dpc-2082	5	9	january	january	PROPN
dpc-2082	5	10	14	14	NUM
dpc-2082	5	11	,	,	PUNCT
dpc-2082	5	12	2022	2022	NUM
dpc-2082	5	13	;	;	PUNCT
dpc-2082	5	14	published	publish	VERB
dpc-2082	5	15	:	:	PUNCT
dpc-2082	5	16	october	october	PROPN
dpc-2082	5	17	2022	2022	NUM
dpc-2082	6	1	copyright	copyright	NOUN
dpc-2082	6	2	:	:	PUNCT
dpc-2082	6	3	©	©	PROPN
dpc-2082	6	4	2022	2022	NUM
dpc-2082	6	5	bostan	bostan	PROPN
dpc-2082	6	6	et	et	PROPN
dpc-2082	6	7	al	al	PROPN
dpc-2082	6	8	.	.	PUNCT
dpc-2082	7	1	this	this	PRON
dpc-2082	7	2	is	be	AUX
dpc-2082	7	3	an	an	DET
dpc-2082	7	4	open	open	ADJ
dpc-2082	7	5	-	-	PUNCT
dpc-2082	7	6	access	access	NOUN
dpc-2082	7	7	article	article	NOUN
dpc-2082	7	8	distributed	distribute	VERB
dpc-2082	7	9	under	under	ADP
dpc-2082	7	10	the	the	DET
dpc-2082	7	11	terms	term	NOUN
dpc-2082	7	12	of	of	ADP
dpc-2082	7	13	the	the	DET
dpc-2082	7	14	creative	creative	ADJ
dpc-2082	7	15	commons	common	NOUN
dpc-2082	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2082	7	17	license	license	NOUN
dpc-2082	7	18	(	(	PUNCT
dpc-2082	7	19	by	by	ADP
dpc-2082	7	20	-	-	PUNCT
dpc-2082	7	21	nc-4.0	nc-4.0	NOUN
dpc-2082	7	22	)	)	PUNCT
dpc-2082	7	23	,	,	PUNCT
dpc-2082	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2082	7	25	,	,	PUNCT
dpc-2082	7	26	which	which	PRON
dpc-2082	7	27	permits	permit	VERB
dpc-2082	7	28	unrestricted	unrestricted	ADJ
dpc-2082	7	29	noncommercial	noncommercial	ADJ
dpc-2082	7	30	use	use	NOUN
dpc-2082	7	31	,	,	PUNCT
dpc-2082	7	32	distribution	distribution	NOUN
dpc-2082	7	33	,	,	PUNCT
dpc-2082	7	34	and	and	CCONJ
dpc-2082	7	35	reproduction	reproduction	NOUN
dpc-2082	7	36	in	in	ADP
dpc-2082	7	37	any	any	DET
dpc-2082	7	38	medium	medium	NOUN
dpc-2082	7	39	,	,	PUNCT
dpc-2082	7	40	provided	provide	VERB
dpc-2082	7	41	the	the	DET
dpc-2082	7	42	original	original	ADJ
dpc-2082	7	43	authors	author	NOUN
dpc-2082	7	44	and	and	CCONJ
dpc-2082	7	45	source	source	NOUN
dpc-2082	7	46	are	be	AUX
dpc-2082	7	47	credited	credit	VERB
dpc-2082	7	48	.	.	PUNCT
dpc-2082	8	1	funding	funding	NOUN
dpc-2082	8	2	:	:	PUNCT
dpc-2082	8	3	none	none	NOUN
dpc-2082	8	4	.	.	PUNCT
dpc-2082	9	1	competing	compete	VERB
dpc-2082	9	2	interests	interest	NOUN
dpc-2082	9	3	:	:	PUNCT
dpc-2082	9	4	none	none	NOUN
dpc-2082	9	5	.	.	PUNCT
dpc-2082	10	1	authorship	authorship	NOUN
dpc-2082	10	2	:	:	PUNCT
dpc-2082	10	3	all	all	DET
dpc-2082	10	4	authors	author	NOUN
dpc-2082	10	5	have	have	AUX
dpc-2082	10	6	contributed	contribute	VERB
dpc-2082	10	7	significantly	significantly	ADV
dpc-2082	10	8	to	to	ADP
dpc-2082	10	9	this	this	DET
dpc-2082	10	10	publication	publication	NOUN
dpc-2082	10	11	.	.	PUNCT
dpc-2082	11	1	corresponding	correspond	VERB
dpc-2082	11	2	author	author	NOUN
dpc-2082	11	3	:	:	PUNCT
dpc-2082	11	4	ecem	ecem	PROPN
dpc-2082	11	5	bostan	bostan	PROPN
dpc-2082	11	6	,	,	PUNCT
dpc-2082	11	7	md	md	PROPN
dpc-2082	11	8	,	,	PUNCT
dpc-2082	11	9	hacettepe	hacettepe	PROPN
dpc-2082	11	10	university	university	NOUN
dpc-2082	11	11	,	,	PUNCT
dpc-2082	11	12	faculty	faculty	NOUN
dpc-2082	11	13	of	of	ADP
dpc-2082	11	14	medicine	medicine	PROPN
dpc-2082	11	15	department	department	PROPN
dpc-2082	11	16	of	of	ADP
dpc-2082	11	17	dermatology	dermatology	NOUN
dpc-2082	11	18	and	and	CCONJ
dpc-2082	11	19	venereology	venereology	NOUN
dpc-2082	11	20	,	,	PUNCT
dpc-2082	11	21	ankara	ankara	PROPN
dpc-2082	11	22	,	,	PUNCT
dpc-2082	11	23	turkey	turkey	PROPN
dpc-2082	11	24	,	,	PUNCT
dpc-2082	11	25	phone:03123051704	phone:03123051704	NOUN
dpc-2082	11	26	,	,	PUNCT
dpc-2082	11	27	fax	fax	NOUN
dpc-2082	11	28	:	:	PUNCT
dpc-2082	11	29	0	0	NUM
dpc-2082	11	30	3123054127	3123054127	NUM
dpc-2082	11	31	,	,	PUNCT
dpc-2082	11	32	e	e	NOUN
dpc-2082	11	33	-	-	NOUN
dpc-2082	11	34	mail	mail	NOUN
dpc-2082	11	35	:	:	PUNCT
dpc-2082	11	36	bostanecem@gmail.com	bostanecem@gmail.com	X
dpc-2082	12	1	introduction	introduction	NOUN
dpc-2082	12	2	:	:	PUNCT
dpc-2082	12	3	erythroderma	erythroderma	NOUN
dpc-2082	12	4	is	be	AUX
dpc-2082	12	5	a	a	DET
dpc-2082	12	6	life	life	NOUN
dpc-2082	12	7	-	-	PUNCT
dpc-2082	12	8	threatening	threaten	VERB
dpc-2082	12	9	dermatologic	dermatologic	ADJ
dpc-2082	12	10	emergency	emergency	NOUN
dpc-2082	12	11	which	which	PRON
dpc-2082	12	12	is	be	AUX
dpc-2082	12	13	characterized	characterize	VERB
dpc-2082	12	14	by	by	ADP
dpc-2082	12	15	diffuse	diffuse	PROPN
dpc-2082	12	16	erythema	erythema	NOUN
dpc-2082	12	17	and	and	CCONJ
dpc-2082	12	18	exfoliation	exfoliation	NOUN
dpc-2082	12	19	affecting	affect	VERB
dpc-2082	12	20	more	more	ADJ
dpc-2082	12	21	than	than	ADP
dpc-2082	12	22	90	90	NUM
dpc-2082	12	23	%	%	NOUN
dpc-2082	12	24	of	of	ADP
dpc-2082	12	25	the	the	DET
dpc-2082	12	26	body	body	NOUN
dpc-2082	12	27	surface	surface	NOUN
dpc-2082	12	28	area	area	NOUN
dpc-2082	12	29	.	.	PUNCT
dpc-2082	13	1	most	most	ADJ
dpc-2082	13	2	common	common	ADJ
dpc-2082	13	3	cutaneous	cutaneous	ADJ
dpc-2082	13	4	diseases	disease	NOUN
dpc-2082	13	5	associated	associate	VERB
dpc-2082	13	6	with	with	ADP
dpc-2082	13	7	erythroderma	erythroderma	NOUN
dpc-2082	13	8	are	be	AUX
dpc-2082	13	9	systemic	systemic	ADJ
dpc-2082	13	10	contact	contact	NOUN
dpc-2082	13	11	dermatitis	dermatitis	NOUN
dpc-2082	13	12	,	,	PUNCT
dpc-2082	13	13	psoriasis	psoriasis	NOUN
dpc-2082	13	14	,	,	PUNCT
dpc-2082	13	15	drug	drug	NOUN
dpc-2082	13	16	eruption	eruption	NOUN
dpc-2082	13	17	and	and	CCONJ
dpc-2082	13	18	atopic	atopic	NOUN
dpc-2082	13	19	dermatitis	dermatitis	NOUN
dpc-2082	13	20	.	.	PUNCT
dpc-2082	14	1	clinical	clinical	ADJ
dpc-2082	14	2	-	-	PUNCT
dpc-2082	14	3	pathological	pathological	ADJ
dpc-2082	14	4	correlation	correlation	NOUN
dpc-2082	14	5	is	be	AUX
dpc-2082	14	6	used	use	VERB
dpc-2082	14	7	to	to	PART
dpc-2082	14	8	determine	determine	VERB
dpc-2082	14	9	the	the	DET
dpc-2082	14	10	underlying	underlie	VERB
dpc-2082	14	11	disease	disease	NOUN
dpc-2082	14	12	.	.	PUNCT
dpc-2082	15	1	in	in	ADP
dpc-2082	15	2	addition	addition	NOUN
dpc-2082	15	3	,	,	PUNCT
dpc-2082	15	4	direct	direct	ADJ
dpc-2082	15	5	immunofluorescence	immunofluorescence	NOUN
dpc-2082	15	6	(	(	PUNCT
dpc-2082	15	7	dif	dif	X
dpc-2082	15	8	)	)	PUNCT
dpc-2082	15	9	may	may	AUX
dpc-2082	15	10	provide	provide	VERB
dpc-2082	15	11	significant	significant	ADJ
dpc-2082	15	12	clues	clue	NOUN
dpc-2082	15	13	for	for	ADP
dpc-2082	15	14	etiology	etiology	NOUN
dpc-2082	15	15	of	of	ADP
dpc-2082	15	16	erythroderma	erythroderma	NOUN
dpc-2082	15	17	especially	especially	ADV
dpc-2082	15	18	in	in	ADP
dpc-2082	15	19	the	the	DET
dpc-2082	15	20	case	case	NOUN
dpc-2082	15	21	of	of	ADP
dpc-2082	15	22	autoimmune	autoimmune	ADJ
dpc-2082	15	23	bullous	bullous	ADJ
dpc-2082	15	24	skin	skin	NOUN
dpc-2082	15	25	diseases	disease	NOUN
dpc-2082	15	26	(	(	PUNCT
dpc-2082	15	27	absds	absds	NOUN
dpc-2082	15	28	)	)	PUNCT
dpc-2082	15	29	.	.	PUNCT
dpc-2082	16	1	objectives	objective	NOUN
dpc-2082	16	2	:	:	PUNCT
dpc-2082	16	3	in	in	ADP
dpc-2082	16	4	our	our	PRON
dpc-2082	16	5	study	study	NOUN
dpc-2082	16	6	,	,	PUNCT
dpc-2082	16	7	we	we	PRON
dpc-2082	16	8	aimed	aim	VERB
dpc-2082	16	9	to	to	PART
dpc-2082	16	10	analyze	analyze	VERB
dpc-2082	16	11	the	the	DET
dpc-2082	16	12	demographic	demographic	ADJ
dpc-2082	16	13	data	datum	NOUN
dpc-2082	16	14	,	,	PUNCT
dpc-2082	16	15	clinical	clinical	ADJ
dpc-2082	16	16	pre	pre	NOUN
dpc-2082	16	17	-	-	NOUN
dpc-2082	16	18	diagnoses	diagnosis	NOUN
dpc-2082	16	19	,	,	PUNCT
dpc-2082	16	20	final	final	ADJ
dpc-2082	16	21	diagnosis	diagnosis	NOUN
dpc-2082	16	22	,	,	PUNCT
dpc-2082	16	23	histopathological	histopathological	ADJ
dpc-2082	16	24	and	and	CCONJ
dpc-2082	16	25	dif	dif	ADV
dpc-2082	16	26	examination	examination	NOUN
dpc-2082	16	27	findings	finding	NOUN
dpc-2082	16	28	,	,	PUNCT
dpc-2082	16	29	accompanying	accompany	VERB
dpc-2082	16	30	systemic	systemic	ADJ
dpc-2082	16	31	signs	sign	NOUN
dpc-2082	16	32	and	and	CCONJ
dpc-2082	16	33	laboratory	laboratory	NOUN
dpc-2082	16	34	abnormalities	abnormality	NOUN
dpc-2082	16	35	of	of	ADP
dpc-2082	16	36	erythrodermic	erythrodermic	ADJ
dpc-2082	16	37	patients	patient	NOUN
dpc-2082	16	38	.	.	PUNCT
dpc-2082	17	1	methods	method	NOUN
dpc-2082	17	2	:	:	PUNCT
dpc-2082	17	3	we	we	PRON
dpc-2082	17	4	conducted	conduct	VERB
dpc-2082	17	5	a	a	DET
dpc-2082	17	6	retrospective	retrospective	ADJ
dpc-2082	17	7	study	study	NOUN
dpc-2082	17	8	of	of	ADP
dpc-2082	17	9	31	31	NUM
dpc-2082	17	10	erythroderma	erythroderma	NOUN
dpc-2082	17	11	patients	patient	NOUN
dpc-2082	17	12	in	in	ADP
dpc-2082	17	13	a	a	DET
dpc-2082	17	14	referral	referral	ADJ
dpc-2082	17	15	hospital	hospital	NOUN
dpc-2082	17	16	between	between	ADP
dpc-2082	17	17	2014	2014	NUM
dpc-2082	17	18	and	and	CCONJ
dpc-2082	17	19	2021	2021	NUM
dpc-2082	17	20	.	.	PUNCT
dpc-2082	18	1	cutaneous	cutaneous	ADJ
dpc-2082	18	2	biopsies	biopsy	NOUN
dpc-2082	18	3	were	be	AUX
dpc-2082	18	4	taken	take	VERB
dpc-2082	18	5	from	from	ADP
dpc-2082	18	6	all	all	DET
dpc-2082	18	7	patients	patient	NOUN
dpc-2082	18	8	for	for	ADP
dpc-2082	18	9	h&e	h&e	PROPN
dpc-2082	18	10	and	and	CCONJ
dpc-2082	18	11	dif	dif	ADV
dpc-2082	18	12	examination	examination	NOUN
dpc-2082	18	13	.	.	PUNCT
dpc-2082	19	1	results	result	NOUN
dpc-2082	19	2	:	:	PUNCT
dpc-2082	19	3	average	average	ADJ
dpc-2082	19	4	age	age	NOUN
dpc-2082	19	5	was	be	AUX
dpc-2082	19	6	54.6	54.6	NUM
dpc-2082	19	7	±	±	NUM
dpc-2082	19	8	23	23	NUM
dpc-2082	19	9	years	year	NOUN
dpc-2082	19	10	,	,	PUNCT
dpc-2082	19	11	48.4	48.4	NUM
dpc-2082	19	12	%	%	NOUN
dpc-2082	19	13	of	of	ADP
dpc-2082	19	14	the	the	DET
dpc-2082	19	15	patients	patient	NOUN
dpc-2082	19	16	were	be	AUX
dpc-2082	19	17	female	female	ADJ
dpc-2082	19	18	(	(	PUNCT
dpc-2082	19	19	n	n	NOUN
dpc-2082	19	20	=	=	NUM
dpc-2082	19	21	15	15	NUM
dpc-2082	19	22	)	)	PUNCT
dpc-2082	19	23	whereas	whereas	SCONJ
dpc-2082	19	24	51.6	51.6	NUM
dpc-2082	19	25	%	%	NOUN
dpc-2082	19	26	of	of	ADP
dpc-2082	19	27	the	the	DET
dpc-2082	19	28	patients	patient	NOUN
dpc-2082	19	29	were	be	AUX
dpc-2082	19	30	male	male	ADJ
dpc-2082	19	31	(	(	PUNCT
dpc-2082	19	32	n	n	NOUN
dpc-2082	19	33	=	=	SYM
dpc-2082	19	34	16	16	NUM
dpc-2082	19	35	)	)	PUNCT
dpc-2082	19	36	.	.	PUNCT
dpc-2082	20	1	average	average	ADJ
dpc-2082	20	2	time	time	NOUN
dpc-2082	20	3	between	between	ADP
dpc-2082	20	4	the	the	DET
dpc-2082	20	5	onset	onset	NOUN
dpc-2082	20	6	of	of	ADP
dpc-2082	20	7	rash	rash	NOUN
dpc-2082	20	8	and	and	CCONJ
dpc-2082	20	9	biopsy	biopsy	NOUN
dpc-2082	20	10	was	be	AUX
dpc-2082	20	11	18.8	18.8	NUM
dpc-2082	20	12	days	day	NOUN
dpc-2082	20	13	.	.	PUNCT
dpc-2082	21	1	dif	dif	PROPN
dpc-2082	21	2	analysis	analysis	NOUN
dpc-2082	21	3	showed	show	VERB
dpc-2082	21	4	immune	immune	ADJ
dpc-2082	21	5	deposits	deposit	NOUN
dpc-2082	21	6	in	in	ADP
dpc-2082	21	7	19.4	19.4	NUM
dpc-2082	21	8	%	%	NOUN
dpc-2082	21	9	(	(	PUNCT
dpc-2082	21	10	n	n	NOUN
dpc-2082	21	11	=	=	SYM
dpc-2082	21	12	6	6	NUM
dpc-2082	21	13	)	)	PUNCT
dpc-2082	21	14	of	of	ADP
dpc-2082	21	15	the	the	DET
dpc-2082	21	16	patients	patient	NOUN
dpc-2082	21	17	;	;	PUNCT
dpc-2082	21	18	whereas	whereas	SCONJ
dpc-2082	21	19	no	no	DET
dpc-2082	21	20	immune	immune	ADJ
dpc-2082	21	21	deposits	deposit	NOUN
dpc-2082	21	22	were	be	AUX
dpc-2082	21	23	detected	detect	VERB
dpc-2082	21	24	in	in	ADP
dpc-2082	21	25	80.6	80.6	NUM
dpc-2082	21	26	%	%	NOUN
dpc-2082	21	27	(	(	PUNCT
dpc-2082	21	28	n	n	NOUN
dpc-2082	21	29	=	=	SYM
dpc-2082	21	30	25	25	NUM
dpc-2082	21	31	)	)	PUNCT
dpc-2082	21	32	of	of	ADP
dpc-2082	21	33	the	the	DET
dpc-2082	21	34	patients	patient	NOUN
dpc-2082	21	35	.	.	PUNCT
dpc-2082	22	1	the	the	DET
dpc-2082	22	2	most	most	ADV
dpc-2082	22	3	frequent	frequent	ADJ
dpc-2082	22	4	final	final	ADJ
dpc-2082	22	5	diagnosis	diagnosis	NOUN
dpc-2082	22	6	was	be	AUX
dpc-2082	22	7	adverse	adverse	ADJ
dpc-2082	22	8	cutaneous	cutaneous	ADJ
dpc-2082	22	9	drug	drug	NOUN
dpc-2082	22	10	eruption	eruption	NOUN
dpc-2082	22	11	followed	follow	VERB
dpc-2082	22	12	by	by	ADP
dpc-2082	22	13	absds	absds	NOUN
dpc-2082	22	14	.	.	PUNCT
dpc-2082	23	1	conclusions	conclusion	NOUN
dpc-2082	23	2	:	:	PUNCT
dpc-2082	23	3	our	our	PRON
dpc-2082	23	4	findings	finding	NOUN
dpc-2082	23	5	suggest	suggest	VERB
dpc-2082	23	6	that	that	SCONJ
dpc-2082	23	7	dif	dif	ADV
dpc-2082	23	8	may	may	AUX
dpc-2082	23	9	be	be	AUX
dpc-2082	23	10	used	use	VERB
dpc-2082	23	11	in	in	ADP
dpc-2082	23	12	conjunction	conjunction	NOUN
dpc-2082	23	13	with	with	ADP
dpc-2082	23	14	clinical	clinical	ADJ
dpc-2082	23	15	-	-	PUNCT
dpc-2082	23	16	pathologic	pathologic	ADJ
dpc-2082	23	17	and	and	CCONJ
dpc-2082	23	18	clinical	clinical	ADJ
dpc-2082	23	19	findings	finding	NOUN
dpc-2082	23	20	to	to	PART
dpc-2082	23	21	reveal	reveal	VERB
dpc-2082	23	22	the	the	DET
dpc-2082	23	23	associated	associated	ADJ
dpc-2082	23	24	skin	skin	NOUN
dpc-2082	23	25	diseases	disease	NOUN
dpc-2082	23	26	in	in	ADP
dpc-2082	23	27	erythrodermic	erythrodermic	ADJ
dpc-2082	23	28	patients	patient	NOUN
dpc-2082	23	29	.	.	PUNCT
dpc-2082	24	1	erythrodermic	erythrodermic	ADJ
dpc-2082	24	2	patients	patient	NOUN
dpc-2082	24	3	presenting	present	VERB
dpc-2082	24	4	with	with	ADP
dpc-2082	24	5	clinical	clinical	ADJ
dpc-2082	24	6	findings	finding	NOUN
dpc-2082	24	7	of	of	ADP
dpc-2082	24	8	absd	absd	ADV
dpc-2082	24	9	should	should	AUX
dpc-2082	24	10	be	be	AUX
dpc-2082	24	11	considered	consider	VERB
dpc-2082	24	12	for	for	ADP
dpc-2082	24	13	dif	dif	ADJ
dpc-2082	24	14	examination	examination	NOUN
dpc-2082	24	15	.	.	PUNCT
dpc-2082	25	1	abstract	abstract	ADJ
dpc-2082	25	2	2	2	NUM
dpc-2082	25	3	original	original	ADJ
dpc-2082	25	4	article	article	NOUN
dpc-2082	25	5	|	|	ADV
dpc-2082	25	6	dermatol	dermatol	ADJ
dpc-2082	25	7	pract	pract	NOUN
dpc-2082	25	8	concept	concept	NOUN
dpc-2082	25	9	.	.	PUNCT
dpc-2082	26	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	26	2	introduction	introduction	NOUN
dpc-2082	26	3	erythroderma	erythroderma	NOUN
dpc-2082	26	4	(	(	PUNCT
dpc-2082	26	5	exfoliative	exfoliative	ADJ
dpc-2082	26	6	dermatitis	dermatitis	NOUN
dpc-2082	26	7	)	)	PUNCT
dpc-2082	26	8	is	be	AUX
dpc-2082	26	9	defined	define	VERB
dpc-2082	26	10	as	as	ADP
dpc-2082	26	11	widespread	widespread	ADJ
dpc-2082	26	12	erythema	erythema	NOUN
dpc-2082	26	13	and	and	CCONJ
dpc-2082	26	14	exfoliation	exfoliation	NOUN
dpc-2082	26	15	involving	involve	VERB
dpc-2082	26	16	more	more	ADJ
dpc-2082	26	17	than	than	ADP
dpc-2082	26	18	90	90	NUM
dpc-2082	26	19	%	%	NOUN
dpc-2082	26	20	of	of	ADP
dpc-2082	26	21	body	body	NOUN
dpc-2082	26	22	surface	surface	NOUN
dpc-2082	26	23	area	area	NOUN
dpc-2082	26	24	[	[	X
dpc-2082	26	25	1	1	NUM
dpc-2082	26	26	]	]	PUNCT
dpc-2082	26	27	.	.	PUNCT
dpc-2082	27	1	men	man	NOUN
dpc-2082	27	2	seem	seem	VERB
dpc-2082	27	3	to	to	PART
dpc-2082	27	4	be	be	AUX
dpc-2082	27	5	more	more	ADV
dpc-2082	27	6	affected	affected	ADJ
dpc-2082	27	7	compared	compare	VERB
dpc-2082	27	8	to	to	ADP
dpc-2082	27	9	women	woman	NOUN
dpc-2082	27	10	male	male	NOUN
dpc-2082	27	11	-	-	PUNCT
dpc-2082	27	12	to	to	ADP
dpc-2082	27	13	-	-	PUNCT
dpc-2082	27	14	female	female	ADJ
dpc-2082	27	15	ratio	ratio	NOUN
dpc-2082	27	16	ranging	range	VERB
dpc-2082	27	17	from	from	ADP
dpc-2082	27	18	1.5	1.5	NUM
dpc-2082	27	19	to	to	ADP
dpc-2082	27	20	2.8	2.8	NUM
dpc-2082	27	21	[	[	SYM
dpc-2082	27	22	1	1	NUM
dpc-2082	27	23	-	-	SYM
dpc-2082	27	24	3	3	NUM
dpc-2082	27	25	]	]	PUNCT
dpc-2082	27	26	.	.	PUNCT
dpc-2082	28	1	average	average	ADJ
dpc-2082	28	2	age	age	NOUN
dpc-2082	28	3	at	at	ADP
dpc-2082	28	4	the	the	DET
dpc-2082	28	5	onset	onset	NOUN
dpc-2082	28	6	differs	differ	VERB
dpc-2082	28	7	among	among	ADP
dpc-2082	28	8	various	various	ADJ
dpc-2082	28	9	studies	study	NOUN
dpc-2082	28	10	and	and	CCONJ
dpc-2082	28	11	reported	report	VERB
dpc-2082	28	12	to	to	PART
dpc-2082	28	13	be	be	AUX
dpc-2082	28	14	50.7	50.7	NUM
dpc-2082	28	15	and	and	CCONJ
dpc-2082	28	16	57	57	NUM
dpc-2082	28	17	years	year	NOUN
dpc-2082	28	18	in	in	ADP
dpc-2082	28	19	two	two	NUM
dpc-2082	28	20	recent	recent	ADJ
dpc-2082	28	21	reports	report	NOUN
dpc-2082	28	22	respectively.3,4	respectively.3,4	ADJ
dpc-2082	28	23	even	even	ADV
dpc-2082	28	24	though	though	SCONJ
dpc-2082	28	25	skin	skin	NOUN
dpc-2082	28	26	involvement	involvement	NOUN
dpc-2082	28	27	is	be	AUX
dpc-2082	28	28	the	the	DET
dpc-2082	28	29	predominant	predominant	ADJ
dpc-2082	28	30	clinical	clinical	ADJ
dpc-2082	28	31	picture	picture	NOUN
dpc-2082	28	32	of	of	ADP
dpc-2082	28	33	the	the	DET
dpc-2082	28	34	condition	condition	NOUN
dpc-2082	28	35	,	,	PUNCT
dpc-2082	28	36	lifethreatening	lifethreatene	VERB
dpc-2082	28	37	systemic	systemic	ADJ
dpc-2082	28	38	complications	complication	NOUN
dpc-2082	28	39	such	such	ADJ
dpc-2082	28	40	as	as	ADP
dpc-2082	28	41	tachycardia	tachycardia	NOUN
dpc-2082	28	42	,	,	PUNCT
dpc-2082	28	43	electrolyte	electrolyte	NOUN
dpc-2082	28	44	imbalance	imbalance	NOUN
dpc-2082	28	45	,	,	PUNCT
dpc-2082	28	46	edema	edema	NOUN
dpc-2082	28	47	and	and	CCONJ
dpc-2082	28	48	unstable	unstable	ADJ
dpc-2082	28	49	body	body	NOUN
dpc-2082	28	50	temperature	temperature	NOUN
dpc-2082	28	51	may	may	AUX
dpc-2082	28	52	accompany	accompany	VERB
dpc-2082	28	53	[	[	X
dpc-2082	28	54	3	3	NUM
dpc-2082	28	55	]	]	PUNCT
dpc-2082	28	56	.	.	PUNCT
dpc-2082	29	1	erythroderma	erythroderma	NOUN
dpc-2082	29	2	generally	generally	ADV
dpc-2082	29	3	arises	arise	VERB
dpc-2082	29	4	from	from	ADP
dpc-2082	29	5	the	the	DET
dpc-2082	29	6	exacerbation	exacerbation	NOUN
dpc-2082	29	7	and	and	CCONJ
dpc-2082	29	8	generalization	generalization	NOUN
dpc-2082	29	9	of	of	ADP
dpc-2082	29	10	a	a	DET
dpc-2082	29	11	pre	pre	ADJ
dpc-2082	29	12	-	-	ADJ
dpc-2082	29	13	existing	existing	ADJ
dpc-2082	29	14	skin	skin	NOUN
dpc-2082	29	15	diseases	disease	NOUN
dpc-2082	29	16	,	,	PUNCT
dpc-2082	29	17	even	even	ADV
dpc-2082	29	18	though	though	SCONJ
dpc-2082	29	19	new	new	ADJ
dpc-2082	29	20	-	-	PUNCT
dpc-2082	29	21	onset	onset	ADJ
dpc-2082	29	22	cutaneous	cutaneous	ADJ
dpc-2082	29	23	eruptions	eruption	NOUN
dpc-2082	29	24	such	such	ADJ
dpc-2082	29	25	as	as	ADP
dpc-2082	29	26	adverse	adverse	ADJ
dpc-2082	29	27	cutaneous	cutaneous	ADJ
dpc-2082	29	28	drug	drug	NOUN
dpc-2082	29	29	eruptions	eruption	NOUN
dpc-2082	29	30	(	(	PUNCT
dpc-2082	29	31	acde	acde	ADV
dpc-2082	29	32	)	)	PUNCT
dpc-2082	29	33	,	,	PUNCT
dpc-2082	29	34	psoriasis	psoriasis	NOUN
dpc-2082	29	35	,	,	PUNCT
dpc-2082	29	36	systemic	systemic	ADJ
dpc-2082	29	37	allergic	allergic	ADJ
dpc-2082	29	38	contact	contact	NOUN
dpc-2082	29	39	dermatitis	dermatitis	NOUN
dpc-2082	29	40	(	(	PUNCT
dpc-2082	29	41	sacd	sacd	NOUN
dpc-2082	29	42	)	)	PUNCT
dpc-2082	29	43	,	,	PUNCT
dpc-2082	29	44	autoimmune	autoimmune	ADJ
dpc-2082	29	45	bullous	bullous	ADJ
dpc-2082	29	46	skin	skin	NOUN
dpc-2082	29	47	diseases	disease	NOUN
dpc-2082	29	48	(	(	PUNCT
dpc-2082	29	49	absd	absd	ADV
dpc-2082	29	50	)	)	PUNCT
dpc-2082	29	51	such	such	ADJ
dpc-2082	29	52	as	as	ADP
dpc-2082	29	53	bullous	bullous	ADJ
dpc-2082	29	54	pemphigoid	pemphigoid	NOUN
dpc-2082	29	55	,	,	PUNCT
dpc-2082	29	56	pemphigus	pemphigus	PROPN
dpc-2082	29	57	foliaceus	foliaceus	PROPN
dpc-2082	29	58	may	may	AUX
dpc-2082	29	59	also	also	ADV
dpc-2082	29	60	be	be	AUX
dpc-2082	29	61	the	the	DET
dpc-2082	29	62	cause	cause	NOUN
dpc-2082	30	1	[	[	X
dpc-2082	30	2	3,4	3,4	NUM
dpc-2082	30	3	]	]	PUNCT
dpc-2082	30	4	.	.	PUNCT
dpc-2082	31	1	identification	identification	NOUN
dpc-2082	31	2	of	of	ADP
dpc-2082	31	3	the	the	DET
dpc-2082	31	4	associated	associate	VERB
dpc-2082	31	5	cutaneous	cutaneous	ADJ
dpc-2082	31	6	disease	disease	NOUN
dpc-2082	31	7	is	be	AUX
dpc-2082	31	8	not	not	PART
dpc-2082	31	9	always	always	ADV
dpc-2082	31	10	that	that	PRON
dpc-2082	31	11	easy	easy	ADJ
dpc-2082	31	12	and	and	CCONJ
dpc-2082	31	13	requires	require	VERB
dpc-2082	31	14	longitudinal	longitudinal	ADJ
dpc-2082	31	15	evaluation	evaluation	NOUN
dpc-2082	31	16	of	of	ADP
dpc-2082	31	17	the	the	DET
dpc-2082	31	18	patient	patient	NOUN
dpc-2082	31	19	to	to	PART
dpc-2082	31	20	reveal	reveal	VERB
dpc-2082	31	21	the	the	DET
dpc-2082	31	22	underlying	underlie	VERB
dpc-2082	31	23	cause	cause	NOUN
dpc-2082	31	24	and	and	CCONJ
dpc-2082	31	25	manage	manage	VERB
dpc-2082	31	26	the	the	DET
dpc-2082	31	27	complications	complication	NOUN
dpc-2082	31	28	.	.	PUNCT
dpc-2082	32	1	histopathological	histopathological	ADJ
dpc-2082	32	2	examination	examination	NOUN
dpc-2082	32	3	of	of	ADP
dpc-2082	32	4	the	the	DET
dpc-2082	32	5	lesional	lesional	ADJ
dpc-2082	32	6	skin	skin	NOUN
dpc-2082	32	7	provides	provide	VERB
dpc-2082	32	8	significant	significant	ADJ
dpc-2082	32	9	clues	clue	NOUN
dpc-2082	32	10	related	relate	VERB
dpc-2082	32	11	to	to	ADP
dpc-2082	32	12	the	the	DET
dpc-2082	32	13	etiology	etiology	NOUN
dpc-2082	32	14	and	and	CCONJ
dpc-2082	32	15	thus	thus	ADV
dpc-2082	32	16	may	may	AUX
dpc-2082	32	17	be	be	AUX
dpc-2082	32	18	the	the	DET
dpc-2082	32	19	most	most	ADV
dpc-2082	32	20	fundamental	fundamental	ADJ
dpc-2082	32	21	evaluation	evaluation	NOUN
dpc-2082	32	22	to	to	PART
dpc-2082	32	23	enlighten	enlighten	VERB
dpc-2082	32	24	the	the	DET
dpc-2082	32	25	pathogenesis	pathogenesis	NOUN
dpc-2082	32	26	of	of	ADP
dpc-2082	32	27	erythroderma	erythroderma	NOUN
dpc-2082	32	28	[	[	X
dpc-2082	32	29	5	5	NUM
dpc-2082	32	30	]	]	PUNCT
dpc-2082	32	31	.	.	PUNCT
dpc-2082	33	1	direct	direct	ADJ
dpc-2082	33	2	immunofluorescence	immunofluorescence	NOUN
dpc-2082	33	3	(	(	PUNCT
dpc-2082	33	4	dif	dif	ADV
dpc-2082	33	5	)	)	PUNCT
dpc-2082	33	6	,	,	PUNCT
dpc-2082	33	7	on	on	ADP
dpc-2082	33	8	the	the	DET
dpc-2082	33	9	other	other	ADJ
dpc-2082	33	10	hand	hand	NOUN
dpc-2082	33	11	,	,	PUNCT
dpc-2082	33	12	might	might	AUX
dpc-2082	33	13	prove	prove	VERB
dpc-2082	33	14	to	to	PART
dpc-2082	33	15	be	be	AUX
dpc-2082	33	16	quite	quite	ADV
dpc-2082	33	17	useful	useful	ADJ
dpc-2082	33	18	in	in	ADP
dpc-2082	33	19	cases	case	NOUN
dpc-2082	33	20	of	of	ADP
dpc-2082	33	21	absd	absd	ADJ
dpc-2082	33	22	and	and	CCONJ
dpc-2082	33	23	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	33	24	vasculitis	vasculitis	PROPN
dpc-2082	33	25	as	as	ADP
dpc-2082	33	26	the	the	DET
dpc-2082	33	27	suspected	suspect	VERB
dpc-2082	33	28	causes	cause	NOUN
dpc-2082	33	29	of	of	ADP
dpc-2082	33	30	exfoliative	exfoliative	ADJ
dpc-2082	33	31	dermatitis	dermatitis	NOUN
dpc-2082	33	32	by	by	ADP
dpc-2082	33	33	revealing	reveal	VERB
dpc-2082	33	34	the	the	DET
dpc-2082	33	35	specific	specific	ADJ
dpc-2082	33	36	immune	immune	ADJ
dpc-2082	33	37	deposition	deposition	NOUN
dpc-2082	33	38	pattern	pattern	NOUN
dpc-2082	33	39	in	in	ADP
dpc-2082	33	40	the	the	DET
dpc-2082	33	41	biopsies	biopsy	NOUN
dpc-2082	33	42	taken	take	VERB
dpc-2082	33	43	from	from	ADP
dpc-2082	33	44	the	the	DET
dpc-2082	33	45	perilesional	perilesional	ADJ
dpc-2082	33	46	and	and	CCONJ
dpc-2082	33	47	lesional	lesional	ADJ
dpc-2082	33	48	skin	skin	NOUN
dpc-2082	33	49	respectively	respectively	ADV
dpc-2082	33	50	[	[	X
dpc-2082	33	51	5,6	5,6	NUM
dpc-2082	33	52	]	]	PUNCT
dpc-2082	33	53	.	.	PUNCT
dpc-2082	34	1	in	in	ADP
dpc-2082	34	2	our	our	PRON
dpc-2082	34	3	study	study	NOUN
dpc-2082	34	4	,	,	PUNCT
dpc-2082	34	5	we	we	PRON
dpc-2082	34	6	aimed	aim	VERB
dpc-2082	34	7	to	to	PART
dpc-2082	34	8	determine	determine	VERB
dpc-2082	34	9	the	the	DET
dpc-2082	34	10	diagnostic	diagnostic	ADJ
dpc-2082	34	11	role	role	NOUN
dpc-2082	34	12	of	of	ADP
dpc-2082	34	13	dif	dif	ADV
dpc-2082	34	14	in	in	ADP
dpc-2082	34	15	identifying	identify	VERB
dpc-2082	34	16	the	the	DET
dpc-2082	34	17	etiology	etiology	NOUN
dpc-2082	34	18	of	of	ADP
dpc-2082	34	19	erythroderma	erythroderma	NOUN
dpc-2082	34	20	and	and	CCONJ
dpc-2082	34	21	show	show	VERB
dpc-2082	34	22	the	the	DET
dpc-2082	34	23	relationship	relationship	NOUN
dpc-2082	34	24	between	between	ADP
dpc-2082	34	25	the	the	DET
dpc-2082	34	26	presence	presence	NOUN
dpc-2082	34	27	of	of	ADP
dpc-2082	34	28	immune	immune	ADJ
dpc-2082	34	29	deposits	deposit	NOUN
dpc-2082	34	30	and	and	CCONJ
dpc-2082	34	31	underlying	underlie	VERB
dpc-2082	34	32	diseases	disease	NOUN
dpc-2082	34	33	of	of	ADP
dpc-2082	34	34	exfoliative	exfoliative	ADJ
dpc-2082	34	35	dermatitis	dermatitis	NOUN
dpc-2082	34	36	.	.	PUNCT
dpc-2082	35	1	methods	method	NOUN
dpc-2082	35	2	the	the	DET
dpc-2082	35	3	present	present	ADJ
dpc-2082	35	4	study	study	NOUN
dpc-2082	35	5	was	be	AUX
dpc-2082	35	6	a	a	DET
dpc-2082	35	7	retrospective	retrospective	ADJ
dpc-2082	35	8	study	study	NOUN
dpc-2082	35	9	conducted	conduct	VERB
dpc-2082	35	10	by	by	ADP
dpc-2082	35	11	review	review	NOUN
dpc-2082	35	12	of	of	ADP
dpc-2082	35	13	electronic	electronic	ADJ
dpc-2082	35	14	medical	medical	ADJ
dpc-2082	35	15	data	datum	NOUN
dpc-2082	35	16	records	record	NOUN
dpc-2082	35	17	and	and	CCONJ
dpc-2082	35	18	histopathologic	histopathologic	ADJ
dpc-2082	35	19	slide	slide	NOUN
dpc-2082	35	20	images	image	NOUN
dpc-2082	35	21	belonging	belong	VERB
dpc-2082	35	22	to	to	ADP
dpc-2082	35	23	31	31	NUM
dpc-2082	35	24	patients	patient	NOUN
dpc-2082	35	25	in	in	ADP
dpc-2082	35	26	a	a	DET
dpc-2082	35	27	tertiary	tertiary	ADJ
dpc-2082	35	28	referral	referral	NOUN
dpc-2082	35	29	hospital	hospital	NOUN
dpc-2082	35	30	between	between	ADP
dpc-2082	35	31	january	january	PROPN
dpc-2082	35	32	2014	2014	NUM
dpc-2082	35	33	and	and	CCONJ
dpc-2082	35	34	september	september	PROPN
dpc-2082	35	35	2020	2020	NUM
dpc-2082	35	36	.	.	PUNCT
dpc-2082	36	1	ethics	ethic	NOUN
dpc-2082	36	2	committee	committee	PROPN
dpc-2082	36	3	approval	approval	NOUN
dpc-2082	36	4	was	be	AUX
dpc-2082	36	5	obtained	obtain	VERB
dpc-2082	36	6	(	(	PUNCT
dpc-2082	36	7	project	project	NOUN
dpc-2082	36	8	number	number	NOUN
dpc-2082	36	9	:	:	PUNCT
dpc-2082	36	10	go	go	VERB
dpc-2082	36	11	20/1099	20/1099	NUM
dpc-2082	36	12	,	,	PUNCT
dpc-2082	36	13	decision	decision	NOUN
dpc-2082	36	14	number	number	NOUN
dpc-2082	36	15	:	:	PUNCT
dpc-2082	36	16	2020/19	2020/19	NUM
dpc-2082	36	17	-	-	SYM
dpc-2082	36	18	45	45	NUM
dpc-2082	36	19	,	,	PUNCT
dpc-2082	36	20	decision	decision	NOUN
dpc-2082	36	21	date	date	NOUN
dpc-2082	36	22	:	:	PUNCT
dpc-2082	36	23	november	november	PROPN
dpc-2082	36	24	17	17	NUM
dpc-2082	36	25	,	,	PUNCT
dpc-2082	36	26	2020	2020	NUM
dpc-2082	36	27	)	)	PUNCT
dpc-2082	36	28	and	and	CCONJ
dpc-2082	36	29	informed	inform	VERB
dpc-2082	36	30	consent	consent	NOUN
dpc-2082	36	31	was	be	AUX
dpc-2082	36	32	taken	take	VERB
dpc-2082	36	33	from	from	ADP
dpc-2082	36	34	the	the	DET
dpc-2082	36	35	participants	participant	NOUN
dpc-2082	36	36	for	for	ADP
dpc-2082	36	37	the	the	DET
dpc-2082	36	38	study	study	NOUN
dpc-2082	36	39	.	.	PUNCT
dpc-2082	37	1	all	all	DET
dpc-2082	37	2	the	the	DET
dpc-2082	37	3	patients	patient	NOUN
dpc-2082	37	4	were	be	AUX
dpc-2082	37	5	diagnosed	diagnose	VERB
dpc-2082	37	6	as	as	ADP
dpc-2082	37	7	erythroderma	erythroderma	NOUN
dpc-2082	37	8	and	and	CCONJ
dpc-2082	37	9	cutaneous	cutaneous	ADJ
dpc-2082	37	10	biopsies	biopsy	NOUN
dpc-2082	37	11	were	be	AUX
dpc-2082	37	12	taken	take	VERB
dpc-2082	37	13	for	for	ADP
dpc-2082	37	14	histopathological	histopathological	ADJ
dpc-2082	37	15	examination	examination	NOUN
dpc-2082	37	16	and	and	CCONJ
dpc-2082	37	17	dif	dif	ADV
dpc-2082	37	18	analysis	analysis	NOUN
dpc-2082	37	19	.	.	PUNCT
dpc-2082	38	1	patients	patient	NOUN
dpc-2082	38	2	without	without	ADP
dpc-2082	38	3	histopathological	histopathological	ADJ
dpc-2082	38	4	and	and	CCONJ
dpc-2082	38	5	dif	dif	ADV
dpc-2082	38	6	examination	examination	NOUN
dpc-2082	38	7	were	be	AUX
dpc-2082	38	8	excluded	exclude	VERB
dpc-2082	38	9	from	from	ADP
dpc-2082	38	10	the	the	DET
dpc-2082	38	11	study	study	NOUN
dpc-2082	38	12	.	.	PUNCT
dpc-2082	39	1	for	for	ADP
dpc-2082	39	2	dif	dif	ADV
dpc-2082	39	3	assay	assay	NOUN
dpc-2082	39	4	,	,	PUNCT
dpc-2082	39	5	skin	skin	NOUN
dpc-2082	39	6	tissue	tissue	NOUN
dpc-2082	39	7	samples	sample	NOUN
dpc-2082	39	8	were	be	AUX
dpc-2082	39	9	frozen	freeze	VERB
dpc-2082	39	10	in	in	ADP
dpc-2082	39	11	a	a	DET
dpc-2082	39	12	cryostat	cryostat	NOUN
dpc-2082	39	13	and	and	CCONJ
dpc-2082	39	14	then	then	ADV
dpc-2082	39	15	sectioned	section	VERB
dpc-2082	39	16	with	with	ADP
dpc-2082	39	17	a	a	DET
dpc-2082	39	18	thickness	thickness	NOUN
dpc-2082	39	19	of	of	ADP
dpc-2082	39	20	5	5	NUM
dpc-2082	39	21	µm	µm	NOUN
dpc-2082	39	22	.	.	PUNCT
dpc-2082	40	1	then	then	ADV
dpc-2082	40	2	,	,	PUNCT
dpc-2082	40	3	fluorescein	fluorescein	NOUN
dpc-2082	40	4	-	-	PUNCT
dpc-2082	40	5	labeled	label	VERB
dpc-2082	40	6	antisera	antisera	NOUN
dpc-2082	40	7	against	against	ADP
dpc-2082	40	8	human	human	ADJ
dpc-2082	40	9	igm	igm	PROPN
dpc-2082	40	10	(	(	PUNCT
dpc-2082	40	11	dako	dako	PROPN
dpc-2082	40	12	,	,	PUNCT
dpc-2082	40	13	dilution	dilution	NOUN
dpc-2082	40	14	ratio	ratio	NOUN
dpc-2082	40	15	:	:	PUNCT
dpc-2082	40	16	1/20	1/20	NUM
dpc-2082	40	17	-	-	PUNCT
dpc-2082	40	18	1/40	1/40	NUM
dpc-2082	40	19	)	)	PUNCT
dpc-2082	40	20	,	,	PUNCT
dpc-2082	40	21	igg	igg	PROPN
dpc-2082	40	22	(	(	PUNCT
dpc-2082	40	23	bio	bio	PROPN
dpc-2082	40	24	sb	sb	PROPN
dpc-2082	40	25	,	,	PUNCT
dpc-2082	40	26	dilution	dilution	NOUN
dpc-2082	40	27	ratio	ratio	NOUN
dpc-2082	40	28	:	:	PUNCT
dpc-2082	40	29	1/25	1/25	NUM
dpc-2082	40	30	-	-	PUNCT
dpc-2082	40	31	1/100	1/100	NUM
dpc-2082	40	32	]	]	PUNCT
dpc-2082	40	33	,	,	PUNCT
dpc-2082	40	34	iga	iga	PROPN
dpc-2082	40	35	(	(	PUNCT
dpc-2082	40	36	dako	dako	PROPN
dpc-2082	40	37	,	,	PUNCT
dpc-2082	40	38	dilution	dilution	NOUN
dpc-2082	40	39	ratio	ratio	NOUN
dpc-2082	40	40	:	:	PUNCT
dpc-2082	40	41	1/20	1/20	NUM
dpc-2082	40	42	-	-	PUNCT
dpc-2082	40	43	1/40	1/40	NUM
dpc-2082	40	44	)	)	PUNCT
dpc-2082	40	45	and	and	CCONJ
dpc-2082	40	46	c3	c3	PROPN
dpc-2082	40	47	(	(	PUNCT
dpc-2082	40	48	diagnostic	diagnostic	PROPN
dpc-2082	40	49	biosystems	biosystems	PROPN
dpc-2082	40	50	inc	inc	PROPN
dpc-2082	40	51	.	.	PROPN
dpc-2082	40	52	,	,	PUNCT
dpc-2082	40	53	dilution	dilution	NOUN
dpc-2082	40	54	ratio	ratio	NOUN
dpc-2082	40	55	:	:	PUNCT
dpc-2082	40	56	1/75	1/75	NUM
dpc-2082	40	57	-	-	PUNCT
dpc-2082	40	58	1/100	1/100	NUM
dpc-2082	40	59	)	)	PUNCT
dpc-2082	40	60	were	be	AUX
dpc-2082	40	61	applied	apply	VERB
dpc-2082	40	62	to	to	ADP
dpc-2082	40	63	sections	section	NOUN
dpc-2082	40	64	and	and	CCONJ
dpc-2082	40	65	incubated	incubate	VERB
dpc-2082	40	66	.	.	PUNCT
dpc-2082	41	1	presence	presence	NOUN
dpc-2082	41	2	of	of	ADP
dpc-2082	41	3	any	any	DET
dpc-2082	41	4	positive	positive	ADJ
dpc-2082	41	5	immunofluorescence	immunofluorescence	NOUN
dpc-2082	41	6	staining	stain	VERB
dpc-2082	41	7	with	with	ADP
dpc-2082	41	8	igm	igm	PROPN
dpc-2082	41	9	,	,	PUNCT
dpc-2082	41	10	igg	igg	PROPN
dpc-2082	41	11	,	,	PUNCT
dpc-2082	41	12	iga	iga	PROPN
dpc-2082	41	13	and	and	CCONJ
dpc-2082	41	14	c3	c3	PROPN
dpc-2082	41	15	antisera	antisera	PROPN
dpc-2082	41	16	was	be	AUX
dpc-2082	41	17	evaluated	evaluate	VERB
dpc-2082	41	18	under	under	ADP
dpc-2082	41	19	immunofluorescence	immunofluorescence	NOUN
dpc-2082	41	20	microscopy	microscopy	NOUN
dpc-2082	41	21	.	.	PUNCT
dpc-2082	42	1	sex	sex	NOUN
dpc-2082	42	2	,	,	PUNCT
dpc-2082	42	3	age	age	NOUN
dpc-2082	42	4	,	,	PUNCT
dpc-2082	42	5	dermatologic	dermatologic	ADJ
dpc-2082	42	6	examination	examination	NOUN
dpc-2082	42	7	findings	finding	NOUN
dpc-2082	42	8	,	,	PUNCT
dpc-2082	42	9	accompanying	accompany	VERB
dpc-2082	42	10	systemic	systemic	ADJ
dpc-2082	42	11	symptoms	symptom	NOUN
dpc-2082	42	12	,	,	PUNCT
dpc-2082	42	13	clinical	clinical	ADJ
dpc-2082	42	14	prediagnoses	prediagnose	NOUN
dpc-2082	42	15	,	,	PUNCT
dpc-2082	42	16	laboratory	laboratory	NOUN
dpc-2082	42	17	findings	finding	NOUN
dpc-2082	42	18	,	,	PUNCT
dpc-2082	42	19	elapsed	elapse	VERB
dpc-2082	42	20	time	time	NOUN
dpc-2082	42	21	between	between	ADP
dpc-2082	42	22	the	the	DET
dpc-2082	42	23	onset	onset	NOUN
dpc-2082	42	24	of	of	ADP
dpc-2082	42	25	the	the	DET
dpc-2082	42	26	rash	rash	ADJ
dpc-2082	42	27	and	and	CCONJ
dpc-2082	42	28	biopsy	biopsy	NOUN
dpc-2082	42	29	procedure	procedure	NOUN
dpc-2082	42	30	,	,	PUNCT
dpc-2082	42	31	histopathologic	histopathologic	NOUN
dpc-2082	42	32	findings	finding	NOUN
dpc-2082	42	33	,	,	PUNCT
dpc-2082	42	34	presence	presence	NOUN
dpc-2082	42	35	of	of	ADP
dpc-2082	42	36	immune	immune	ADJ
dpc-2082	42	37	deposits	deposit	NOUN
dpc-2082	42	38	in	in	ADP
dpc-2082	42	39	dif	dif	ADJ
dpc-2082	42	40	analysis	analysis	NOUN
dpc-2082	42	41	,	,	PUNCT
dpc-2082	42	42	final	final	ADJ
dpc-2082	42	43	diagnosis	diagnosis	NOUN
dpc-2082	42	44	,	,	PUNCT
dpc-2082	42	45	treatment	treatment	NOUN
dpc-2082	42	46	given	give	VERB
dpc-2082	42	47	and	and	CCONJ
dpc-2082	42	48	were	be	AUX
dpc-2082	42	49	evaluated	evaluate	VERB
dpc-2082	42	50	and	and	CCONJ
dpc-2082	42	51	recorded	record	VERB
dpc-2082	42	52	.	.	PUNCT
dpc-2082	43	1	the	the	DET
dpc-2082	43	2	underlying	underlie	VERB
dpc-2082	43	3	etiologies	etiology	NOUN
dpc-2082	43	4	of	of	ADP
dpc-2082	43	5	erythroderma	erythroderma	NOUN
dpc-2082	43	6	were	be	AUX
dpc-2082	43	7	divided	divide	VERB
dpc-2082	43	8	into	into	ADP
dpc-2082	43	9	4	4	NUM
dpc-2082	43	10	categories	category	NOUN
dpc-2082	43	11	as	as	SCONJ
dpc-2082	43	12	follows	follow	VERB
dpc-2082	43	13	:	:	PUNCT
dpc-2082	43	14	‘	'	PUNCT
dpc-2082	43	15	category	category	NOUN
dpc-2082	43	16	1	1	NUM
dpc-2082	43	17	(	(	PUNCT
dpc-2082	43	18	absd	absd	ADV
dpc-2082	43	19	)	)	PUNCT
dpc-2082	43	20	’	'	PUNCT
dpc-2082	43	21	,	,	PUNCT
dpc-2082	43	22	‘	'	PUNCT
dpc-2082	43	23	category	category	NOUN
dpc-2082	43	24	2	2	NUM
dpc-2082	43	25	(	(	PUNCT
dpc-2082	43	26	acde	acde	PROPN
dpc-2082	43	27	)	)	PUNCT
dpc-2082	43	28	’	'	PUNCT
dpc-2082	43	29	,	,	PUNCT
dpc-2082	43	30	‘	'	PUNCT
dpc-2082	43	31	category	category	NOUN
dpc-2082	43	32	3	3	NUM
dpc-2082	43	33	(	(	PUNCT
dpc-2082	43	34	vascular	vascular	ADJ
dpc-2082	43	35	skin	skin	NOUN
dpc-2082	43	36	diseases	disease	NOUN
dpc-2082	43	37	)	)	PUNCT
dpc-2082	43	38	’	'	PUNCT
dpc-2082	43	39	and	and	CCONJ
dpc-2082	43	40	‘	'	PUNCT
dpc-2082	43	41	category	category	NOUN
dpc-2082	43	42	4	4	NUM
dpc-2082	43	43	(	(	PUNCT
dpc-2082	43	44	miscellaneous	miscellaneous	ADJ
dpc-2082	43	45	other	other	ADJ
dpc-2082	43	46	skin	skin	NOUN
dpc-2082	43	47	diseases	disease	NOUN
dpc-2082	43	48	)	)	PUNCT
dpc-2082	43	49	(	(	PUNCT
dpc-2082	43	50	table	table	NOUN
dpc-2082	43	51	1	1	NUM
dpc-2082	43	52	)	)	PUNCT
dpc-2082	43	53	.	.	PUNCT
dpc-2082	44	1	for	for	ADP
dpc-2082	44	2	cases	case	NOUN
dpc-2082	44	3	with	with	ADP
dpc-2082	44	4	a	a	DET
dpc-2082	44	5	final	final	ADJ
dpc-2082	44	6	diagnosis	diagnosis	NOUN
dpc-2082	44	7	of	of	ADP
dpc-2082	44	8	acde	acde	NOUN
dpc-2082	44	9	including	include	VERB
dpc-2082	44	10	drug	drug	NOUN
dpc-2082	44	11	rash	rash	NOUN
dpc-2082	44	12	with	with	ADP
dpc-2082	44	13	eosinophilia	eosinophilia	PROPN
dpc-2082	44	14	and	and	CCONJ
dpc-2082	44	15	systemic	systemic	ADJ
dpc-2082	44	16	symptoms	symptom	NOUN
dpc-2082	44	17	(	(	PUNCT
dpc-2082	44	18	dress	dress	NOUN
dpc-2082	44	19	)	)	PUNCT
dpc-2082	44	20	syndrome	syndrome	NOUN
dpc-2082	44	21	,	,	PUNCT
dpc-2082	44	22	maculopapular	maculopapular	ADJ
dpc-2082	44	23	drug	drug	NOUN
dpc-2082	44	24	eruption	eruption	NOUN
dpc-2082	44	25	(	(	PUNCT
dpc-2082	44	26	mde	mde	PROPN
dpc-2082	44	27	)	)	PUNCT
dpc-2082	44	28	,	,	PUNCT
dpc-2082	44	29	stevens	stevens	PROPN
dpc-2082	44	30	-	-	PUNCT
dpc-2082	44	31	johnson	johnson	PROPN
dpc-2082	44	32	syndrome	syndrome	PROPN
dpc-2082	44	33	/	/	SYM
dpc-2082	44	34	toxic	toxic	ADJ
dpc-2082	44	35	epidermal	epidermal	ADJ
dpc-2082	44	36	necrolysis	necrolysis	NOUN
dpc-2082	44	37	spectrum	spectrum	NOUN
dpc-2082	44	38	(	(	PUNCT
dpc-2082	44	39	sjs	sjs	PROPN
dpc-2082	44	40	-	-	PUNCT
dpc-2082	44	41	ten	ten	NUM
dpc-2082	44	42	)	)	PUNCT
dpc-2082	44	43	and	and	CCONJ
dpc-2082	44	44	vasculitic	vasculitic	ADJ
dpc-2082	44	45	drug	drug	NOUN
dpc-2082	44	46	eruption	eruption	NOUN
dpc-2082	44	47	,	,	PUNCT
dpc-2082	44	48	the	the	DET
dpc-2082	44	49	most	most	ADV
dpc-2082	44	50	probable	probable	ADJ
dpc-2082	44	51	inciting	incite	VERB
dpc-2082	44	52	drug	drug	NOUN
dpc-2082	44	53	/	/	SYM
dpc-2082	44	54	drugs	drug	NOUN
dpc-2082	44	55	were	be	AUX
dpc-2082	44	56	determined	determine	VERB
dpc-2082	44	57	and	and	CCONJ
dpc-2082	44	58	time	time	NOUN
dpc-2082	44	59	between	between	ADP
dpc-2082	44	60	the	the	DET
dpc-2082	44	61	onset	onset	NOUN
dpc-2082	44	62	of	of	ADP
dpc-2082	44	63	the	the	DET
dpc-2082	44	64	erythroderma	erythroderma	NOUN
dpc-2082	44	65	and	and	CCONJ
dpc-2082	44	66	first	first	ADJ
dpc-2082	44	67	drug	drug	NOUN
dpc-2082	44	68	intake	intake	NOUN
dpc-2082	44	69	was	be	AUX
dpc-2082	44	70	also	also	ADV
dpc-2082	44	71	evaluated	evaluate	VERB
dpc-2082	44	72	.	.	PUNCT
dpc-2082	45	1	statistics	statistic	NOUN
dpc-2082	45	2	statistical	statistical	ADJ
dpc-2082	45	3	analyses	analysis	NOUN
dpc-2082	45	4	were	be	AUX
dpc-2082	45	5	performed	perform	VERB
dpc-2082	45	6	with	with	ADP
dpc-2082	45	7	the	the	DET
dpc-2082	45	8	ibm	ibm	PROPN
dpc-2082	45	9	spss	spss	NOUN
dpc-2082	45	10	for	for	ADP
dpc-2082	45	11	windows	window	NOUN
dpc-2082	45	12	version	version	PROPN
dpc-2082	45	13	22.0	22.0	NUM
dpc-2082	45	14	and	and	CCONJ
dpc-2082	45	15	ms	ms	PROPN
dpc-2082	45	16	excel	excel	NOUN
dpc-2082	45	17	.	.	PUNCT
dpc-2082	46	1	categorical	categorical	ADJ
dpc-2082	46	2	variables	variable	NOUN
dpc-2082	46	3	were	be	AUX
dpc-2082	46	4	given	give	VERB
dpc-2082	46	5	as	as	ADP
dpc-2082	46	6	frequencies	frequency	NOUN
dpc-2082	46	7	and	and	CCONJ
dpc-2082	46	8	percentages	percentage	NOUN
dpc-2082	46	9	.	.	PUNCT
dpc-2082	47	1	numerical	numerical	ADJ
dpc-2082	47	2	variables	variable	NOUN
dpc-2082	47	3	were	be	AUX
dpc-2082	47	4	summarized	summarize	VERB
dpc-2082	47	5	as	as	ADP
dpc-2082	47	6	mean	mean	NOUN
dpc-2082	47	7	±	±	NUM
dpc-2082	47	8	standard	standard	ADJ
dpc-2082	47	9	deviation	deviation	NOUN
dpc-2082	47	10	or	or	CCONJ
dpc-2082	47	11	median	median	ADJ
dpc-2082	47	12	(	(	PUNCT
dpc-2082	47	13	minimum	minimum	ADJ
dpc-2082	47	14	-	-	PUNCT
dpc-2082	47	15	maximum	maximum	NOUN
dpc-2082	47	16	)	)	PUNCT
dpc-2082	47	17	.	.	PUNCT
dpc-2082	48	1	results	result	VERB
dpc-2082	48	2	demographical	demographical	ADJ
dpc-2082	48	3	,	,	PUNCT
dpc-2082	48	4	clinical	clinical	ADJ
dpc-2082	48	5	,	,	PUNCT
dpc-2082	48	6	pathological	pathological	ADJ
dpc-2082	48	7	characteristics	characteristic	NOUN
dpc-2082	48	8	;	;	PUNCT
dpc-2082	48	9	pre	pre	NOUN
dpc-2082	48	10	-	-	NOUN
dpc-2082	48	11	diagnoses	diagnosis	NOUN
dpc-2082	48	12	and	and	CCONJ
dpc-2082	48	13	final	final	ADJ
dpc-2082	48	14	diagnoses	diagnosis	NOUN
dpc-2082	48	15	of	of	ADP
dpc-2082	48	16	the	the	DET
dpc-2082	48	17	all	all	DET
dpc-2082	48	18	study	study	NOUN
dpc-2082	48	19	subjects	subject	NOUN
dpc-2082	48	20	along	along	ADP
dpc-2082	48	21	with	with	ADP
dpc-2082	48	22	dif	dif	X
dpc-2082	48	23	findings	finding	NOUN
dpc-2082	48	24	and	and	CCONJ
dpc-2082	48	25	laboratory	laboratory	NOUN
dpc-2082	48	26	abnormalities	abnormality	NOUN
dpc-2082	48	27	are	be	AUX
dpc-2082	48	28	shown	show	VERB
dpc-2082	48	29	in	in	ADP
dpc-2082	48	30	supplementary	supplementary	ADJ
dpc-2082	48	31	file	file	NOUN
dpc-2082	48	32	1	1	NUM
dpc-2082	48	33	.	.	PUNCT
dpc-2082	49	1	the	the	DET
dpc-2082	49	2	average	average	ADJ
dpc-2082	49	3	age	age	NOUN
dpc-2082	49	4	of	of	ADP
dpc-2082	49	5	the	the	DET
dpc-2082	49	6	subjects	subject	NOUN
dpc-2082	49	7	was	be	AUX
dpc-2082	49	8	54	54	NUM
dpc-2082	49	9	.	.	PUNCT
dpc-2082	49	10	6	6	NUM
dpc-2082	49	11	±	±	NUM
dpc-2082	49	12	23	23	NUM
dpc-2082	49	13	years	year	NOUN
dpc-2082	49	14	(	(	PUNCT
dpc-2082	49	15	range	range	NOUN
dpc-2082	49	16	:	:	PUNCT
dpc-2082	49	17	386	386	NUM
dpc-2082	49	18	years	year	NOUN
dpc-2082	49	19	,	,	PUNCT
dpc-2082	49	20	median	median	NOUN
dpc-2082	49	21	:	:	PUNCT
dpc-2082	49	22	61	61	NUM
dpc-2082	49	23	years	year	NOUN
dpc-2082	49	24	)	)	PUNCT
dpc-2082	49	25	.	.	PUNCT
dpc-2082	50	1	48.4	48.4	NUM
dpc-2082	50	2	%	%	NOUN
dpc-2082	50	3	of	of	ADP
dpc-2082	50	4	the	the	DET
dpc-2082	50	5	patients	patient	NOUN
dpc-2082	50	6	were	be	AUX
dpc-2082	50	7	female	female	ADJ
dpc-2082	50	8	(	(	PUNCT
dpc-2082	50	9	n	n	NOUN
dpc-2082	50	10	=	=	NUM
dpc-2082	50	11	15	15	NUM
dpc-2082	50	12	)	)	PUNCT
dpc-2082	50	13	whereas	whereas	SCONJ
dpc-2082	50	14	,	,	PUNCT
dpc-2082	50	15	51.6	51.6	NUM
dpc-2082	50	16	%	%	NOUN
dpc-2082	50	17	of	of	ADP
dpc-2082	50	18	the	the	DET
dpc-2082	50	19	patients	patient	NOUN
dpc-2082	50	20	were	be	AUX
dpc-2082	50	21	male	male	ADJ
dpc-2082	50	22	(	(	PUNCT
dpc-2082	50	23	n	n	NOUN
dpc-2082	50	24	=	=	SYM
dpc-2082	50	25	16	16	NUM
dpc-2082	50	26	)	)	PUNCT
dpc-2082	50	27	.	.	PUNCT
dpc-2082	51	1	all	all	DET
dpc-2082	51	2	patients	patient	NOUN
dpc-2082	51	3	presented	present	VERB
dpc-2082	51	4	with	with	ADP
dpc-2082	51	5	erythema	erythema	NOUN
dpc-2082	51	6	and	and	CCONJ
dpc-2082	51	7	scaling	scale	VERB
dpc-2082	51	8	covering	cover	VERB
dpc-2082	51	9	>	>	X
dpc-2082	51	10	90	90	NUM
dpc-2082	51	11	%	%	NOUN
dpc-2082	51	12	of	of	ADP
dpc-2082	51	13	body	body	NOUN
dpc-2082	51	14	surface	surface	NOUN
dpc-2082	51	15	area	area	NOUN
dpc-2082	51	16	,	,	PUNCT
dpc-2082	51	17	48.4	48.4	NUM
dpc-2082	51	18	%	%	NOUN
dpc-2082	51	19	of	of	ADP
dpc-2082	51	20	the	the	DET
dpc-2082	51	21	patients	patient	NOUN
dpc-2082	51	22	(	(	PUNCT
dpc-2082	51	23	n	n	NOUN
dpc-2082	51	24	=	=	SYM
dpc-2082	51	25	15	15	NUM
dpc-2082	51	26	)	)	PUNCT
dpc-2082	51	27	had	have	VERB
dpc-2082	51	28	also	also	ADV
dpc-2082	51	29	one	one	NUM
dpc-2082	51	30	or	or	CCONJ
dpc-2082	51	31	more	more	ADJ
dpc-2082	51	32	mucosal	mucosal	ADJ
dpc-2082	51	33	area	area	NOUN
dpc-2082	51	34	(	(	PUNCT
dpc-2082	51	35	oral	oral	ADJ
dpc-2082	51	36	,	,	PUNCT
dpc-2082	51	37	anogenital	anogenital	ADJ
dpc-2082	51	38	and	and	CCONJ
dpc-2082	51	39	ocular	ocular	ADJ
dpc-2082	51	40	)	)	PUNCT
dpc-2082	51	41	involvement	involvement	NOUN
dpc-2082	51	42	.	.	PUNCT
dpc-2082	52	1	all	all	DET
dpc-2082	52	2	patients	patient	NOUN
dpc-2082	52	3	with	with	ADP
dpc-2082	52	4	sjs	sjs	PROPN
dpc-2082	52	5	(	(	PUNCT
dpc-2082	52	6	n	n	NOUN
dpc-2082	52	7	=	=	SYM
dpc-2082	52	8	4	4	NUM
dpc-2082	52	9	)	)	PUNCT
dpc-2082	52	10	,	,	PUNCT
dpc-2082	52	11	five	five	NUM
dpc-2082	52	12	patients	patient	NOUN
dpc-2082	52	13	with	with	ADP
dpc-2082	52	14	mde	mde	PROPN
dpc-2082	52	15	,	,	PUNCT
dpc-2082	52	16	two	two	NUM
dpc-2082	52	17	patients	patient	NOUN
dpc-2082	52	18	with	with	ADP
dpc-2082	52	19	dress	dress	NOUN
dpc-2082	52	20	,	,	PUNCT
dpc-2082	52	21	one	one	NUM
dpc-2082	52	22	patient	patient	NOUN
dpc-2082	52	23	with	with	ADP
dpc-2082	52	24	bullous	bullous	ADJ
dpc-2082	52	25	mycosis	mycosis	NOUN
dpc-2082	52	26	fungoides	fungoide	NOUN
dpc-2082	52	27	,	,	PUNCT
dpc-2082	52	28	one	one	NUM
dpc-2082	52	29	patient	patient	NOUN
dpc-2082	52	30	with	with	ADP
dpc-2082	52	31	pemphigus	pemphigus	PROPN
dpc-2082	52	32	foliaceus	foliaceus	PROPN
dpc-2082	52	33	and	and	CCONJ
dpc-2082	52	34	two	two	NUM
dpc-2082	52	35	patients	patient	NOUN
dpc-2082	52	36	with	with	ADP
dpc-2082	52	37	sacd	sacd	NOUN
dpc-2082	52	38	had	have	VERB
dpc-2082	52	39	mucosal	mucosal	ADJ
dpc-2082	52	40	involvement	involvement	NOUN
dpc-2082	52	41	.	.	PUNCT
dpc-2082	53	1	the	the	DET
dpc-2082	53	2	most	most	ADV
dpc-2082	53	3	common	common	ADJ
dpc-2082	53	4	clinical	clinical	ADJ
dpc-2082	53	5	presentations	presentation	NOUN
dpc-2082	53	6	of	of	ADP
dpc-2082	53	7	oral	oral	ADJ
dpc-2082	53	8	mucosal	mucosal	NOUN
dpc-2082	53	9	involvement	involvement	NOUN
dpc-2082	53	10	were	be	AUX
dpc-2082	53	11	hemorrhagic	hemorrhagic	NOUN
dpc-2082	53	12	-	-	PUNCT
dpc-2082	53	13	crusted	crust	VERB
dpc-2082	53	14	plaques	plaque	NOUN
dpc-2082	53	15	covering	cover	VERB
dpc-2082	53	16	the	the	DET
dpc-2082	53	17	lips	lip	NOUN
dpc-2082	53	18	,	,	PUNCT
dpc-2082	53	19	erosions	erosion	NOUN
dpc-2082	53	20	on	on	ADP
dpc-2082	53	21	the	the	DET
dpc-2082	53	22	buccal	buccal	ADJ
dpc-2082	53	23	and	and	CCONJ
dpc-2082	53	24	palatal	palatal	ADJ
dpc-2082	53	25	mucosa	mucosa	NOUN
dpc-2082	53	26	which	which	PRON
dpc-2082	53	27	were	be	AUX
dpc-2082	53	28	predominantly	predominantly	ADV
dpc-2082	53	29	observed	observe	VERB
dpc-2082	53	30	in	in	ADP
dpc-2082	53	31	cases	case	NOUN
dpc-2082	53	32	with	with	ADP
dpc-2082	53	33	sjs	sjs	PROPN
dpc-2082	53	34	.	.	PUNCT
dpc-2082	54	1	mucopurulent	mucopurulent	NOUN
dpc-2082	54	2	conjunctivitis	conjunctivitis	NOUN
dpc-2082	54	3	,	,	PUNCT
dpc-2082	54	4	eyelid	eyelid	NOUN
dpc-2082	54	5	margin	margin	NOUN
dpc-2082	54	6	ulceration	ulceration	NOUN
dpc-2082	54	7	original	original	ADJ
dpc-2082	54	8	article	article	NOUN
dpc-2082	54	9	|	|	ADV
dpc-2082	54	10	dermatol	dermatol	ADJ
dpc-2082	54	11	pract	pract	NOUN
dpc-2082	54	12	concept	concept	NOUN
dpc-2082	54	13	.	.	PUNCT
dpc-2082	55	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	55	2	3	3	NUM
dpc-2082	55	3	and	and	CCONJ
dpc-2082	55	4	vulvovaginal	vulvovaginal	ADJ
dpc-2082	55	5	/	/	SYM
dpc-2082	55	6	penile	penile	ADJ
dpc-2082	55	7	erosions	erosion	NOUN
dpc-2082	55	8	were	be	AUX
dpc-2082	55	9	also	also	ADV
dpc-2082	55	10	present	present	ADJ
dpc-2082	55	11	in	in	ADP
dpc-2082	55	12	patients	patient	NOUN
dpc-2082	55	13	with	with	ADP
dpc-2082	55	14	sjs	sjs	PROPN
dpc-2082	55	15	.	.	PUNCT
dpc-2082	56	1	patients	patient	NOUN
dpc-2082	56	2	with	with	ADP
dpc-2082	56	3	mde	mde	PROPN
dpc-2082	56	4	,	,	PUNCT
dpc-2082	56	5	dress	dress	NOUN
dpc-2082	56	6	and	and	CCONJ
dpc-2082	56	7	sacd	sacd	NOUN
dpc-2082	56	8	most	most	ADV
dpc-2082	56	9	commonly	commonly	ADV
dpc-2082	56	10	had	have	VERB
dpc-2082	56	11	superficial	superficial	ADJ
dpc-2082	56	12	erosions	erosion	NOUN
dpc-2082	56	13	on	on	ADP
dpc-2082	56	14	the	the	DET
dpc-2082	56	15	lips	lip	NOUN
dpc-2082	56	16	as	as	ADP
dpc-2082	56	17	the	the	DET
dpc-2082	56	18	mucosal	mucosal	NOUN
dpc-2082	56	19	manifestation	manifestation	NOUN
dpc-2082	56	20	.	.	PUNCT
dpc-2082	57	1	the	the	DET
dpc-2082	57	2	most	most	ADV
dpc-2082	57	3	frequent	frequent	ADJ
dpc-2082	57	4	systemic	systemic	ADJ
dpc-2082	57	5	symptoms	symptom	NOUN
dpc-2082	57	6	and	and	CCONJ
dpc-2082	57	7	signs	sign	NOUN
dpc-2082	57	8	associated	associate	VERB
dpc-2082	57	9	with	with	ADP
dpc-2082	57	10	erythroderma	erythroderma	NOUN
dpc-2082	57	11	were	be	AUX
dpc-2082	57	12	fever	fever	NOUN
dpc-2082	57	13	(	(	PUNCT
dpc-2082	57	14	67.7	67.7	NUM
dpc-2082	57	15	%	%	NOUN
dpc-2082	57	16	,	,	PUNCT
dpc-2082	57	17	n	n	NOUN
dpc-2082	57	18	=	=	SYM
dpc-2082	57	19	21	21	NUM
dpc-2082	57	20	)	)	PUNCT
dpc-2082	57	21	,	,	PUNCT
dpc-2082	57	22	followed	follow	VERB
dpc-2082	57	23	by	by	ADP
dpc-2082	57	24	pruritus	pruritus	PROPN
dpc-2082	57	25	(	(	PUNCT
dpc-2082	57	26	38.7	38.7	NUM
dpc-2082	57	27	%	%	NOUN
dpc-2082	57	28	,	,	PUNCT
dpc-2082	57	29	n	n	NOUN
dpc-2082	57	30	=	=	NOUN
dpc-2082	57	31	12	12	NUM
dpc-2082	57	32	)	)	PUNCT
dpc-2082	57	33	.	.	PUNCT
dpc-2082	58	1	hypotension	hypotension	NOUN
dpc-2082	58	2	,	,	PUNCT
dpc-2082	58	3	pain	pain	NOUN
dpc-2082	58	4	,	,	PUNCT
dpc-2082	58	5	irritability	irritability	NOUN
dpc-2082	58	6	,	,	PUNCT
dpc-2082	58	7	facial	facial	ADJ
dpc-2082	58	8	/	/	SYM
dpc-2082	58	9	peripheral	peripheral	ADJ
dpc-2082	58	10	edema	edema	NOUN
dpc-2082	58	11	,	,	PUNCT
dpc-2082	58	12	lymphadenopathy	lymphadenopathy	ADJ
dpc-2082	58	13	,	,	PUNCT
dpc-2082	58	14	malaise	malaise	NOUN
dpc-2082	58	15	,	,	PUNCT
dpc-2082	58	16	arthralgia	arthralgia	NOUN
dpc-2082	58	17	and	and	CCONJ
dpc-2082	58	18	myalgia	myalgia	NOUN
dpc-2082	58	19	were	be	AUX
dpc-2082	58	20	also	also	ADV
dpc-2082	58	21	present	present	ADJ
dpc-2082	58	22	.	.	PUNCT
dpc-2082	59	1	29	29	NUM
dpc-2082	59	2	%	%	NOUN
dpc-2082	59	3	of	of	ADP
dpc-2082	59	4	the	the	DET
dpc-2082	59	5	patients	patient	NOUN
dpc-2082	59	6	(	(	PUNCT
dpc-2082	59	7	n	n	NOUN
dpc-2082	59	8	=	=	SYM
dpc-2082	59	9	9	9	NUM
dpc-2082	59	10	)	)	PUNCT
dpc-2082	59	11	had	have	VERB
dpc-2082	59	12	eosinophilia	eosinophilia	PROPN
dpc-2082	59	13	(	(	PUNCT
dpc-2082	59	14	>	>	X
dpc-2082	59	15	500	500	NUM
dpc-2082	59	16	/	/	SYM
dpc-2082	59	17	mm3	mm3	ADJ
dpc-2082	59	18	cells	cell	NOUN
dpc-2082	59	19	)	)	PUNCT
dpc-2082	59	20	;	;	PUNCT
dpc-2082	59	21	other	other	ADJ
dpc-2082	59	22	accompanying	accompany	VERB
dpc-2082	59	23	laboratory	laboratory	NOUN
dpc-2082	59	24	anomalies	anomaly	NOUN
dpc-2082	59	25	are	be	AUX
dpc-2082	59	26	shown	show	VERB
dpc-2082	59	27	in	in	ADP
dpc-2082	59	28	supplementary	supplementary	ADJ
dpc-2082	59	29	table	table	NOUN
dpc-2082	59	30	1	1	NUM
dpc-2082	59	31	.	.	PUNCT
dpc-2082	60	1	the	the	DET
dpc-2082	60	2	average	average	ADJ
dpc-2082	60	3	elapsed	elapse	VERB
dpc-2082	60	4	time	time	NOUN
dpc-2082	60	5	between	between	ADP
dpc-2082	60	6	the	the	DET
dpc-2082	60	7	onset	onset	NOUN
dpc-2082	60	8	of	of	ADP
dpc-2082	60	9	rash	rash	NOUN
dpc-2082	60	10	and	and	CCONJ
dpc-2082	60	11	performing	perform	VERB
dpc-2082	60	12	the	the	DET
dpc-2082	60	13	biopsy	biopsy	NOUN
dpc-2082	60	14	was	be	AUX
dpc-2082	60	15	18.8	18.8	NUM
dpc-2082	60	16	±	±	NUM
dpc-2082	60	17	28.3	28.3	NUM
dpc-2082	60	18	days	day	NOUN
dpc-2082	60	19	(	(	PUNCT
dpc-2082	60	20	range	range	NOUN
dpc-2082	60	21	:	:	PUNCT
dpc-2082	60	22	1	1	NUM
dpc-2082	60	23	-	-	SYM
dpc-2082	60	24	150	150	NUM
dpc-2082	60	25	days	day	NOUN
dpc-2082	60	26	)	)	PUNCT
dpc-2082	60	27	.	.	PUNCT
dpc-2082	61	1	dif	dif	PROPN
dpc-2082	61	2	analysis	analysis	NOUN
dpc-2082	61	3	showed	show	VERB
dpc-2082	61	4	immune	immune	ADJ
dpc-2082	61	5	deposits	deposit	NOUN
dpc-2082	61	6	in	in	ADP
dpc-2082	61	7	19.4	19.4	NUM
dpc-2082	61	8	%	%	NOUN
dpc-2082	61	9	(	(	PUNCT
dpc-2082	61	10	n	n	NOUN
dpc-2082	61	11	=	=	SYM
dpc-2082	61	12	6	6	NUM
dpc-2082	61	13	)	)	PUNCT
dpc-2082	61	14	of	of	ADP
dpc-2082	61	15	the	the	DET
dpc-2082	61	16	patients	patient	NOUN
dpc-2082	61	17	;	;	PUNCT
dpc-2082	61	18	whereas	whereas	SCONJ
dpc-2082	61	19	no	no	DET
dpc-2082	61	20	immune	immune	ADJ
dpc-2082	61	21	deposits	deposit	NOUN
dpc-2082	61	22	were	be	AUX
dpc-2082	61	23	detected	detect	VERB
dpc-2082	61	24	in	in	ADP
dpc-2082	61	25	80.6	80.6	NUM
dpc-2082	61	26	%	%	NOUN
dpc-2082	61	27	(	(	PUNCT
dpc-2082	61	28	n	n	NOUN
dpc-2082	61	29	=	=	SYM
dpc-2082	61	30	25	25	NUM
dpc-2082	61	31	)	)	PUNCT
dpc-2082	61	32	of	of	ADP
dpc-2082	61	33	the	the	DET
dpc-2082	61	34	patients	patient	NOUN
dpc-2082	61	35	.	.	PUNCT
dpc-2082	62	1	the	the	DET
dpc-2082	62	2	final	final	ADJ
dpc-2082	62	3	diagnoses	diagnosis	NOUN
dpc-2082	62	4	of	of	ADP
dpc-2082	62	5	the	the	DET
dpc-2082	62	6	underlying	underlie	VERB
dpc-2082	62	7	cutaneous	cutaneous	ADJ
dpc-2082	62	8	diseases	disease	NOUN
dpc-2082	62	9	were	be	AUX
dpc-2082	62	10	classified	classify	VERB
dpc-2082	62	11	as	as	ADP
dpc-2082	62	12	‘	'	PUNCT
dpc-2082	62	13	category	category	NOUN
dpc-2082	62	14	1	1	NUM
dpc-2082	62	15	(	(	PUNCT
dpc-2082	62	16	absd	absd	ADV
dpc-2082	62	17	)	)	PUNCT
dpc-2082	62	18	’	'	PUNCT
dpc-2082	62	19	,	,	PUNCT
dpc-2082	62	20	‘	'	PUNCT
dpc-2082	62	21	category	category	NOUN
dpc-2082	62	22	2	2	NUM
dpc-2082	62	23	(	(	PUNCT
dpc-2082	62	24	acde	acde	PROPN
dpc-2082	62	25	)	)	PUNCT
dpc-2082	62	26	’	'	PUNCT
dpc-2082	62	27	,	,	PUNCT
dpc-2082	62	28	‘	'	PUNCT
dpc-2082	62	29	category	category	NOUN
dpc-2082	62	30	3	3	NUM
dpc-2082	62	31	(	(	PUNCT
dpc-2082	62	32	vascular	vascular	ADJ
dpc-2082	62	33	skin	skin	NOUN
dpc-2082	62	34	diseases	disease	NOUN
dpc-2082	62	35	)	)	PUNCT
dpc-2082	62	36	’	'	PUNCT
dpc-2082	62	37	and	and	CCONJ
dpc-2082	62	38	‘	'	PUNCT
dpc-2082	62	39	category	category	NOUN
dpc-2082	62	40	4	4	NUM
dpc-2082	62	41	(	(	PUNCT
dpc-2082	62	42	miscellaneous	miscellaneous	ADJ
dpc-2082	62	43	)	)	PUNCT
dpc-2082	62	44	’	'	PUNCT
dpc-2082	62	45	.	.	PUNCT
dpc-2082	63	1	category	category	NOUN
dpc-2082	63	2	1	1	NUM
dpc-2082	63	3	consists	consist	VERB
dpc-2082	63	4	of	of	ADP
dpc-2082	63	5	bullous	bullous	ADJ
dpc-2082	63	6	pemphigoid	pemphigoid	NOUN
dpc-2082	63	7	,	,	PUNCT
dpc-2082	63	8	pemphigus	pemphigus	PROPN
dpc-2082	63	9	foliaceus	foliaceus	NOUN
dpc-2082	63	10	;	;	PUNCT
dpc-2082	63	11	category	category	NOUN
dpc-2082	63	12	2	2	NUM
dpc-2082	63	13	consists	consist	VERB
dpc-2082	63	14	of	of	ADP
dpc-2082	63	15	acdes	acde	NOUN
dpc-2082	63	16	including	include	VERB
dpc-2082	63	17	sjs	sjs	PROPN
dpc-2082	63	18	/	/	SYM
dpc-2082	63	19	ten	ten	NUM
dpc-2082	63	20	spectrum	spectrum	NOUN
dpc-2082	63	21	,	,	PUNCT
dpc-2082	63	22	dress	dress	NOUN
dpc-2082	63	23	,	,	PUNCT
dpc-2082	63	24	mde	mde	PROPN
dpc-2082	63	25	,	,	PUNCT
dpc-2082	63	26	agep	agep	NOUN
dpc-2082	63	27	(	(	PUNCT
dpc-2082	63	28	acute	acute	PROPN
dpc-2082	63	29	generalized	generalize	VERB
dpc-2082	63	30	exanthematous	exanthematous	ADJ
dpc-2082	63	31	pustulosis	pustulosis	NOUN
dpc-2082	63	32	)	)	PUNCT
dpc-2082	63	33	,	,	PUNCT
dpc-2082	63	34	fixed	fix	VERB
dpc-2082	63	35	drug	drug	NOUN
dpc-2082	63	36	eruption	eruption	NOUN
dpc-2082	63	37	,	,	PUNCT
dpc-2082	63	38	vasculitic	vasculitic	ADJ
dpc-2082	63	39	table	table	NOUN
dpc-2082	63	40	1	1	NUM
dpc-2082	63	41	.	.	PUNCT
dpc-2082	63	42	underlying	underlie	VERB
dpc-2082	63	43	etiologies	etiology	NOUN
dpc-2082	63	44	of	of	ADP
dpc-2082	63	45	erythroderma	erythroderma	NOUN
dpc-2082	63	46	and	and	CCONJ
dpc-2082	63	47	direct	direct	ADJ
dpc-2082	63	48	immunofluorescence	immunofluorescence	NOUN
dpc-2082	63	49	findings	finding	NOUN
dpc-2082	63	50	.	.	PUNCT
dpc-2082	64	1	number	number	NOUN
dpc-2082	64	2	of	of	ADP
dpc-2082	64	3	patients	patient	NOUN
dpc-2082	64	4	n	n	CCONJ
dpc-2082	64	5	(	(	PUNCT
dpc-2082	64	6	%	%	INTJ
dpc-2082	64	7	)	)	PUNCT
dpc-2082	64	8	presence	presence	NOUN
dpc-2082	64	9	of	of	ADP
dpc-2082	64	10	any	any	DET
dpc-2082	64	11	accompanying	accompany	VERB
dpc-2082	64	12	bulla	bulla	NOUN
dpc-2082	64	13	,	,	PUNCT
dpc-2082	64	14	vesicle	vesicle	NOUN
dpc-2082	64	15	pustule	pustule	NOUN
dpc-2082	64	16	,	,	PUNCT
dpc-2082	64	17	erosion	erosion	NOUN
dpc-2082	64	18	,	,	PUNCT
dpc-2082	64	19	crusting	crusting	NOUN
dpc-2082	64	20	or	or	CCONJ
dpc-2082	64	21	necrosis	necrosis	VERB
dpc-2082	64	22	direct	direct	ADJ
dpc-2082	64	23	immunofluorescence	immunofluorescence	NOUN
dpc-2082	64	24	findings	finding	NOUN
dpc-2082	64	25	total	total	NOUN
dpc-2082	64	26	(	(	PUNCT
dpc-2082	64	27	n	n	CCONJ
dpc-2082	64	28	,	,	PUNCT
dpc-2082	64	29	%	%	INTJ
dpc-2082	64	30	)	)	PUNCT
dpc-2082	64	31	category	category	NOUN
dpc-2082	64	32	1	1	NUM
dpc-2082	64	33	(	(	PUNCT
dpc-2082	64	34	autoimmune	autoimmune	ADJ
dpc-2082	64	35	bullous	bullous	ADJ
dpc-2082	64	36	skin	skin	NOUN
dpc-2082	64	37	disorders	disorder	NOUN
dpc-2082	64	38	)	)	PUNCT
dpc-2082	64	39	3	3	NUM
dpc-2082	64	40	(	(	PUNCT
dpc-2082	64	41	9.7	9.7	NUM
dpc-2082	64	42	%	%	NOUN
dpc-2082	64	43	)	)	PUNCT
dpc-2082	64	44	bullous	bullous	ADJ
dpc-2082	64	45	pemphigoid	pemphigoid	ADJ
dpc-2082	64	46	2	2	NUM
dpc-2082	64	47	(	(	PUNCT
dpc-2082	64	48	2.9	2.9	NUM
dpc-2082	64	49	%	%	NOUN
dpc-2082	64	50	)	)	PUNCT
dpc-2082	64	51	bulla	bulla	NOUN
dpc-2082	64	52	,	,	PUNCT
dpc-2082	64	53	crusting	crusting	NOUN
dpc-2082	64	54	and	and	CCONJ
dpc-2082	64	55	erosion	erosion	NOUN
dpc-2082	64	56	linear	linear	PROPN
dpc-2082	64	57	igg	igg	PROPN
dpc-2082	64	58	and	and	CCONJ
dpc-2082	64	59	c3	c3	PROPN
dpc-2082	64	60	deposition	deposition	NOUN
dpc-2082	64	61	at	at	ADP
dpc-2082	64	62	the	the	DET
dpc-2082	64	63	dermoepidermal	dermoepidermal	ADJ
dpc-2082	64	64	junction	junction	NOUN
dpc-2082	64	65	pemphigus	pemphigus	NOUN
dpc-2082	64	66	foliaceus	foliaceus	NOUN
dpc-2082	64	67	1	1	NUM
dpc-2082	64	68	(	(	PUNCT
dpc-2082	64	69	1.4	1.4	NUM
dpc-2082	64	70	%	%	NOUN
dpc-2082	64	71	)	)	PUNCT
dpc-2082	64	72	flaccid	flaccid	ADJ
dpc-2082	64	73	bulla	bulla	NOUN
dpc-2082	64	74	,	,	PUNCT
dpc-2082	64	75	vesicle	vesicle	NOUN
dpc-2082	64	76	and	and	CCONJ
dpc-2082	64	77	crusting	crust	VERB
dpc-2082	64	78	intercellular	intercellular	ADJ
dpc-2082	64	79	igg	igg	NOUN
dpc-2082	64	80	deposition	deposition	NOUN
dpc-2082	64	81	category	category	NOUN
dpc-2082	64	82	2	2	NUM
dpc-2082	64	83	(	(	PUNCT
dpc-2082	64	84	adverse	adverse	ADJ
dpc-2082	64	85	cutaneous	cutaneous	ADJ
dpc-2082	64	86	drug	drug	NOUN
dpc-2082	64	87	eruptions	eruption	NOUN
dpc-2082	64	88	)	)	PUNCT
dpc-2082	64	89	20	20	NUM
dpc-2082	64	90	(	(	PUNCT
dpc-2082	64	91	64.5	64.5	NUM
dpc-2082	64	92	%	%	NOUN
dpc-2082	64	93	)	)	PUNCT
dpc-2082	64	94	stevens	stevens	PROPN
dpc-2082	64	95	-	-	PUNCT
dpc-2082	64	96	johnson	johnson	PROPN
dpc-2082	64	97	syndrome/	syndrome/	NUM
dpc-2082	64	98	toxic	toxic	ADJ
dpc-2082	64	99	epidermal	epidermal	ADJ
dpc-2082	64	100	necrolysis	necrolysis	NOUN
dpc-2082	64	101	4	4	NUM
dpc-2082	64	102	(	(	PUNCT
dpc-2082	64	103	5.8	5.8	NUM
dpc-2082	64	104	%	%	NOUN
dpc-2082	64	105	)	)	PUNCT
dpc-2082	64	106	erosion	erosion	NOUN
dpc-2082	64	107	,	,	PUNCT
dpc-2082	64	108	crusting	crusting	NOUN
dpc-2082	64	109	and	and	CCONJ
dpc-2082	64	110	nikolsky	nikolsky	ADJ
dpc-2082	64	111	(	(	PUNCT
dpc-2082	64	112	+	+	ADJ
dpc-2082	64	113	)	)	PUNCT
dpc-2082	64	114	bulla	bulla	ADJ
dpc-2082	64	115	none	none	NOUN
dpc-2082	64	116	maculopapular	maculopapular	ADJ
dpc-2082	64	117	drug	drug	NOUN
dpc-2082	64	118	eruption	eruption	NOUN
dpc-2082	64	119	10	10	NUM
dpc-2082	64	120	(	(	PUNCT
dpc-2082	64	121	14.5	14.5	NUM
dpc-2082	64	122	%	%	NOUN
dpc-2082	64	123	)	)	PUNCT
dpc-2082	64	124	only	only	ADV
dpc-2082	64	125	one	one	NUM
dpc-2082	64	126	patient	patient	NOUN
dpc-2082	64	127	had	have	VERB
dpc-2082	64	128	linear	linear	PROPN
dpc-2082	64	129	igm	igm	PROPN
dpc-2082	64	130	,	,	PUNCT
dpc-2082	64	131	granular	granular	ADJ
dpc-2082	64	132	igg	igg	PROPN
dpc-2082	64	133	and	and	CCONJ
dpc-2082	64	134	iga	iga	PROPN
dpc-2082	64	135	deposition	deposition	NOUN
dpc-2082	64	136	at	at	ADP
dpc-2082	64	137	the	the	DET
dpc-2082	64	138	dermoepidermal	dermoepidermal	ADJ
dpc-2082	64	139	junction	junction	NOUN
dpc-2082	64	140	drug	drug	NOUN
dpc-2082	64	141	rash	rash	NOUN
dpc-2082	64	142	with	with	ADP
dpc-2082	64	143	eosinopilia	eosinopilia	ADJ
dpc-2082	64	144	and	and	CCONJ
dpc-2082	64	145	systemic	systemic	ADJ
dpc-2082	64	146	symptoms	symptom	NOUN
dpc-2082	64	147	3	3	NUM
dpc-2082	64	148	(	(	PUNCT
dpc-2082	64	149	4.3	4.3	NUM
dpc-2082	64	150	%	%	NOUN
dpc-2082	64	151	)	)	PUNCT
dpc-2082	64	152	none	none	NOUN
dpc-2082	64	153	vasculitic	vasculitic	ADJ
dpc-2082	64	154	drug	drug	NOUN
dpc-2082	64	155	eruption	eruption	NOUN
dpc-2082	64	156	1	1	NUM
dpc-2082	64	157	(	(	PUNCT
dpc-2082	64	158	1.4	1.4	NUM
dpc-2082	64	159	%	%	NOUN
dpc-2082	64	160	)	)	PUNCT
dpc-2082	64	161	none	none	NOUN
dpc-2082	64	162	fixed	fix	VERB
dpc-2082	64	163	drug	drug	NOUN
dpc-2082	64	164	eruption	eruption	NOUN
dpc-2082	64	165	1	1	NUM
dpc-2082	64	166	(	(	PUNCT
dpc-2082	64	167	1.4	1.4	NUM
dpc-2082	64	168	%	%	NOUN
dpc-2082	64	169	)	)	PUNCT
dpc-2082	64	170	bulla	bulla	NOUN
dpc-2082	64	171	,	,	PUNCT
dpc-2082	64	172	erosion	erosion	NOUN
dpc-2082	64	173	,	,	PUNCT
dpc-2082	64	174	crusting	crust	VERB
dpc-2082	64	175	none	none	NOUN
dpc-2082	64	176	acute	acute	NOUN
dpc-2082	64	177	generalized	generalize	VERB
dpc-2082	64	178	exantematous	exantematous	ADJ
dpc-2082	64	179	pustulosis	pustulosis	NOUN
dpc-2082	64	180	1	1	NUM
dpc-2082	64	181	(	(	PUNCT
dpc-2082	64	182	1.4	1.4	NUM
dpc-2082	64	183	%	%	NOUN
dpc-2082	64	184	)	)	PUNCT
dpc-2082	64	185	pustule	pustule	NOUN
dpc-2082	64	186	none	none	NOUN
dpc-2082	64	187	category	category	NOUN
dpc-2082	64	188	3	3	NUM
dpc-2082	64	189	(	(	PUNCT
dpc-2082	64	190	vascular	vascular	ADJ
dpc-2082	64	191	skin	skin	NOUN
dpc-2082	64	192	diseases	disease	NOUN
dpc-2082	64	193	)	)	PUNCT
dpc-2082	64	194	3	3	NUM
dpc-2082	64	195	(	(	PUNCT
dpc-2082	64	196	9.7	9.7	NUM
dpc-2082	64	197	%	%	NOUN
dpc-2082	64	198	)	)	PUNCT
dpc-2082	64	199	purpura	purpura	NOUN
dpc-2082	64	200	fulminans	fulminan	NOUN
dpc-2082	64	201	1	1	NUM
dpc-2082	64	202	(	(	PUNCT
dpc-2082	64	203	1.4	1.4	NUM
dpc-2082	64	204	%	%	NOUN
dpc-2082	64	205	)	)	PUNCT
dpc-2082	64	206	hemorrhagic	hemorrhagic	NOUN
dpc-2082	64	207	bulla	bulla	NOUN
dpc-2082	64	208	,	,	PUNCT
dpc-2082	64	209	necrosis	necrosis	NOUN
dpc-2082	64	210	none	none	NOUN
dpc-2082	64	211	antiphospholipid	antiphospholipid	NOUN
dpc-2082	64	212	syndrome	syndrome	NOUN
dpc-2082	64	213	1	1	NUM
dpc-2082	64	214	(	(	PUNCT
dpc-2082	64	215	1.4	1.4	NUM
dpc-2082	64	216	%	%	NOUN
dpc-2082	64	217	)	)	PUNCT
dpc-2082	64	218	hemorrhagic	hemorrhagic	NOUN
dpc-2082	64	219	bulla	bulla	NOUN
dpc-2082	64	220	,	,	PUNCT
dpc-2082	64	221	necrosis	necrosis	NOUN
dpc-2082	64	222	none	none	NOUN
dpc-2082	64	223	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	64	224	vasculitis	vasculitis	PROPN
dpc-2082	64	225	1	1	NUM
dpc-2082	64	226	(	(	PUNCT
dpc-2082	64	227	1.4	1.4	NUM
dpc-2082	64	228	%	%	NOUN
dpc-2082	64	229	)	)	PUNCT
dpc-2082	65	1	none	none	NOUN
dpc-2082	65	2	category	category	NOUN
dpc-2082	65	3	4	4	NUM
dpc-2082	65	4	(	(	PUNCT
dpc-2082	65	5	miscellaneous	miscellaneous	ADJ
dpc-2082	65	6	)	)	PUNCT
dpc-2082	65	7	5	5	NUM
dpc-2082	65	8	(	(	PUNCT
dpc-2082	65	9	16.1	16.1	NUM
dpc-2082	65	10	%	%	NOUN
dpc-2082	65	11	)	)	PUNCT
dpc-2082	65	12	mycosis	mycosis	NOUN
dpc-2082	65	13	fungoides	fungoide	NOUN
dpc-2082	65	14	1	1	NUM
dpc-2082	65	15	(	(	PUNCT
dpc-2082	65	16	1.4	1.4	NUM
dpc-2082	65	17	%	%	NOUN
dpc-2082	65	18	)	)	PUNCT
dpc-2082	65	19	bulla	bulla	NOUN
dpc-2082	65	20	interrupted	interrupt	VERB
dpc-2082	65	21	c3	c3	PROPN
dpc-2082	65	22	deposition	deposition	NOUN
dpc-2082	65	23	along	along	ADP
dpc-2082	65	24	dermal	dermal	NOUN
dpc-2082	65	25	vessels	vessel	NOUN
dpc-2082	65	26	and	and	CCONJ
dpc-2082	65	27	dermoepidermal	dermoepidermal	ADJ
dpc-2082	65	28	junction	junction	NOUN
dpc-2082	65	29	psoriasis	psoriasis	NOUN
dpc-2082	65	30	1	1	NUM
dpc-2082	65	31	(	(	PUNCT
dpc-2082	65	32	1.4	1.4	NUM
dpc-2082	65	33	%	%	NOUN
dpc-2082	65	34	)	)	PUNCT
dpc-2082	65	35	none	none	NOUN
dpc-2082	65	36	psoriasiform	psoriasiform	NOUN
dpc-2082	65	37	dermatisis	dermatisis	NOUN
dpc-2082	65	38	(	(	PUNCT
dpc-2082	65	39	finally	finally	ADV
dpc-2082	65	40	diagnosed	diagnose	VERB
dpc-2082	65	41	as	as	ADP
dpc-2082	65	42	idiopathic	idiopathic	ADJ
dpc-2082	65	43	erythroderma	erythroderma	NOUN
dpc-2082	65	44	)	)	PUNCT
dpc-2082	65	45	1	1	NUM
dpc-2082	65	46	(	(	PUNCT
dpc-2082	65	47	1.4	1.4	NUM
dpc-2082	65	48	%	%	NOUN
dpc-2082	65	49	)	)	PUNCT
dpc-2082	65	50	pustule	pustule	ADJ
dpc-2082	65	51	linear	linear	PROPN
dpc-2082	65	52	c3	c3	PROPN
dpc-2082	65	53	deposition	deposition	NOUN
dpc-2082	65	54	at	at	ADP
dpc-2082	65	55	the	the	DET
dpc-2082	65	56	basal	basal	ADJ
dpc-2082	65	57	membrane	membrane	NOUN
dpc-2082	65	58	systemic	systemic	ADJ
dpc-2082	65	59	allergic	allergic	ADJ
dpc-2082	65	60	contact	contact	NOUN
dpc-2082	65	61	dermatitis	dermatitis	NOUN
dpc-2082	65	62	2	2	NUM
dpc-2082	65	63	(	(	PUNCT
dpc-2082	65	64	2.9	2.9	NUM
dpc-2082	65	65	%	%	NOUN
dpc-2082	65	66	)	)	PUNCT
dpc-2082	65	67	none	none	NOUN
dpc-2082	65	68	4	4	NUM
dpc-2082	65	69	original	original	ADJ
dpc-2082	65	70	article	article	NOUN
dpc-2082	65	71	|	|	ADV
dpc-2082	65	72	dermatol	dermatol	ADJ
dpc-2082	65	73	pract	pract	NOUN
dpc-2082	65	74	concept	concept	NOUN
dpc-2082	65	75	.	.	PUNCT
dpc-2082	66	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	66	2	from	from	ADP
dpc-2082	66	3	the	the	DET
dpc-2082	66	4	intact	intact	ADJ
dpc-2082	66	5	skin	skin	NOUN
dpc-2082	66	6	just	just	ADV
dpc-2082	66	7	at	at	ADP
dpc-2082	66	8	the	the	DET
dpc-2082	66	9	periphery	periphery	NOUN
dpc-2082	66	10	of	of	ADP
dpc-2082	66	11	a	a	DET
dpc-2082	66	12	bulla	bulla	NOUN
dpc-2082	66	13	that	that	PRON
dpc-2082	66	14	had	have	VERB
dpc-2082	66	15	a	a	DET
dpc-2082	66	16	pre	pre	NOUN
dpc-2082	66	17	-	-	NOUN
dpc-2082	66	18	diagnosis	diagnosis	NOUN
dpc-2082	66	19	of	of	ADP
dpc-2082	66	20	bullous	bullous	ADJ
dpc-2082	66	21	pemphigoid	pemphigoid	NOUN
dpc-2082	66	22	or	or	CCONJ
dpc-2082	66	23	pemphigus	pemphigus	NOUN
dpc-2082	66	24	foliaceus	foliaceus	NOUN
dpc-2082	66	25	,	,	PUNCT
dpc-2082	66	26	whereas	whereas	SCONJ
dpc-2082	66	27	skin	skin	NOUN
dpc-2082	66	28	samples	sample	NOUN
dpc-2082	66	29	were	be	AUX
dpc-2082	66	30	obtained	obtain	VERB
dpc-2082	66	31	from	from	ADP
dpc-2082	66	32	a	a	DET
dpc-2082	66	33	vesicle	vesicle	NOUN
dpc-2082	66	34	,	,	PUNCT
dpc-2082	66	35	bulla	bulla	NOUN
dpc-2082	66	36	or	or	CCONJ
dpc-2082	66	37	pustule	pustule	NOUN
dpc-2082	66	38	for	for	ADP
dpc-2082	66	39	the	the	DET
dpc-2082	66	40	subjects	subject	NOUN
dpc-2082	66	41	who	who	PRON
dpc-2082	66	42	had	have	VERB
dpc-2082	66	43	pre	pre	ADJ
dpc-2082	66	44	-	-	NOUN
dpc-2082	66	45	diagnosis	diagnosis	NOUN
dpc-2082	66	46	of	of	ADP
dpc-2082	66	47	vasculitis	vasculitis	NOUN
dpc-2082	66	48	or	or	CCONJ
dpc-2082	66	49	drug	drug	NOUN
dpc-2082	66	50	eruption	eruption	NOUN
dpc-2082	66	51	.	.	PUNCT
dpc-2082	67	1	all	all	DET
dpc-2082	67	2	3	3	NUM
dpc-2082	67	3	cases	case	NOUN
dpc-2082	67	4	of	of	ADP
dpc-2082	67	5	erythrodermic	erythrodermic	ADJ
dpc-2082	67	6	patients	patient	NOUN
dpc-2082	67	7	in	in	ADP
dpc-2082	67	8	the	the	DET
dpc-2082	67	9	category	category	NOUN
dpc-2082	67	10	1	1	NUM
dpc-2082	67	11	diagnosed	diagnose	VERB
dpc-2082	67	12	with	with	ADP
dpc-2082	67	13	either	either	CCONJ
dpc-2082	67	14	bullous	bullous	ADJ
dpc-2082	67	15	pemphigoid	pemphigoid	NOUN
dpc-2082	67	16	(	(	PUNCT
dpc-2082	67	17	n	n	NOUN
dpc-2082	67	18	=	=	NOUN
dpc-2082	67	19	 	 	SPACE
dpc-2082	67	20	2	2	NUM
dpc-2082	67	21	)	)	PUNCT
dpc-2082	67	22	or	or	CCONJ
dpc-2082	67	23	pemphigus	pemphigus	PROPN
dpc-2082	67	24	foliaceus	foliaceus	NOUN
dpc-2082	67	25	(	(	PUNCT
dpc-2082	67	26	n	n	NOUN
dpc-2082	67	27	=	=	SYM
dpc-2082	67	28	1	1	NUM
dpc-2082	67	29	)	)	PUNCT
dpc-2082	67	30	,	,	PUNCT
dpc-2082	67	31	1	1	NUM
dpc-2082	67	32	patient	patient	NOUN
dpc-2082	67	33	from	from	ADP
dpc-2082	67	34	category	category	NOUN
dpc-2082	67	35	2	2	NUM
dpc-2082	67	36	diagnosed	diagnose	VERB
dpc-2082	67	37	with	with	ADP
dpc-2082	67	38	mde	mde	NOUN
dpc-2082	67	39	and	and	CCONJ
dpc-2082	67	40	2	2	NUM
dpc-2082	67	41	cases	case	NOUN
dpc-2082	67	42	from	from	ADP
dpc-2082	67	43	category	category	NOUN
dpc-2082	67	44	4	4	NUM
dpc-2082	67	45	diagnosed	diagnose	VERB
dpc-2082	67	46	with	with	ADP
dpc-2082	67	47	bullous	bullous	ADJ
dpc-2082	67	48	mycosis	mycosis	NOUN
dpc-2082	67	49	fungoides	fungoide	NOUN
dpc-2082	67	50	and	and	CCONJ
dpc-2082	67	51	psoriasiform	psoriasiform	PROPN
dpc-2082	67	52	dermatitis	dermatitis	PROPN
dpc-2082	67	53	,	,	PUNCT
dpc-2082	67	54	respectively	respectively	ADV
dpc-2082	67	55	,	,	PUNCT
dpc-2082	67	56	showed	show	VERB
dpc-2082	67	57	positive	positive	ADJ
dpc-2082	67	58	immunofluorescence	immunofluorescence	NOUN
dpc-2082	67	59	in	in	ADP
dpc-2082	67	60	dif	dif	X
dpc-2082	67	61	assay	assay	NOUN
dpc-2082	67	62	.	.	PUNCT
dpc-2082	68	1	two	two	NUM
dpc-2082	68	2	cases	case	NOUN
dpc-2082	68	3	of	of	ADP
dpc-2082	68	4	bullous	bullous	ADJ
dpc-2082	68	5	pemphigoid	pemphigoid	NOUN
dpc-2082	68	6	showed	show	VERB
dpc-2082	68	7	linear	linear	PROPN
dpc-2082	68	8	igg	igg	PROPN
dpc-2082	68	9	and	and	CCONJ
dpc-2082	68	10	c3	c3	PROPN
dpc-2082	68	11	deposition	deposition	NOUN
dpc-2082	68	12	at	at	ADP
dpc-2082	68	13	the	the	DET
dpc-2082	68	14	dermoepidermal	dermoepidermal	ADJ
dpc-2082	68	15	junction	junction	NOUN
dpc-2082	68	16	(	(	PUNCT
dpc-2082	68	17	figure	figure	NOUN
dpc-2082	68	18	4	4	NUM
dpc-2082	68	19	)	)	PUNCT
dpc-2082	68	20	,	,	PUNCT
dpc-2082	68	21	whereas	whereas	SCONJ
dpc-2082	68	22	intercellular	intercellular	ADJ
dpc-2082	68	23	igg	igg	NOUN
dpc-2082	68	24	deposition	deposition	NOUN
dpc-2082	68	25	was	be	AUX
dpc-2082	68	26	detected	detect	VERB
dpc-2082	68	27	in	in	ADP
dpc-2082	68	28	pemphigus	pemphigus	PROPN
dpc-2082	68	29	foliaceus	foliaceus	NOUN
dpc-2082	68	30	.	.	PUNCT
dpc-2082	69	1	conclusions	conclusion	NOUN
dpc-2082	69	2	to	to	ADP
dpc-2082	69	3	our	our	PRON
dpc-2082	69	4	knowledge	knowledge	NOUN
dpc-2082	69	5	,	,	PUNCT
dpc-2082	69	6	this	this	PRON
dpc-2082	69	7	is	be	AUX
dpc-2082	69	8	the	the	DET
dpc-2082	69	9	first	first	ADJ
dpc-2082	69	10	study	study	NOUN
dpc-2082	69	11	which	which	PRON
dpc-2082	69	12	evaluates	evaluate	VERB
dpc-2082	69	13	diagnostic	diagnostic	ADJ
dpc-2082	69	14	significance	significance	NOUN
dpc-2082	69	15	of	of	ADP
dpc-2082	69	16	dif	dif	ADJ
dpc-2082	69	17	examination	examination	NOUN
dpc-2082	69	18	in	in	ADP
dpc-2082	69	19	clarifying	clarify	VERB
dpc-2082	69	20	the	the	DET
dpc-2082	69	21	etiopathogenesis	etiopathogenesis	NOUN
dpc-2082	69	22	of	of	ADP
dpc-2082	69	23	exfoliative	exfoliative	ADJ
dpc-2082	69	24	dermatitis	dermatitis	NOUN
dpc-2082	69	25	.	.	PUNCT
dpc-2082	70	1	immunofluorescence	immunofluorescence	NOUN
dpc-2082	70	2	microscopy	microscopy	NOUN
dpc-2082	70	3	is	be	AUX
dpc-2082	70	4	a	a	DET
dpc-2082	70	5	well	well	ADV
dpc-2082	70	6	-	-	PUNCT
dpc-2082	70	7	developed	develop	VERB
dpc-2082	70	8	,	,	PUNCT
dpc-2082	70	9	advanced	advanced	ADJ
dpc-2082	70	10	technique	technique	NOUN
dpc-2082	70	11	which	which	PRON
dpc-2082	70	12	is	be	AUX
dpc-2082	70	13	utilized	utilize	VERB
dpc-2082	70	14	for	for	ADP
dpc-2082	70	15	the	the	DET
dpc-2082	70	16	detection	detection	NOUN
dpc-2082	70	17	of	of	ADP
dpc-2082	70	18	tissue	tissue	NOUN
dpc-2082	70	19	-	-	PUNCT
dpc-2082	70	20	fixed	fix	VERB
dpc-2082	70	21	antibodies	antibody	NOUN
dpc-2082	70	22	.	.	PUNCT
dpc-2082	71	1	for	for	ADP
dpc-2082	71	2	cutaneous	cutaneous	ADJ
dpc-2082	71	3	disorders	disorder	NOUN
dpc-2082	71	4	,	,	PUNCT
dpc-2082	71	5	dif	dif	ADV
dpc-2082	71	6	is	be	AUX
dpc-2082	71	7	used	use	VERB
dpc-2082	71	8	for	for	ADP
dpc-2082	71	9	designation	designation	NOUN
dpc-2082	71	10	of	of	ADP
dpc-2082	71	11	the	the	DET
dpc-2082	71	12	antibodies	antibody	NOUN
dpc-2082	71	13	bound	bind	VERB
dpc-2082	71	14	to	to	ADP
dpc-2082	71	15	a	a	DET
dpc-2082	71	16	specific	specific	ADJ
dpc-2082	71	17	antigen	antigen	NOUN
dpc-2082	71	18	in	in	ADP
dpc-2082	71	19	the	the	DET
dpc-2082	71	20	skin	skin	NOUN
dpc-2082	71	21	[	[	X
dpc-2082	71	22	7	7	NUM
dpc-2082	71	23	]	]	PUNCT
dpc-2082	71	24	.	.	PUNCT
dpc-2082	72	1	dif	dif	PROPN
dpc-2082	72	2	assay	assay	PROPN
dpc-2082	72	3	simply	simply	ADV
dpc-2082	72	4	involves	involve	VERB
dpc-2082	72	5	the	the	DET
dpc-2082	72	6	application	application	NOUN
dpc-2082	72	7	of	of	ADP
dpc-2082	72	8	fluorescein	fluorescein	NOUN
dpc-2082	72	9	-	-	PUNCT
dpc-2082	72	10	labeled	label	VERB
dpc-2082	72	11	secondary	secondary	ADJ
dpc-2082	72	12	antibodies	antibody	NOUN
dpc-2082	72	13	to	to	ADP
dpc-2082	72	14	a	a	DET
dpc-2082	72	15	frozen	frozen	ADJ
dpc-2082	72	16	section	section	NOUN
dpc-2082	72	17	of	of	ADP
dpc-2082	72	18	sample	sample	NOUN
dpc-2082	72	19	tissue	tissue	NOUN
dpc-2082	72	20	followed	follow	VERB
dpc-2082	72	21	by	by	ADP
dpc-2082	72	22	examination	examination	NOUN
dpc-2082	72	23	of	of	ADP
dpc-2082	72	24	the	the	DET
dpc-2082	72	25	issue	issue	NOUN
dpc-2082	72	26	for	for	ADP
dpc-2082	72	27	the	the	DET
dpc-2082	72	28	deposition	deposition	NOUN
dpc-2082	72	29	of	of	ADP
dpc-2082	72	30	immune	immune	ADJ
dpc-2082	72	31	reactants	reactant	NOUN
dpc-2082	72	32	under	under	ADP
dpc-2082	72	33	immunofluorescence	immunofluorescence	NOUN
dpc-2082	72	34	microscopy	microscopy	NOUN
dpc-2082	72	35	[	[	X
dpc-2082	72	36	7	7	NUM
dpc-2082	72	37	]	]	PUNCT
dpc-2082	72	38	.	.	PUNCT
dpc-2082	73	1	dif	dif	PROPN
dpc-2082	73	2	is	be	AUX
dpc-2082	73	3	generally	generally	ADV
dpc-2082	73	4	considered	consider	VERB
dpc-2082	73	5	to	to	PART
dpc-2082	73	6	be	be	AUX
dpc-2082	73	7	an	an	DET
dpc-2082	73	8	auxiliary	auxiliary	ADJ
dpc-2082	73	9	tool	tool	NOUN
dpc-2082	73	10	which	which	PRON
dpc-2082	73	11	aids	aid	VERB
dpc-2082	73	12	drug	drug	NOUN
dpc-2082	73	13	eruption	eruption	NOUN
dpc-2082	73	14	;	;	PUNCT
dpc-2082	73	15	category	category	NOUN
dpc-2082	73	16	3	3	NUM
dpc-2082	73	17	encompasses	encompass	VERB
dpc-2082	73	18	purpura	purpura	NOUN
dpc-2082	73	19	fulminans	fulminan	NOUN
dpc-2082	73	20	,	,	PUNCT
dpc-2082	73	21	antiphospholipid	antiphospholipid	NOUN
dpc-2082	73	22	syndrome	syndrome	NOUN
dpc-2082	73	23	and	and	CCONJ
dpc-2082	73	24	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	73	25	vasculitis	vasculitis	PROPN
dpc-2082	73	26	,	,	PUNCT
dpc-2082	73	27	whereas	whereas	SCONJ
dpc-2082	73	28	category	category	NOUN
dpc-2082	73	29	4	4	NUM
dpc-2082	73	30	consists	consist	VERB
dpc-2082	73	31	of	of	ADP
dpc-2082	73	32	miscellaneous	miscellaneous	ADJ
dpc-2082	73	33	causes	cause	NOUN
dpc-2082	73	34	of	of	ADP
dpc-2082	73	35	erythroderma	erythroderma	NOUN
dpc-2082	73	36	including	include	VERB
dpc-2082	73	37	,	,	PUNCT
dpc-2082	73	38	bullous	bullous	ADJ
dpc-2082	73	39	mycosis	mycosis	NOUN
dpc-2082	73	40	fungoides	fungoide	NOUN
dpc-2082	73	41	,	,	PUNCT
dpc-2082	73	42	sacd	sacd	NOUN
dpc-2082	73	43	,	,	PUNCT
dpc-2082	73	44	psoriasis	psoriasis	NOUN
dpc-2082	73	45	and	and	CCONJ
dpc-2082	73	46	psoriasiform	psoriasiform	PROPN
dpc-2082	73	47	dermatitis	dermatitis	PROPN
dpc-2082	73	48	(	(	PUNCT
dpc-2082	73	49	table	table	NOUN
dpc-2082	73	50	1	1	NUM
dpc-2082	73	51	)	)	PUNCT
dpc-2082	73	52	.	.	PUNCT
dpc-2082	74	1	patients	patient	NOUN
dpc-2082	74	2	in	in	ADP
dpc-2082	74	3	category	category	NOUN
dpc-2082	74	4	3	3	NUM
dpc-2082	74	5	(	(	PUNCT
dpc-2082	74	6	purpura	purpura	NOUN
dpc-2082	74	7	fulminans	fulminan	NOUN
dpc-2082	74	8	,	,	PUNCT
dpc-2082	74	9	antiphospholipid	antiphospholipid	NOUN
dpc-2082	74	10	syndrome	syndrome	NOUN
dpc-2082	74	11	and	and	CCONJ
dpc-2082	74	12	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	74	13	vasculitis	vasculitis	PROPN
dpc-2082	74	14	)	)	PUNCT
dpc-2082	74	15	were	be	AUX
dpc-2082	74	16	accepted	accept	VERB
dpc-2082	74	17	to	to	PART
dpc-2082	74	18	present	present	VERB
dpc-2082	74	19	an	an	DET
dpc-2082	74	20	erythrodermic	erythrodermic	ADJ
dpc-2082	74	21	-	-	PUNCT
dpc-2082	74	22	purpuric	purpuric	ADJ
dpc-2082	74	23	form	form	NOUN
dpc-2082	74	24	of	of	ADP
dpc-2082	74	25	the	the	DET
dpc-2082	74	26	disease	disease	NOUN
dpc-2082	74	27	described	describe	VERB
dpc-2082	74	28	,	,	PUNCT
dpc-2082	74	29	since	since	SCONJ
dpc-2082	74	30	>	>	X
dpc-2082	74	31	90	90	NUM
dpc-2082	74	32	%	%	NOUN
dpc-2082	74	33	of	of	ADP
dpc-2082	74	34	the	the	DET
dpc-2082	74	35	body	body	NOUN
dpc-2082	74	36	surface	surface	NOUN
dpc-2082	74	37	area	area	NOUN
dpc-2082	74	38	were	be	AUX
dpc-2082	74	39	covered	cover	VERB
dpc-2082	74	40	with	with	ADP
dpc-2082	74	41	erythema	erythema	NOUN
dpc-2082	74	42	accompanied	accompany	VERB
dpc-2082	74	43	by	by	ADP
dpc-2082	74	44	hemorrhagic	hemorrhagic	NOUN
dpc-2082	74	45	bullae	bullae	NOUN
dpc-2082	74	46	and	and	CCONJ
dpc-2082	74	47	ecchymotic	ecchymotic	ADJ
dpc-2082	74	48	plaque	plaque	NOUN
dpc-2082	74	49	.	.	PUNCT
dpc-2082	75	1	the	the	DET
dpc-2082	75	2	most	most	ADV
dpc-2082	75	3	frequent	frequent	ADJ
dpc-2082	75	4	final	final	ADJ
dpc-2082	75	5	clinical	clinical	ADJ
dpc-2082	75	6	-	-	PUNCT
dpc-2082	75	7	pathological	pathological	ADJ
dpc-2082	75	8	diagnosis	diagnosis	NOUN
dpc-2082	75	9	was	be	AUX
dpc-2082	75	10	acde	acde	ADV
dpc-2082	75	11	category	category	NOUN
dpc-2082	75	12	(	(	PUNCT
dpc-2082	75	13	category	category	NOUN
dpc-2082	75	14	2	2	NUM
dpc-2082	75	15	)	)	PUNCT
dpc-2082	75	16	(	(	PUNCT
dpc-2082	75	17	64.5	64.5	NUM
dpc-2082	75	18	%	%	NOUN
dpc-2082	75	19	,	,	PUNCT
dpc-2082	75	20	n	n	NOUN
dpc-2082	75	21	=	=	SYM
dpc-2082	75	22	20	20	NUM
dpc-2082	75	23	)	)	PUNCT
dpc-2082	75	24	followed	follow	VERB
dpc-2082	75	25	by	by	ADP
dpc-2082	75	26	bullous	bullous	ADJ
dpc-2082	75	27	pemphigoid	pemphigoid	NOUN
dpc-2082	75	28	(	(	PUNCT
dpc-2082	75	29	6.5	6.5	NUM
dpc-2082	75	30	%	%	NOUN
dpc-2082	75	31	,	,	PUNCT
dpc-2082	75	32	n	n	NOUN
dpc-2082	75	33	=	=	SYM
dpc-2082	75	34	2	2	NUM
dpc-2082	75	35	)	)	PUNCT
dpc-2082	75	36	and	and	CCONJ
dpc-2082	75	37	sacd	sacd	NOUN
dpc-2082	75	38	(	(	PUNCT
dpc-2082	75	39	6.5	6.5	NUM
dpc-2082	75	40	%	%	NOUN
dpc-2082	75	41	,	,	PUNCT
dpc-2082	75	42	n	n	NOUN
dpc-2082	76	1	=	=	SYM
dpc-2082	76	2	2	2	NUM
dpc-2082	76	3	)	)	PUNCT
dpc-2082	76	4	(	(	PUNCT
dpc-2082	76	5	table	table	NOUN
dpc-2082	76	6	1	1	NUM
dpc-2082	76	7	)	)	PUNCT
dpc-2082	76	8	.	.	PUNCT
dpc-2082	77	1	the	the	DET
dpc-2082	77	2	only	only	ADJ
dpc-2082	77	3	patient	patient	NOUN
dpc-2082	77	4	diagnosed	diagnose	VERB
dpc-2082	77	5	histopathologically	histopathologically	ADV
dpc-2082	77	6	with	with	ADP
dpc-2082	77	7	‘	'	PUNCT
dpc-2082	77	8	psoriasiform	psoriasiform	NOUN
dpc-2082	77	9	dermatitis	dermatitis	NOUN
dpc-2082	77	10	’	'	PUNCT
dpc-2082	77	11	was	be	AUX
dpc-2082	77	12	accepted	accept	VERB
dpc-2082	77	13	to	to	PART
dpc-2082	77	14	have	have	VERB
dpc-2082	77	15	an	an	DET
dpc-2082	77	16	idiopathic	idiopathic	ADJ
dpc-2082	77	17	form	form	NOUN
dpc-2082	77	18	of	of	ADP
dpc-2082	77	19	erythroderma	erythroderma	NOUN
dpc-2082	77	20	.	.	PUNCT
dpc-2082	78	1	clinical	clinical	ADJ
dpc-2082	78	2	and	and	CCONJ
dpc-2082	78	3	histopathological	histopathological	ADJ
dpc-2082	78	4	pictures	picture	NOUN
dpc-2082	78	5	of	of	ADP
dpc-2082	78	6	erythrodermic	erythrodermic	ADJ
dpc-2082	78	7	patients	patient	NOUN
dpc-2082	78	8	with	with	ADP
dpc-2082	78	9	different	different	ADJ
dpc-2082	78	10	underlying	underlie	VERB
dpc-2082	78	11	etiologies	etiology	NOUN
dpc-2082	78	12	are	be	AUX
dpc-2082	78	13	shown	show	VERB
dpc-2082	78	14	in	in	ADP
dpc-2082	78	15	figures	figure	NOUN
dpc-2082	78	16	1	1	NUM
dpc-2082	78	17	-	-	SYM
dpc-2082	78	18	5	5	NUM
dpc-2082	78	19	.	.	PUNCT
dpc-2082	78	20	presence	presence	NOUN
dpc-2082	78	21	of	of	ADP
dpc-2082	78	22	any	any	DET
dpc-2082	78	23	accompanying	accompanying	ADJ
dpc-2082	78	24	pustule	pustule	NOUN
dpc-2082	78	25	,	,	PUNCT
dpc-2082	78	26	bulla	bulla	NOUN
dpc-2082	78	27	,	,	PUNCT
dpc-2082	78	28	vesicle	vesicle	NOUN
dpc-2082	78	29	,	,	PUNCT
dpc-2082	78	30	necrosis	necrosis	NOUN
dpc-2082	78	31	,	,	PUNCT
dpc-2082	78	32	erosion	erosion	NOUN
dpc-2082	78	33	and	and	CCONJ
dpc-2082	78	34	crusting	crusting	NOUN
dpc-2082	78	35	were	be	AUX
dpc-2082	78	36	also	also	ADV
dpc-2082	78	37	determined	determined	ADJ
dpc-2082	78	38	as	as	ADP
dpc-2082	78	39	the	the	DET
dpc-2082	78	40	part	part	NOUN
dpc-2082	78	41	of	of	ADP
dpc-2082	78	42	dermatological	dermatological	ADJ
dpc-2082	78	43	examination	examination	NOUN
dpc-2082	78	44	as	as	SCONJ
dpc-2082	78	45	shown	show	VERB
dpc-2082	78	46	in	in	ADP
dpc-2082	78	47	table	table	NOUN
dpc-2082	78	48	1	1	NUM
dpc-2082	78	49	.	.	PUNCT
dpc-2082	79	1	for	for	ADP
dpc-2082	79	2	the	the	DET
dpc-2082	79	3	category	category	NOUN
dpc-2082	79	4	2	2	NUM
dpc-2082	79	5	,	,	PUNCT
dpc-2082	79	6	the	the	DET
dpc-2082	79	7	mean	mean	NOUN
dpc-2082	79	8	elapsed	elapse	VERB
dpc-2082	79	9	time	time	NOUN
dpc-2082	79	10	between	between	ADP
dpc-2082	79	11	the	the	DET
dpc-2082	79	12	onset	onset	NOUN
dpc-2082	79	13	of	of	ADP
dpc-2082	79	14	the	the	DET
dpc-2082	79	15	rash	rash	NOUN
dpc-2082	79	16	and	and	CCONJ
dpc-2082	79	17	most	most	ADV
dpc-2082	79	18	probable	probable	ADJ
dpc-2082	79	19	inciting	incite	VERB
dpc-2082	79	20	drug	drug	NOUN
dpc-2082	79	21	intake	intake	NOUN
dpc-2082	79	22	was	be	AUX
dpc-2082	79	23	14.6	14.6	NUM
dpc-2082	79	24	±	±	NUM
dpc-2082	79	25	13.9	13.9	NUM
dpc-2082	79	26	days	day	NOUN
dpc-2082	79	27	(	(	PUNCT
dpc-2082	79	28	range	range	NOUN
dpc-2082	79	29	:	:	PUNCT
dpc-2082	79	30	0	0	NUM
dpc-2082	79	31	-	-	SYM
dpc-2082	79	32	42	42	NUM
dpc-2082	79	33	days	day	NOUN
dpc-2082	79	34	)	)	PUNCT
dpc-2082	79	35	.	.	PUNCT
dpc-2082	80	1	the	the	DET
dpc-2082	80	2	most	most	ADV
dpc-2082	80	3	common	common	ADJ
dpc-2082	80	4	probable	probable	ADJ
dpc-2082	80	5	causes	cause	NOUN
dpc-2082	80	6	of	of	ADP
dpc-2082	80	7	erythroderma	erythroderma	NOUN
dpc-2082	80	8	were	be	AUX
dpc-2082	80	9	antimicrobials	antimicrobial	NOUN
dpc-2082	80	10	(	(	PUNCT
dpc-2082	80	11	40	40	NUM
dpc-2082	80	12	%	%	NOUN
dpc-2082	80	13	,	,	PUNCT
dpc-2082	80	14	n	n	PROPN
dpc-2082	80	15	=	=	SYM
dpc-2082	80	16	8)	8)	NUM
dpc-2082	80	17	,	,	PUNCT
dpc-2082	80	18	followed	follow	VERB
dpc-2082	80	19	by	by	ADP
dpc-2082	80	20	allopurinol	allopurinol	NOUN
dpc-2082	80	21	(	(	PUNCT
dpc-2082	80	22	20	20	NUM
dpc-2082	80	23	%	%	NOUN
dpc-2082	80	24	,	,	PUNCT
dpc-2082	80	25	n	n	NOUN
dpc-2082	80	26	=	=	SYM
dpc-2082	80	27	4	4	NUM
dpc-2082	80	28	)	)	PUNCT
dpc-2082	80	29	,	,	PUNCT
dpc-2082	80	30	phenytoin	phenytoin	NOUN
dpc-2082	80	31	(	(	PUNCT
dpc-2082	80	32	15	15	NUM
dpc-2082	80	33	%	%	NOUN
dpc-2082	80	34	,	,	PUNCT
dpc-2082	80	35	n	n	NOUN
dpc-2082	80	36	=	=	SYM
dpc-2082	80	37	3	3	NUM
dpc-2082	80	38	)	)	PUNCT
dpc-2082	80	39	,	,	PUNCT
dpc-2082	80	40	hydroxychloroquine	hydroxychloroquine	PROPN
dpc-2082	80	41	(	(	PUNCT
dpc-2082	80	42	10	10	NUM
dpc-2082	80	43	%	%	NOUN
dpc-2082	80	44	,	,	PUNCT
dpc-2082	80	45	n	n	NOUN
dpc-2082	80	46	=	=	SYM
dpc-2082	80	47	2	2	NUM
dpc-2082	80	48	)	)	PUNCT
dpc-2082	80	49	,	,	PUNCT
dpc-2082	80	50	intravenous	intravenous	ADJ
dpc-2082	80	51	contrast	contrast	NOUN
dpc-2082	80	52	media	medium	NOUN
dpc-2082	80	53	(	(	PUNCT
dpc-2082	80	54	10	10	NUM
dpc-2082	80	55	%	%	NOUN
dpc-2082	80	56	,	,	PUNCT
dpc-2082	80	57	n	n	NOUN
dpc-2082	80	58	=	=	SYM
dpc-2082	80	59	2	2	NUM
dpc-2082	80	60	)	)	PUNCT
dpc-2082	80	61	,	,	PUNCT
dpc-2082	80	62	chemotherapy	chemotherapy	NOUN
dpc-2082	80	63	agents	agent	NOUN
dpc-2082	80	64	(	(	PUNCT
dpc-2082	80	65	10	10	NUM
dpc-2082	80	66	%	%	NOUN
dpc-2082	80	67	,	,	PUNCT
dpc-2082	80	68	n	n	NOUN
dpc-2082	80	69	=	=	SYM
dpc-2082	80	70	2	2	NUM
dpc-2082	80	71	)	)	PUNCT
dpc-2082	80	72	and	and	CCONJ
dpc-2082	80	73	others	other	NOUN
dpc-2082	80	74	(	(	PUNCT
dpc-2082	80	75	15	15	NUM
dpc-2082	80	76	%	%	NOUN
dpc-2082	80	77	,	,	PUNCT
dpc-2082	80	78	n	n	NOUN
dpc-2082	80	79	=	=	SYM
dpc-2082	80	80	3	3	NUM
dpc-2082	80	81	)	)	PUNCT
dpc-2082	80	82	.	.	PUNCT
dpc-2082	81	1	the	the	DET
dpc-2082	81	2	sample	sample	NOUN
dpc-2082	81	3	tissue	tissue	NOUN
dpc-2082	81	4	for	for	ADP
dpc-2082	81	5	dif	dif	X
dpc-2082	81	6	examination	examination	NOUN
dpc-2082	81	7	was	be	AUX
dpc-2082	81	8	taken	take	VERB
dpc-2082	81	9	figure	figure	NOUN
dpc-2082	81	10	1	1	NUM
dpc-2082	81	11	.	.	PUNCT
dpc-2082	82	1	(	(	PUNCT
dpc-2082	82	2	a	a	X
dpc-2082	82	3	)	)	PUNCT
dpc-2082	82	4	presentation	presentation	NOUN
dpc-2082	82	5	of	of	ADP
dpc-2082	82	6	erythroderma	erythroderma	NOUN
dpc-2082	82	7	in	in	ADP
dpc-2082	82	8	a	a	DET
dpc-2082	82	9	patient	patient	NOUN
dpc-2082	82	10	diagnosed	diagnose	VERB
dpc-2082	82	11	with	with	ADP
dpc-2082	82	12	mycosis	mycosis	NOUN
dpc-2082	82	13	fungoides	fungoide	NOUN
dpc-2082	82	14	widespread	widespread	ADJ
dpc-2082	82	15	erythema	erythema	ADJ
dpc-2082	82	16	and	and	CCONJ
dpc-2082	82	17	scaling	scaling	NOUN
dpc-2082	82	18	.	.	PUNCT
dpc-2082	83	1	(	(	PUNCT
dpc-2082	83	2	b	b	X
dpc-2082	83	3	)	)	PUNCT
dpc-2082	83	4	yellow	yellow	ADJ
dpc-2082	83	5	/	/	SYM
dpc-2082	83	6	brown	brown	ADJ
dpc-2082	83	7	color	color	NOUN
dpc-2082	83	8	change	change	NOUN
dpc-2082	83	9	and	and	CCONJ
dpc-2082	83	10	subungal	subungal	ADJ
dpc-2082	83	11	hyperkeratosis	hyperkeratosis	NOUN
dpc-2082	83	12	of	of	ADP
dpc-2082	83	13	the	the	DET
dpc-2082	83	14	fingernails	fingernail	NOUN
dpc-2082	83	15	.	.	PUNCT
dpc-2082	84	1	(	(	PUNCT
dpc-2082	84	2	c	c	X
dpc-2082	84	3	)	)	PUNCT
dpc-2082	84	4	diffuse	diffuse	VERB
dpc-2082	84	5	dermo	dermo	NOUN
dpc-2082	84	6	-	-	PUNCT
dpc-2082	84	7	epidermal	epidermal	ADJ
dpc-2082	84	8	atypical	atypical	ADJ
dpc-2082	84	9	lymphoid	lymphoid	NOUN
dpc-2082	84	10	infiltrate	infiltrate	NOUN
dpc-2082	84	11	which	which	PRON
dpc-2082	84	12	shows	show	VERB
dpc-2082	84	13	epidermotropism	epidermotropism	NOUN
dpc-2082	84	14	(	(	PUNCT
dpc-2082	84	15	h&e	h&e	PROPN
dpc-2082	84	16	,	,	PUNCT
dpc-2082	84	17	x200	x200	PROPN
dpc-2082	84	18	)	)	PUNCT
dpc-2082	84	19	.	.	PUNCT
dpc-2082	85	1	original	original	ADJ
dpc-2082	85	2	article	article	NOUN
dpc-2082	85	3	|	|	ADV
dpc-2082	85	4	dermatol	dermatol	ADJ
dpc-2082	85	5	pract	pract	NOUN
dpc-2082	85	6	concept	concept	NOUN
dpc-2082	85	7	.	.	PUNCT
dpc-2082	86	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	86	2	5	5	NUM
dpc-2082	86	3	figure	figure	NOUN
dpc-2082	86	4	2	2	NUM
dpc-2082	86	5	.	.	PUNCT
dpc-2082	87	1	(	(	PUNCT
dpc-2082	87	2	a	a	X
dpc-2082	87	3	)	)	PUNCT
dpc-2082	87	4	dusky	dusky	ADJ
dpc-2082	87	5	red	red	ADJ
dpc-2082	87	6	,	,	PUNCT
dpc-2082	87	7	violaceous	violaceous	ADJ
dpc-2082	87	8	targetoid	targetoid	NOUN
dpc-2082	87	9	plaque	plaque	NOUN
dpc-2082	87	10	and	and	CCONJ
dpc-2082	87	11	bulla	bulla	ADJ
dpc-2082	87	12	formation	formation	NOUN
dpc-2082	87	13	in	in	ADP
dpc-2082	87	14	a	a	DET
dpc-2082	87	15	patient	patient	NOUN
dpc-2082	87	16	with	with	ADP
dpc-2082	87	17	sjs	sjs	PROPN
dpc-2082	87	18	.	.	PUNCT
dpc-2082	88	1	(	(	PUNCT
dpc-2082	88	2	b	b	X
dpc-2082	88	3	)	)	PUNCT
dpc-2082	88	4	in	in	ADP
dpc-2082	88	5	the	the	DET
dpc-2082	88	6	same	same	ADJ
dpc-2082	88	7	patient	patient	ADJ
dpc-2082	88	8	skin	skin	NOUN
dpc-2082	88	9	biopsy	biopsy	NOUN
dpc-2082	88	10	,	,	PUNCT
dpc-2082	88	11	vacuolar	vacuolar	ADJ
dpc-2082	88	12	degeneration	degeneration	NOUN
dpc-2082	88	13	,	,	PUNCT
dpc-2082	88	14	necrotic	necrotic	ADJ
dpc-2082	88	15	keratinocytes	keratinocyte	NOUN
dpc-2082	88	16	and	and	CCONJ
dpc-2082	88	17	pigment	pigment	NOUN
dpc-2082	88	18	incontinence	incontinence	NOUN
dpc-2082	88	19	compatible	compatible	ADJ
dpc-2082	88	20	with	with	ADP
dpc-2082	88	21	stevens	stevens	PROPN
dpc-2082	88	22	-	-	PUNCT
dpc-2082	88	23	johnson	johnson	PROPN
dpc-2082	88	24	syndrome	syndrome	NOUN
dpc-2082	88	25	are	be	AUX
dpc-2082	88	26	observed	observe	VERB
dpc-2082	88	27	(	(	PUNCT
dpc-2082	88	28	h&e	h&e	PROPN
dpc-2082	88	29	,	,	PUNCT
dpc-2082	88	30	x200	x200	PROPN
dpc-2082	88	31	)	)	PUNCT
dpc-2082	88	32	.	.	PUNCT
dpc-2082	89	1	(	(	PUNCT
dpc-2082	89	2	c	c	X
dpc-2082	89	3	)	)	PUNCT
dpc-2082	89	4	widespread	widespread	ADV
dpc-2082	89	5	annular	annular	ADJ
dpc-2082	89	6	,	,	PUNCT
dpc-2082	89	7	polycyclic	polycyclic	NOUN
dpc-2082	89	8	-	-	PUNCT
dpc-2082	89	9	erythematous	erythematous	ADJ
dpc-2082	89	10	plaques	plaque	NOUN
dpc-2082	89	11	with	with	ADP
dpc-2082	89	12	scale	scale	NOUN
dpc-2082	89	13	involving	involve	VERB
dpc-2082	89	14	the	the	DET
dpc-2082	89	15	trunk	trunk	NOUN
dpc-2082	89	16	and	and	CCONJ
dpc-2082	89	17	the	the	DET
dpc-2082	89	18	extremities	extremity	NOUN
dpc-2082	89	19	,	,	PUNCT
dpc-2082	89	20	(	(	PUNCT
dpc-2082	89	21	inset	inset	NOUN
dpc-2082	89	22	)	)	PUNCT
dpc-2082	89	23	closer	close	ADJ
dpc-2082	89	24	view	view	NOUN
dpc-2082	89	25	of	of	ADP
dpc-2082	89	26	the	the	DET
dpc-2082	89	27	plaques	plaque	NOUN
dpc-2082	89	28	in	in	ADP
dpc-2082	89	29	a	a	DET
dpc-2082	89	30	patient	patient	NOUN
dpc-2082	89	31	finally	finally	ADV
dpc-2082	89	32	diagnosed	diagnose	VERB
dpc-2082	89	33	with	with	ADP
dpc-2082	89	34	idiopathic	idiopathic	ADJ
dpc-2082	89	35	erythroderma	erythroderma	NOUN
dpc-2082	89	36	.	.	PUNCT
dpc-2082	90	1	(	(	PUNCT
dpc-2082	90	2	d	d	X
dpc-2082	90	3	)	)	PUNCT
dpc-2082	90	4	histopathological	histopathological	ADJ
dpc-2082	90	5	examination	examination	NOUN
dpc-2082	90	6	of	of	ADP
dpc-2082	90	7	the	the	DET
dpc-2082	90	8	patient	patient	NOUN
dpc-2082	90	9	revealed	reveal	VERB
dpc-2082	90	10	psoriasiform	psoriasiform	NOUN
dpc-2082	90	11	dermatitis	dermatitis	PROPN
dpc-2082	90	12	with	with	ADP
dpc-2082	90	13	sub	sub	ADJ
dpc-2082	90	14	-	-	ADJ
dpc-2082	90	15	corneal	corneal	ADJ
dpc-2082	90	16	pustule	pustule	ADJ
dpc-2082	90	17	formation	formation	NOUN
dpc-2082	90	18	(	(	PUNCT
dpc-2082	90	19	h&e	h&e	PROPN
dpc-2082	90	20	,	,	PUNCT
dpc-2082	90	21	x200	x200	PROPN
dpc-2082	90	22	)	)	PUNCT
dpc-2082	90	23	.	.	PUNCT
dpc-2082	91	1	(	(	PUNCT
dpc-2082	91	2	e	e	NOUN
dpc-2082	91	3	)	)	PUNCT
dpc-2082	91	4	widespread	widespread	ADJ
dpc-2082	91	5	erythematous	erythematous	ADJ
dpc-2082	91	6	,	,	PUNCT
dpc-2082	91	7	confluent	confluent	ADJ
dpc-2082	91	8	patches	patch	NOUN
dpc-2082	91	9	and	and	CCONJ
dpc-2082	91	10	plaques	plaque	NOUN
dpc-2082	91	11	on	on	ADP
dpc-2082	91	12	the	the	DET
dpc-2082	91	13	trunk	trunk	NOUN
dpc-2082	91	14	in	in	ADP
dpc-2082	91	15	a	a	DET
dpc-2082	91	16	patient	patient	NOUN
dpc-2082	91	17	with	with	ADP
dpc-2082	91	18	drug	drug	NOUN
dpc-2082	91	19	eruption	eruption	NOUN
dpc-2082	91	20	.	.	PUNCT
dpc-2082	92	1	(	(	PUNCT
dpc-2082	92	2	f	f	X
dpc-2082	92	3	)	)	PUNCT
dpc-2082	92	4	the	the	DET
dpc-2082	92	5	same	same	ADJ
dpc-2082	92	6	patient	patient	NOUN
dpc-2082	92	7	’s	’s	PART
dpc-2082	92	8	skin	skin	NOUN
dpc-2082	92	9	biopsy	biopsy	NOUN
dpc-2082	92	10	showed	show	VERB
dpc-2082	92	11	vacuolar	vacuolar	ADJ
dpc-2082	92	12	degeneration	degeneration	NOUN
dpc-2082	92	13	at	at	ADP
dpc-2082	92	14	the	the	DET
dpc-2082	92	15	basal	basal	ADJ
dpc-2082	92	16	layer	layer	NOUN
dpc-2082	92	17	,	,	PUNCT
dpc-2082	92	18	capillary	capillary	ADJ
dpc-2082	92	19	congestion	congestion	NOUN
dpc-2082	92	20	and	and	CCONJ
dpc-2082	92	21	perivascular	perivascular	ADJ
dpc-2082	92	22	eosinophilic	eosinophilic	ADJ
dpc-2082	92	23	and	and	CCONJ
dpc-2082	92	24	neutrophilic	neutrophilic	ADJ
dpc-2082	92	25	inflammation	inflammation	NOUN
dpc-2082	92	26	compatible	compatible	ADJ
dpc-2082	92	27	with	with	ADP
dpc-2082	92	28	drug	drug	NOUN
dpc-2082	92	29	eruption	eruption	NOUN
dpc-2082	92	30	.	.	PUNCT
dpc-2082	93	1	figure	figure	NOUN
dpc-2082	93	2	3	3	NUM
dpc-2082	93	3	.	.	PUNCT
dpc-2082	94	1	(	(	PUNCT
dpc-2082	94	2	a	a	PRON
dpc-2082	94	3	)	)	PUNCT
dpc-2082	94	4	erythroderma	erythroderma	NOUN
dpc-2082	94	5	in	in	ADP
dpc-2082	94	6	a	a	DET
dpc-2082	94	7	patient	patient	NOUN
dpc-2082	94	8	with	with	ADP
dpc-2082	94	9	psoriasis	psoriasis	NOUN
dpc-2082	94	10	.	.	PUNCT
dpc-2082	95	1	histopathological	histopathological	ADJ
dpc-2082	95	2	findings	finding	NOUN
dpc-2082	95	3	in	in	ADP
dpc-2082	95	4	an	an	DET
dpc-2082	95	5	erythrodermic	erythrodermic	ADJ
dpc-2082	95	6	patient	patient	NOUN
dpc-2082	95	7	diagnosed	diagnose	VERB
dpc-2082	95	8	with	with	ADP
dpc-2082	95	9	psoriasis	psoriasis	NOUN
dpc-2082	95	10	.	.	PUNCT
dpc-2082	96	1	(	(	PUNCT
dpc-2082	96	2	b	b	X
dpc-2082	96	3	)	)	PUNCT
dpc-2082	96	4	subcorneal	subcorneal	ADJ
dpc-2082	96	5	neutrophilic	neutrophilic	ADJ
dpc-2082	96	6	pustule	pustule	NOUN
dpc-2082	96	7	(	(	PUNCT
dpc-2082	96	8	kogoj	kogoj	NOUN
dpc-2082	96	9	pustule	pustule	NOUN
dpc-2082	96	10	)	)	PUNCT
dpc-2082	96	11	formation	formation	NOUN
dpc-2082	96	12	is	be	AUX
dpc-2082	96	13	seen	see	VERB
dpc-2082	96	14	(	(	PUNCT
dpc-2082	96	15	arrowhead	arrowhead	NOUN
dpc-2082	96	16	,	,	PUNCT
dpc-2082	96	17	h&e	h&e	PROPN
dpc-2082	96	18	,	,	PUNCT
dpc-2082	96	19	x100	x100	PROPN
dpc-2082	96	20	)	)	PUNCT
dpc-2082	96	21	.	.	PUNCT
dpc-2082	97	1	(	(	PUNCT
dpc-2082	97	2	c	c	X
dpc-2082	97	3	)	)	PUNCT
dpc-2082	97	4	hypo	hypo	ADJ
dpc-2082	97	5	-	-	PUNCT
dpc-2082	97	6	granulosis	granulosis	NOUN
dpc-2082	97	7	and	and	CCONJ
dpc-2082	97	8	psoriasiform	psoriasiform	NOUN
dpc-2082	97	9	acanthosis	acanthosis	NOUN
dpc-2082	97	10	are	be	AUX
dpc-2082	97	11	present	present	ADJ
dpc-2082	97	12	(	(	PUNCT
dpc-2082	97	13	h&e	h&e	PROPN
dpc-2082	97	14	,	,	PUNCT
dpc-2082	97	15	x100	x100	PROPN
dpc-2082	97	16	)	)	PUNCT
dpc-2082	97	17	.	.	PUNCT
dpc-2082	98	1	to	to	PART
dpc-2082	98	2	reach	reach	VERB
dpc-2082	98	3	the	the	DET
dpc-2082	98	4	accurate	accurate	ADJ
dpc-2082	98	5	diagnosis	diagnosis	NOUN
dpc-2082	98	6	of	of	ADP
dpc-2082	98	7	various	various	ADJ
dpc-2082	98	8	dermatologic	dermatologic	ADJ
dpc-2082	98	9	disorders	disorder	NOUN
dpc-2082	98	10	especially	especially	ADV
dpc-2082	98	11	when	when	SCONJ
dpc-2082	98	12	supportive	supportive	ADJ
dpc-2082	98	13	histopathological	histopathological	ADJ
dpc-2082	98	14	changes	change	NOUN
dpc-2082	98	15	are	be	AUX
dpc-2082	98	16	minimal	minimal	ADJ
dpc-2082	98	17	.	.	PUNCT
dpc-2082	99	1	in	in	ADP
dpc-2082	99	2	dermatology	dermatology	NOUN
dpc-2082	99	3	practice	practice	NOUN
dpc-2082	99	4	,	,	PUNCT
dpc-2082	99	5	incorporating	incorporate	VERB
dpc-2082	99	6	dif	dif	ADV
dpc-2082	99	7	findings	finding	NOUN
dpc-2082	99	8	with	with	ADP
dpc-2082	99	9	routine	routine	ADJ
dpc-2082	99	10	pathological	pathological	ADJ
dpc-2082	99	11	findings	finding	NOUN
dpc-2082	99	12	are	be	AUX
dpc-2082	99	13	particularly	particularly	ADV
dpc-2082	99	14	useful	useful	ADJ
dpc-2082	99	15	in	in	ADP
dpc-2082	99	16	the	the	DET
dpc-2082	99	17	patients	patient	NOUN
dpc-2082	99	18	pre	pre	VERB
dpc-2082	99	19	-	-	VERB
dpc-2082	99	20	diagnosed	diagnose	VERB
dpc-2082	99	21	with	with	ADP
dpc-2082	99	22	absd	absd	ADJ
dpc-2082	99	23	,	,	PUNCT
dpc-2082	99	24	connective	connective	ADJ
dpc-2082	99	25	tissue	tissue	NOUN
dpc-2082	99	26	diseases	disease	NOUN
dpc-2082	99	27	and	and	CCONJ
dpc-2082	99	28	cutaneous	cutaneous	ADJ
dpc-2082	99	29	vasculitis	vasculitis	PROPN
dpc-2082	99	30	[	[	X
dpc-2082	99	31	7	7	NUM
dpc-2082	99	32	]	]	PUNCT
dpc-2082	99	33	.	.	PUNCT
dpc-2082	100	1	a	a	DET
dpc-2082	100	2	study	study	NOUN
dpc-2082	100	3	by	by	ADP
dpc-2082	100	4	buch	buch	PROPN
dpc-2082	100	5	et	et	PROPN
dpc-2082	100	6	al	al	PROPN
dpc-2082	100	7	showed	show	VERB
dpc-2082	100	8	that	that	SCONJ
dpc-2082	100	9	the	the	DET
dpc-2082	100	10	sensitivity	sensitivity	NOUN
dpc-2082	100	11	of	of	ADP
dpc-2082	100	12	dif	dif	ADV
dpc-2082	100	13	was	be	AUX
dpc-2082	100	14	94.44	94.44	NUM
dpc-2082	100	15	%	%	NOUN
dpc-2082	100	16	and	and	CCONJ
dpc-2082	100	17	84	84	NUM
dpc-2082	100	18	%	%	NOUN
dpc-2082	100	19	in	in	ADP
dpc-2082	100	20	the	the	DET
dpc-2082	100	21	pemphigus	pemphigus	NOUN
dpc-2082	100	22	vs	vs	ADP
dpc-2082	100	23	bullous	bullous	ADJ
dpc-2082	100	24	pemphigoid	pemphigoid	PROPN
dpc-2082	100	25	group	group	NOUN
dpc-2082	100	26	respectively	respectively	ADV
dpc-2082	100	27	[	[	X
dpc-2082	100	28	8	8	NUM
dpc-2082	100	29	]	]	PUNCT
dpc-2082	100	30	.	.	PUNCT
dpc-2082	101	1	dif	dif	PROPN
dpc-2082	101	2	was	be	AUX
dpc-2082	101	3	shown	show	VERB
dpc-2082	101	4	to	to	PART
dpc-2082	101	5	have	have	VERB
dpc-2082	101	6	diagnostic	diagnostic	ADJ
dpc-2082	101	7	significance	significance	NOUN
dpc-2082	101	8	in	in	ADP
dpc-2082	101	9	the	the	DET
dpc-2082	101	10	classification	classification	NOUN
dpc-2082	101	11	of	of	ADP
dpc-2082	101	12	cutaneous	cutaneous	ADJ
dpc-2082	101	13	small	small	ADJ
dpc-2082	101	14	vessel	vessel	NOUN
dpc-2082	101	15	vasculitides	vasculitide	NOUN
dpc-2082	101	16	especially	especially	ADV
dpc-2082	101	17	in	in	ADP
dpc-2082	101	18	iga	iga	PROPN
dpc-2082	101	19	vasculitis	vasculitis	NOUN
dpc-2082	101	20	and	and	CCONJ
dpc-2082	101	21	lupus	lupus	NOUN
dpc-2082	101	22	vasculitis	vasculitis	PROPN
dpc-2082	102	1	[	[	X
dpc-2082	102	2	9	9	NUM
dpc-2082	102	3	]	]	PUNCT
dpc-2082	102	4	.	.	PUNCT
dpc-2082	103	1	in	in	ADP
dpc-2082	103	2	erythrodermic	erythrodermic	ADJ
dpc-2082	103	3	patients	patient	NOUN
dpc-2082	103	4	,	,	PUNCT
dpc-2082	103	5	expeditious	expeditious	ADJ
dpc-2082	103	6	diagnosis	diagnosis	NOUN
dpc-2082	103	7	of	of	ADP
dpc-2082	103	8	the	the	DET
dpc-2082	103	9	underlying	underlying	ADJ
dpc-2082	103	10	cause	cause	NOUN
dpc-2082	103	11	is	be	AUX
dpc-2082	103	12	the	the	DET
dpc-2082	103	13	essential	essential	ADJ
dpc-2082	103	14	step	step	NOUN
dpc-2082	103	15	which	which	PRON
dpc-2082	103	16	enables	enable	VERB
dpc-2082	103	17	the	the	DET
dpc-2082	103	18	accurate	accurate	ADJ
dpc-2082	103	19	intervention	intervention	NOUN
dpc-2082	103	20	.	.	PUNCT
dpc-2082	104	1	in	in	ADP
dpc-2082	104	2	our	our	PRON
dpc-2082	104	3	study	study	NOUN
dpc-2082	104	4	,	,	PUNCT
dpc-2082	104	5	we	we	PRON
dpc-2082	104	6	aimed	aim	VERB
dpc-2082	104	7	to	to	PART
dpc-2082	104	8	determine	determine	VERB
dpc-2082	104	9	the	the	DET
dpc-2082	104	10	diagnostic	diagnostic	ADJ
dpc-2082	104	11	utility	utility	NOUN
dpc-2082	104	12	of	of	ADP
dpc-2082	104	13	dif	dif	ADV
dpc-2082	104	14	in	in	ADP
dpc-2082	104	15	patients	patient	NOUN
dpc-2082	104	16	with	with	ADP
dpc-2082	104	17	exfoliative	exfoliative	ADJ
dpc-2082	104	18	dermatitis	dermatitis	NOUN
dpc-2082	104	19	.	.	PUNCT
dpc-2082	105	1	erythroderma	erythroderma	PROPN
dpc-2082	105	2	appears	appear	VERB
dpc-2082	105	3	to	to	PART
dpc-2082	105	4	affect	affect	VERB
dpc-2082	105	5	men	man	NOUN
dpc-2082	105	6	more	more	ADJ
dpc-2082	105	7	than	than	ADP
dpc-2082	105	8	women	woman	NOUN
dpc-2082	105	9	even	even	ADV
dpc-2082	105	10	though	though	SCONJ
dpc-2082	105	11	in	in	ADP
dpc-2082	105	12	some	some	DET
dpc-2082	105	13	studies	study	NOUN
dpc-2082	105	14	no	no	DET
dpc-2082	105	15	sex	sex	NOUN
dpc-2082	105	16	predilection	predilection	NOUN
dpc-2082	105	17	is	be	AUX
dpc-2082	105	18	showed	show	VERB
dpc-2082	105	19	[	[	PUNCT
dpc-2082	105	20	3,10	3,10	NUM
dpc-2082	105	21	]	]	X
dpc-2082	105	22	.	.	PUNCT
dpc-2082	106	1	in	in	ADP
dpc-2082	106	2	line	line	NOUN
dpc-2082	106	3	with	with	ADP
dpc-2082	106	4	the	the	DET
dpc-2082	106	5	present	present	ADJ
dpc-2082	106	6	data	datum	NOUN
dpc-2082	106	7	in	in	ADP
dpc-2082	106	8	the	the	DET
dpc-2082	106	9	literature	literature	NOUN
dpc-2082	106	10	,	,	PUNCT
dpc-2082	106	11	our	our	PRON
dpc-2082	106	12	study	study	NOUN
dpc-2082	106	13	also	also	ADV
dpc-2082	106	14	showed	show	VERB
dpc-2082	106	15	a	a	DET
dpc-2082	106	16	slight	slight	ADJ
dpc-2082	106	17	male	male	ADJ
dpc-2082	106	18	predominance	predominance	NOUN
dpc-2082	106	19	with	with	ADP
dpc-2082	106	20	a	a	DET
dpc-2082	106	21	male	male	NOUN
dpc-2082	106	22	-	-	PUNCT
dpc-2082	106	23	to	to	ADP
dpc-2082	106	24	-	-	PUNCT
dpc-2082	106	25	female	female	ADJ
dpc-2082	106	26	ratio	ratio	NOUN
dpc-2082	106	27	of	of	ADP
dpc-2082	106	28	1.07	1.07	NUM
dpc-2082	106	29	.	.	PUNCT
dpc-2082	107	1	the	the	DET
dpc-2082	107	2	mean	mean	ADJ
dpc-2082	107	3	age	age	NOUN
dpc-2082	107	4	of	of	ADP
dpc-2082	107	5	affect	affect	VERB
dpc-2082	107	6	study	study	NOUN
dpc-2082	107	7	subjects	subject	NOUN
dpc-2082	107	8	in	in	ADP
dpc-2082	107	9	our	our	PRON
dpc-2082	107	10	study	study	NOUN
dpc-2082	107	11	was	be	AUX
dpc-2082	107	12	54.6	54.6	NUM
dpc-2082	107	13	±	±	NUM
dpc-2082	107	14	23	23	NUM
dpc-2082	107	15	years	year	NOUN
dpc-2082	107	16	(	(	PUNCT
dpc-2082	107	17	range	range	NOUN
dpc-2082	107	18	:	:	PUNCT
dpc-2082	107	19	386	386	NUM
dpc-2082	107	20	years	year	NOUN
dpc-2082	107	21	,	,	PUNCT
dpc-2082	107	22	median	median	NOUN
dpc-2082	107	23	:	:	PUNCT
dpc-2082	107	24	61	61	NUM
dpc-2082	107	25	years	year	NOUN
dpc-2082	107	26	)	)	PUNCT
dpc-2082	107	27	.	.	PUNCT
dpc-2082	108	1	in	in	ADP
dpc-2082	108	2	a	a	DET
dpc-2082	108	3	retrospective	retrospective	ADJ
dpc-2082	108	4	study	study	NOUN
dpc-2082	108	5	of	of	ADP
dpc-2082	108	6	49	49	NUM
dpc-2082	108	7	erythrodermic	erythrodermic	ADJ
dpc-2082	108	8	patients	patient	NOUN
dpc-2082	108	9	,	,	PUNCT
dpc-2082	108	10	the	the	DET
dpc-2082	108	11	average	average	ADJ
dpc-2082	108	12	age	age	NOUN
dpc-2082	108	13	was	be	AUX
dpc-2082	108	14	reported	report	VERB
dpc-2082	108	15	to	to	PART
dpc-2082	108	16	be	be	AUX
dpc-2082	108	17	50.7	50.7	NUM
dpc-2082	108	18	±	±	NUM
dpc-2082	108	19	17.9	17.9	NUM
dpc-2082	108	20	years	year	NOUN
dpc-2082	108	21	which	which	PRON
dpc-2082	108	22	was	be	AUX
dpc-2082	108	23	in	in	ADP
dpc-2082	108	24	concordance	concordance	NOUN
dpc-2082	108	25	with	with	ADP
dpc-2082	108	26	our	our	PRON
dpc-2082	108	27	findings	finding	NOUN
dpc-2082	108	28	[	[	X
dpc-2082	108	29	4	4	NUM
dpc-2082	108	30	]	]	PUNCT
dpc-2082	108	31	.	.	PUNCT
dpc-2082	109	1	as	as	ADP
dpc-2082	109	2	an	an	DET
dpc-2082	109	3	acquired	acquire	VERB
dpc-2082	109	4	-	-	PUNCT
dpc-2082	109	5	adulthood	adulthood	NOUN
dpc-2082	109	6	disease	disease	NOUN
dpc-2082	109	7	,	,	PUNCT
dpc-2082	109	8	erythroderma	erythroderma	NOUN
dpc-2082	109	9	may	may	AUX
dpc-2082	109	10	have	have	VERB
dpc-2082	109	11	various	various	ADJ
dpc-2082	109	12	underlying	underlie	VERB
dpc-2082	109	13	etiologies	etiology	NOUN
dpc-2082	109	14	or	or	CCONJ
dpc-2082	109	15	may	may	AUX
dpc-2082	109	16	be	be	AUX
dpc-2082	109	17	idiopathic	idiopathic	ADJ
dpc-2082	109	18	in	in	ADP
dpc-2082	109	19	at	at	ADV
dpc-2082	109	20	least	least	ADV
dpc-2082	109	21	25	25	NUM
dpc-2082	109	22	%	%	NOUN
dpc-2082	109	23	of	of	ADP
dpc-2082	109	24	6	6	NUM
dpc-2082	109	25	original	original	ADJ
dpc-2082	109	26	article	article	NOUN
dpc-2082	109	27	|	|	ADV
dpc-2082	109	28	dermatol	dermatol	ADJ
dpc-2082	109	29	pract	pract	NOUN
dpc-2082	109	30	concept	concept	NOUN
dpc-2082	109	31	.	.	PUNCT
dpc-2082	110	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	110	2	dermatoses	dermatose	VERB
dpc-2082	110	3	leading	lead	VERB
dpc-2082	110	4	causes	cause	NOUN
dpc-2082	110	5	being	be	AUX
dpc-2082	110	6	psoriasis	psoriasis	NOUN
dpc-2082	110	7	,	,	PUNCT
dpc-2082	110	8	eczema	eczema	NOUN
dpc-2082	110	9	and	and	CCONJ
dpc-2082	110	10	atopic	atopic	NOUN
dpc-2082	110	11	dermatitis	dermatitis	NOUN
dpc-2082	110	12	,	,	PUNCT
dpc-2082	110	13	in	in	ADP
dpc-2082	110	14	contrast	contrast	NOUN
dpc-2082	110	15	to	to	ADP
dpc-2082	110	16	our	our	PRON
dpc-2082	110	17	study	study	NOUN
dpc-2082	110	18	[	[	X
dpc-2082	110	19	4,12,13	4,12,13	NUM
dpc-2082	110	20	]	]	PUNCT
dpc-2082	110	21	.	.	PUNCT
dpc-2082	111	1	in	in	ADP
dpc-2082	111	2	our	our	PRON
dpc-2082	111	3	retrospective	retrospective	ADJ
dpc-2082	111	4	study	study	NOUN
dpc-2082	111	5	,	,	PUNCT
dpc-2082	111	6	we	we	PRON
dpc-2082	111	7	only	only	ADV
dpc-2082	111	8	included	include	VERB
dpc-2082	111	9	erythrodermic	erythrodermic	ADJ
dpc-2082	111	10	patients	patient	NOUN
dpc-2082	111	11	with	with	ADP
dpc-2082	111	12	available	available	ADJ
dpc-2082	111	13	dif	dif	PROPN
dpc-2082	111	14	examination	examination	NOUN
dpc-2082	111	15	results	result	NOUN
dpc-2082	111	16	:	:	PUNCT
dpc-2082	111	17	this	this	DET
dpc-2082	111	18	factor	factor	NOUN
dpc-2082	111	19	might	might	AUX
dpc-2082	111	20	explain	explain	VERB
dpc-2082	111	21	the	the	DET
dpc-2082	111	22	discrepancy	discrepancy	NOUN
dpc-2082	111	23	between	between	ADP
dpc-2082	111	24	the	the	DET
dpc-2082	111	25	results	result	NOUN
dpc-2082	111	26	of	of	ADP
dpc-2082	111	27	our	our	PRON
dpc-2082	111	28	study	study	NOUN
dpc-2082	111	29	and	and	CCONJ
dpc-2082	111	30	other	other	ADJ
dpc-2082	111	31	ones	one	NOUN
dpc-2082	111	32	.	.	PUNCT
dpc-2082	112	1	our	our	PRON
dpc-2082	112	2	results	result	NOUN
dpc-2082	112	3	show	show	VERB
dpc-2082	112	4	that	that	SCONJ
dpc-2082	112	5	skin	skin	NOUN
dpc-2082	112	6	samples	sample	NOUN
dpc-2082	112	7	for	for	ADP
dpc-2082	112	8	dif	dif	X
dpc-2082	112	9	examination	examination	NOUN
dpc-2082	112	10	were	be	AUX
dpc-2082	112	11	mostly	mostly	ADV
dpc-2082	112	12	taken	take	VERB
dpc-2082	112	13	from	from	ADP
dpc-2082	112	14	the	the	DET
dpc-2082	112	15	patients	patient	NOUN
dpc-2082	112	16	with	with	ADP
dpc-2082	112	17	a	a	DET
dpc-2082	112	18	suspected	suspect	VERB
dpc-2082	112	19	the	the	DET
dpc-2082	112	20	cases	case	NOUN
dpc-2082	112	21	[	[	X
dpc-2082	112	22	11	11	NUM
dpc-2082	112	23	]	]	PUNCT
dpc-2082	112	24	.	.	PUNCT
dpc-2082	113	1	in	in	ADP
dpc-2082	113	2	the	the	DET
dpc-2082	113	3	present	present	ADJ
dpc-2082	113	4	study	study	NOUN
dpc-2082	113	5	,	,	PUNCT
dpc-2082	113	6	the	the	DET
dpc-2082	113	7	most	most	ADV
dpc-2082	113	8	frequent	frequent	ADJ
dpc-2082	113	9	underlying	underlying	ADJ
dpc-2082	113	10	etiology	etiology	NOUN
dpc-2082	113	11	of	of	ADP
dpc-2082	113	12	erythroderma	erythroderma	NOUN
dpc-2082	113	13	was	be	AUX
dpc-2082	113	14	acde	acde	VERB
dpc-2082	113	15	followed	follow	VERB
dpc-2082	113	16	by	by	ADP
dpc-2082	113	17	absd	absd	ADJ
dpc-2082	113	18	,	,	PUNCT
dpc-2082	113	19	sacd	sacd	NOUN
dpc-2082	113	20	,	,	PUNCT
dpc-2082	113	21	psoriasis	psoriasis	NOUN
dpc-2082	113	22	and	and	CCONJ
dpc-2082	113	23	mycosis	mycosis	NOUN
dpc-2082	113	24	fungoides	fungoide	NOUN
dpc-2082	113	25	.	.	PUNCT
dpc-2082	114	1	in	in	ADP
dpc-2082	114	2	two	two	NUM
dpc-2082	114	3	patients	patient	NOUN
dpc-2082	114	4	with	with	ADP
dpc-2082	114	5	diagnoses	diagnosis	NOUN
dpc-2082	114	6	of	of	ADP
dpc-2082	114	7	mycosis	mycosis	NOUN
dpc-2082	114	8	fungoides	fungoide	NOUN
dpc-2082	114	9	and	and	CCONJ
dpc-2082	114	10	psoriasis	psoriasis	NOUN
dpc-2082	114	11	,	,	PUNCT
dpc-2082	114	12	generalization/	generalization/	NUM
dpc-2082	114	13	accentuation	accentuation	NOUN
dpc-2082	114	14	of	of	ADP
dpc-2082	114	15	the	the	DET
dpc-2082	114	16	pre	pre	ADJ
dpc-2082	114	17	-	-	ADJ
dpc-2082	114	18	existing	existing	ADJ
dpc-2082	114	19	dermatoses	dermatosis	NOUN
dpc-2082	114	20	had	have	AUX
dpc-2082	114	21	evoked	evoke	VERB
dpc-2082	114	22	the	the	DET
dpc-2082	114	23	erythrodermic	erythrodermic	ADJ
dpc-2082	114	24	status	status	NOUN
dpc-2082	114	25	.	.	PUNCT
dpc-2082	115	1	in	in	ADP
dpc-2082	115	2	different	different	ADJ
dpc-2082	115	3	studies	study	NOUN
dpc-2082	115	4	,	,	PUNCT
dpc-2082	115	5	the	the	DET
dpc-2082	115	6	most	most	ADV
dpc-2082	115	7	common	common	ADJ
dpc-2082	115	8	diseases	disease	NOUN
dpc-2082	115	9	associated	associate	VERB
dpc-2082	115	10	with	with	ADP
dpc-2082	115	11	erythroderma	erythroderma	NOUN
dpc-2082	115	12	were	be	AUX
dpc-2082	115	13	pre	pre	ADJ
dpc-2082	115	14	-	-	ADJ
dpc-2082	115	15	existing	exist	VERB
dpc-2082	115	16	figure	figure	NOUN
dpc-2082	115	17	5	5	NUM
dpc-2082	115	18	.	.	PUNCT
dpc-2082	116	1	(	(	PUNCT
dpc-2082	116	2	a	a	DET
dpc-2082	116	3	)	)	PUNCT
dpc-2082	116	4	subcorneal	subcorneal	ADJ
dpc-2082	116	5	/	/	SYM
dpc-2082	116	6	intragranular	intragranular	ADJ
dpc-2082	116	7	blister	blister	NOUN
dpc-2082	116	8	formation	formation	NOUN
dpc-2082	116	9	with	with	ADP
dpc-2082	116	10	neutrophils	neutrophil	NOUN
dpc-2082	116	11	and	and	CCONJ
dpc-2082	116	12	few	few	ADJ
dpc-2082	116	13	acantholytic	acantholytic	ADJ
dpc-2082	116	14	cells	cell	NOUN
dpc-2082	116	15	(	(	PUNCT
dpc-2082	116	16	arrow	arrow	NOUN
dpc-2082	116	17	)	)	PUNCT
dpc-2082	116	18	.	.	PUNCT
dpc-2082	117	1	dermal	dermal	NOUN
dpc-2082	117	2	edema	edema	NOUN
dpc-2082	117	3	with	with	ADP
dpc-2082	117	4	mixed	mixed	ADJ
dpc-2082	117	5	cellular	cellular	ADJ
dpc-2082	117	6	infiltrate	infiltrate	ADJ
dpc-2082	117	7	bearing	bearing	NOUN
dpc-2082	117	8	eosinophil	eosinophil	ADJ
dpc-2082	117	9	leukocytes	leukocyte	NOUN
dpc-2082	117	10	(	(	PUNCT
dpc-2082	117	11	h&e	h&e	PROPN
dpc-2082	117	12	,	,	PUNCT
dpc-2082	117	13	x200	x200	PROPN
dpc-2082	117	14	)	)	PUNCT
dpc-2082	117	15	.	.	PUNCT
dpc-2082	118	1	(	(	PUNCT
dpc-2082	118	2	b	b	X
dpc-2082	118	3	)	)	PUNCT
dpc-2082	118	4	basal	basal	NOUN
dpc-2082	118	5	cell	cell	NOUN
dpc-2082	118	6	vacuolization	vacuolization	NOUN
dpc-2082	118	7	,	,	PUNCT
dpc-2082	118	8	spongiosis	spongiosis	NOUN
dpc-2082	118	9	,	,	PUNCT
dpc-2082	118	10	necrotic	necrotic	ADJ
dpc-2082	118	11	keratinocytes	keratinocyte	NOUN
dpc-2082	118	12	,	,	PUNCT
dpc-2082	118	13	and	and	CCONJ
dpc-2082	118	14	lymphocyte	lymphocyte	ADJ
dpc-2082	118	15	exocytosis	exocytosis	NOUN
dpc-2082	118	16	in	in	ADP
dpc-2082	118	17	the	the	DET
dpc-2082	118	18	epidermis	epidermis	NOUN
dpc-2082	118	19	.	.	PUNCT
dpc-2082	119	1	lymphohistiocytic	lymphohistiocytic	ADJ
dpc-2082	119	2	inflammation	inflammation	NOUN
dpc-2082	119	3	and	and	CCONJ
dpc-2082	119	4	a	a	DET
dpc-2082	119	5	few	few	ADJ
dpc-2082	119	6	extravasated	extravasate	VERB
dpc-2082	119	7	erythrocytes	erythrocyte	NOUN
dpc-2082	119	8	in	in	ADP
dpc-2082	119	9	the	the	DET
dpc-2082	119	10	dermis	dermis	NOUN
dpc-2082	119	11	(	(	PUNCT
dpc-2082	119	12	h&e	h&e	PROPN
dpc-2082	119	13	,	,	PUNCT
dpc-2082	119	14	x200	x200	PROPN
dpc-2082	119	15	)	)	PUNCT
dpc-2082	119	16	.	.	PUNCT
dpc-2082	120	1	figure	figure	VERB
dpc-2082	120	2	4	4	NUM
dpc-2082	120	3	.	.	PUNCT
dpc-2082	121	1	(	(	PUNCT
dpc-2082	121	2	a	a	X
dpc-2082	121	3	)	)	PUNCT
dpc-2082	121	4	histopathological	histopathological	ADJ
dpc-2082	121	5	findings	finding	NOUN
dpc-2082	121	6	in	in	ADP
dpc-2082	121	7	an	an	DET
dpc-2082	121	8	erythrodermic	erythrodermic	ADJ
dpc-2082	121	9	patient	patient	NOUN
dpc-2082	121	10	with	with	ADP
dpc-2082	121	11	bullous	bullous	ADJ
dpc-2082	121	12	pemphigoid	pemphigoid	NOUN
dpc-2082	121	13	:	:	PUNCT
dpc-2082	121	14	sub	sub	ADJ
dpc-2082	121	15	-	-	ADJ
dpc-2082	121	16	epidermal	epidermal	ADJ
dpc-2082	121	17	cleavage	cleavage	NOUN
dpc-2082	121	18	(	(	PUNCT
dpc-2082	121	19	arrowhead	arrowhead	NOUN
dpc-2082	121	20	)	)	PUNCT
dpc-2082	121	21	,	,	PUNCT
dpc-2082	121	22	eosinophilic	eosinophilic	ADJ
dpc-2082	121	23	spongiosis	spongiosis	NOUN
dpc-2082	121	24	,	,	PUNCT
dpc-2082	121	25	superficial	superficial	ADJ
dpc-2082	121	26	dermal	dermal	NOUN
dpc-2082	121	27	edema	edema	NOUN
dpc-2082	121	28	and	and	CCONJ
dpc-2082	121	29	interstitial	interstitial	ADJ
dpc-2082	121	30	eosinophilic	eosinophilic	ADJ
dpc-2082	121	31	infiltration	infiltration	NOUN
dpc-2082	121	32	(	(	PUNCT
dpc-2082	121	33	h&e	h&e	PROPN
dpc-2082	121	34	,	,	PUNCT
dpc-2082	121	35	x200	x200	PROPN
dpc-2082	121	36	)	)	PUNCT
dpc-2082	121	37	.	.	PUNCT
dpc-2082	122	1	dif	dif	PROPN
dpc-2082	122	2	revealed	reveal	VERB
dpc-2082	122	3	linear	linear	PROPN
dpc-2082	122	4	(	(	PUNCT
dpc-2082	122	5	b	b	NOUN
dpc-2082	122	6	)	)	PUNCT
dpc-2082	122	7	c3	c3	NOUN
dpc-2082	122	8	and	and	CCONJ
dpc-2082	122	9	(	(	PUNCT
dpc-2082	122	10	c	c	X
dpc-2082	122	11	)	)	PUNCT
dpc-2082	122	12	igg	igg	NOUN
dpc-2082	122	13	deposition	deposition	NOUN
dpc-2082	122	14	at	at	ADP
dpc-2082	122	15	dermoepidermal	dermoepidermal	ADJ
dpc-2082	122	16	junction	junction	NOUN
dpc-2082	122	17	(	(	PUNCT
dpc-2082	122	18	dif	dif	X
dpc-2082	122	19	,	,	PUNCT
dpc-2082	122	20	x200	x200	PROPN
dpc-2082	122	21	)	)	PUNCT
dpc-2082	122	22	.	.	PUNCT
dpc-2082	123	1	original	original	ADJ
dpc-2082	123	2	article	article	NOUN
dpc-2082	123	3	|	|	ADV
dpc-2082	123	4	dermatol	dermatol	ADJ
dpc-2082	123	5	pract	pract	NOUN
dpc-2082	123	6	concept	concept	NOUN
dpc-2082	123	7	.	.	PUNCT
dpc-2082	124	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	124	2	7	7	NUM
dpc-2082	124	3	formation	formation	NOUN
dpc-2082	124	4	with	with	ADP
dpc-2082	124	5	neutrophils	neutrophil	NOUN
dpc-2082	124	6	and	and	CCONJ
dpc-2082	124	7	few	few	ADJ
dpc-2082	124	8	acantholytic	acantholytic	ADJ
dpc-2082	124	9	cells	cell	NOUN
dpc-2082	124	10	which	which	PRON
dpc-2082	124	11	was	be	AUX
dpc-2082	124	12	compatible	compatible	ADJ
dpc-2082	124	13	with	with	ADP
dpc-2082	124	14	pemphigus	pemphigus	PROPN
dpc-2082	124	15	foliaceus	foliaceus	PROPN
dpc-2082	124	16	(	(	PUNCT
dpc-2082	124	17	figure	figure	NOUN
dpc-2082	124	18	5	5	NUM
dpc-2082	124	19	)	)	PUNCT
dpc-2082	124	20	.	.	PUNCT
dpc-2082	125	1	with	with	ADP
dpc-2082	125	2	the	the	DET
dpc-2082	125	3	aid	aid	NOUN
dpc-2082	125	4	of	of	ADP
dpc-2082	125	5	dif	dif	X
dpc-2082	125	6	examination	examination	NOUN
dpc-2082	125	7	which	which	PRON
dpc-2082	125	8	revealed	reveal	VERB
dpc-2082	125	9	intercellular	intercellular	ADJ
dpc-2082	125	10	igg	igg	NOUN
dpc-2082	125	11	deposition	deposition	NOUN
dpc-2082	125	12	,	,	PUNCT
dpc-2082	125	13	the	the	DET
dpc-2082	125	14	diagnosis	diagnosis	NOUN
dpc-2082	125	15	of	of	ADP
dpc-2082	125	16	pemphigus	pemphigus	PROPN
dpc-2082	125	17	foliaceus	foliaceus	PROPN
dpc-2082	125	18	was	be	AUX
dpc-2082	125	19	confirmed	confirm	VERB
dpc-2082	125	20	.	.	PUNCT
dpc-2082	126	1	on	on	ADP
dpc-2082	126	2	the	the	DET
dpc-2082	126	3	other	other	ADJ
dpc-2082	126	4	hand	hand	NOUN
dpc-2082	126	5	joly	joly	PROPN
dpc-2082	126	6	et	et	PROPN
dpc-2082	126	7	al	al	PROPN
dpc-2082	126	8	reported	report	VERB
dpc-2082	126	9	three	three	NUM
dpc-2082	126	10	black	black	ADJ
dpc-2082	126	11	african	african	ADJ
dpc-2082	126	12	men	man	NOUN
dpc-2082	126	13	diagnosed	diagnose	VERB
dpc-2082	126	14	with	with	ADP
dpc-2082	126	15	lichenoid	lichenoid	PROPN
dpc-2082	126	16	erythrodermic	erythrodermic	ADJ
dpc-2082	126	17	bullous	bullous	ADJ
dpc-2082	126	18	pemphigoid	pemphigoid	NOUN
dpc-2082	126	19	[	[	X
dpc-2082	126	20	17	17	NUM
dpc-2082	126	21	]	]	PUNCT
dpc-2082	126	22	.	.	PUNCT
dpc-2082	127	1	in	in	ADP
dpc-2082	127	2	these	these	DET
dpc-2082	127	3	patients	patient	NOUN
dpc-2082	127	4	,	,	PUNCT
dpc-2082	127	5	histopathological	histopathological	ADJ
dpc-2082	127	6	examination	examination	NOUN
dpc-2082	127	7	showed	show	VERB
dpc-2082	127	8	subepidermal	subepidermal	NOUN
dpc-2082	127	9	bulla	bulla	NOUN
dpc-2082	127	10	with	with	ADP
dpc-2082	127	11	lichenoid	lichenoid	PROPN
dpc-2082	127	12	infiltrate	infiltrate	VERB
dpc-2082	127	13	along	along	ADP
dpc-2082	127	14	with	with	ADP
dpc-2082	127	15	linear	linear	ADJ
dpc-2082	127	16	deposits	deposit	NOUN
dpc-2082	127	17	of	of	ADP
dpc-2082	127	18	c3	c3	PROPN
dpc-2082	127	19	along	along	ADP
dpc-2082	127	20	the	the	DET
dpc-2082	127	21	basal	basal	ADJ
dpc-2082	127	22	membrane.17	membrane.17	PROPN
dpc-2082	127	23	two	two	NUM
dpc-2082	127	24	erythrodermic	erythrodermic	ADJ
dpc-2082	127	25	patients	patient	NOUN
dpc-2082	127	26	in	in	ADP
dpc-2082	127	27	our	our	PRON
dpc-2082	127	28	study	study	NOUN
dpc-2082	127	29	presented	present	VERB
dpc-2082	127	30	with	with	ADP
dpc-2082	127	31	widespread	widespread	ADJ
dpc-2082	127	32	intact	intact	ADJ
dpc-2082	127	33	/	/	SYM
dpc-2082	127	34	flaccid	flaccid	ADJ
dpc-2082	127	35	bullae	bullae	NOUN
dpc-2082	127	36	,	,	PUNCT
dpc-2082	127	37	erosion	erosion	NOUN
dpc-2082	127	38	and	and	CCONJ
dpc-2082	127	39	crust	crust	NOUN
dpc-2082	127	40	formation	formation	NOUN
dpc-2082	127	41	.	.	PUNCT
dpc-2082	128	1	histopathological	histopathological	ADJ
dpc-2082	128	2	examination	examination	NOUN
dpc-2082	128	3	revealed	reveal	VERB
dpc-2082	128	4	sub	sub	ADJ
dpc-2082	128	5	-	-	ADJ
dpc-2082	128	6	epidermal	epidermal	ADJ
dpc-2082	128	7	bulla	bulla	NOUN
dpc-2082	128	8	,	,	PUNCT
dpc-2082	128	9	basal	basal	ADJ
dpc-2082	128	10	vacuolar	vacuolar	ADJ
dpc-2082	128	11	degeneration	degeneration	NOUN
dpc-2082	128	12	and	and	CCONJ
dpc-2082	128	13	eosinophil	eosinophil	ADJ
dpc-2082	128	14	-	-	PUNCT
dpc-2082	128	15	rich	rich	ADJ
dpc-2082	128	16	infiltrate	infiltrate	NOUN
dpc-2082	128	17	.	.	PUNCT
dpc-2082	129	1	with	with	ADP
dpc-2082	129	2	the	the	DET
dpc-2082	129	3	help	help	NOUN
dpc-2082	129	4	of	of	ADP
dpc-2082	129	5	dif	dif	ADJ
dpc-2082	129	6	analysis	analysis	NOUN
dpc-2082	129	7	which	which	PRON
dpc-2082	129	8	detected	detect	VERB
dpc-2082	129	9	linear	linear	ADJ
dpc-2082	129	10	deposits	deposit	NOUN
dpc-2082	129	11	of	of	ADP
dpc-2082	129	12	igg	igg	PROPN
dpc-2082	129	13	and	and	CCONJ
dpc-2082	129	14	c3	c3	PROPN
dpc-2082	129	15	along	along	ADP
dpc-2082	129	16	the	the	DET
dpc-2082	129	17	dermo	dermo	NOUN
dpc-2082	129	18	-	-	PUNCT
dpc-2082	129	19	epidermal	epidermal	ADJ
dpc-2082	129	20	junction	junction	NOUN
dpc-2082	129	21	;	;	PUNCT
dpc-2082	129	22	the	the	DET
dpc-2082	129	23	final	final	ADJ
dpc-2082	129	24	diagnosis	diagnosis	NOUN
dpc-2082	129	25	was	be	AUX
dpc-2082	129	26	bullous	bullous	ADJ
dpc-2082	129	27	pemphigoid	pemphigoid	ADV
dpc-2082	129	28	;	;	PUNCT
dpc-2082	129	29	the	the	DET
dpc-2082	129	30	etiology	etiology	NOUN
dpc-2082	129	31	of	of	ADP
dpc-2082	129	32	exfoliative	exfoliative	ADJ
dpc-2082	129	33	dermatitis	dermatitis	NOUN
dpc-2082	129	34	was	be	AUX
dpc-2082	129	35	unraveled	unravel	VERB
dpc-2082	129	36	.	.	PUNCT
dpc-2082	130	1	in	in	ADP
dpc-2082	130	2	the	the	DET
dpc-2082	130	3	category	category	NOUN
dpc-2082	130	4	4	4	NUM
dpc-2082	130	5	,	,	PUNCT
dpc-2082	130	6	the	the	DET
dpc-2082	130	7	study	study	NOUN
dpc-2082	130	8	subject	subject	ADJ
dpc-2082	130	9	with	with	ADP
dpc-2082	130	10	a	a	DET
dpc-2082	130	11	final	final	ADJ
dpc-2082	130	12	diagnosis	diagnosis	NOUN
dpc-2082	130	13	of	of	ADP
dpc-2082	130	14	bullous	bullous	ADJ
dpc-2082	130	15	mf	mf	NOUN
dpc-2082	130	16	showed	show	VERB
dpc-2082	130	17	interrupted	interrupt	VERB
dpc-2082	130	18	c3	c3	PROPN
dpc-2082	130	19	deposition	deposition	NOUN
dpc-2082	130	20	along	along	ADP
dpc-2082	130	21	dermal	dermal	NOUN
dpc-2082	130	22	vessels	vessel	NOUN
dpc-2082	130	23	and	and	CCONJ
dpc-2082	130	24	dermoepidermal	dermoepidermal	ADJ
dpc-2082	130	25	junction	junction	NOUN
dpc-2082	130	26	in	in	ADP
dpc-2082	130	27	the	the	DET
dpc-2082	130	28	perilesional	perilesional	ADJ
dpc-2082	130	29	skin	skin	NOUN
dpc-2082	130	30	,	,	PUNCT
dpc-2082	130	31	whereas	whereas	SCONJ
dpc-2082	130	32	the	the	DET
dpc-2082	130	33	case	case	NOUN
dpc-2082	130	34	with	with	ADP
dpc-2082	130	35	the	the	DET
dpc-2082	130	36	histopathological	histopathological	ADJ
dpc-2082	130	37	diagnosis	diagnosis	NOUN
dpc-2082	130	38	of	of	ADP
dpc-2082	130	39	psoriasiform	psoriasiform	NOUN
dpc-2082	130	40	dermatitis	dermatitis	NOUN
dpc-2082	130	41	and	and	CCONJ
dpc-2082	130	42	final	final	ADJ
dpc-2082	130	43	clinical	clinical	ADJ
dpc-2082	130	44	diagnosis	diagnosis	NOUN
dpc-2082	130	45	of	of	ADP
dpc-2082	130	46	idiopathic	idiopathic	ADJ
dpc-2082	130	47	erythroderma	erythroderma	NOUN
dpc-2082	130	48	showed	show	VERB
dpc-2082	130	49	linear	linear	PROPN
dpc-2082	130	50	c3	c3	PROPN
dpc-2082	130	51	deposition	deposition	NOUN
dpc-2082	130	52	at	at	ADP
dpc-2082	130	53	the	the	DET
dpc-2082	130	54	basal	basal	ADJ
dpc-2082	130	55	membrane	membrane	NOUN
dpc-2082	130	56	in	in	ADP
dpc-2082	130	57	the	the	DET
dpc-2082	130	58	perilesional	perilesional	ADJ
dpc-2082	130	59	skin	skin	NOUN
dpc-2082	130	60	.	.	PUNCT
dpc-2082	131	1	we	we	PRON
dpc-2082	131	2	believe	believe	VERB
dpc-2082	131	3	that	that	SCONJ
dpc-2082	131	4	these	these	DET
dpc-2082	131	5	c3	c3	PROPN
dpc-2082	131	6	deposition	deposition	NOUN
dpc-2082	131	7	are	be	AUX
dpc-2082	131	8	non	non	ADJ
dpc-2082	131	9	-	-	ADJ
dpc-2082	131	10	specific	specific	ADJ
dpc-2082	131	11	,	,	PUNCT
dpc-2082	131	12	thus	thus	ADV
dpc-2082	131	13	does	do	AUX
dpc-2082	131	14	not	not	PART
dpc-2082	131	15	seem	seem	VERB
dpc-2082	131	16	to	to	PART
dpc-2082	131	17	carry	carry	VERB
dpc-2082	131	18	any	any	DET
dpc-2082	131	19	diagnostic	diagnostic	ADJ
dpc-2082	131	20	significance	significance	NOUN
dpc-2082	131	21	as	as	SCONJ
dpc-2082	131	22	reported	report	VERB
dpc-2082	131	23	in	in	ADP
dpc-2082	131	24	a	a	DET
dpc-2082	131	25	study	study	NOUN
dpc-2082	131	26	by	by	ADP
dpc-2082	131	27	leibold	leibold	VERB
dpc-2082	131	28	et	et	PROPN
dpc-2082	131	29	al	al	PROPN
dpc-2082	132	1	[	[	X
dpc-2082	132	2	18	18	NUM
dpc-2082	132	3	]	]	PUNCT
dpc-2082	132	4	.	.	PUNCT
dpc-2082	133	1	in	in	ADP
dpc-2082	133	2	this	this	DET
dpc-2082	133	3	study	study	NOUN
dpc-2082	133	4	,	,	PUNCT
dpc-2082	133	5	41	41	NUM
dpc-2082	133	6	non	non	ADJ
dpc-2082	133	7	-	-	ADJ
dpc-2082	133	8	lesional	lesional	ADJ
dpc-2082	133	9	,	,	PUNCT
dpc-2082	133	10	sun	sun	NOUN
dpc-2082	133	11	-	-	PUNCT
dpc-2082	133	12	exposed	expose	VERB
dpc-2082	133	13	skin	skin	NOUN
dpc-2082	133	14	samples	sample	NOUN
dpc-2082	133	15	obtained	obtain	VERB
dpc-2082	133	16	from	from	ADP
dpc-2082	133	17	mohs	mohs	PROPN
dpc-2082	133	18	surgery	surgery	NOUN
dpc-2082	133	19	sites	site	NOUN
dpc-2082	133	20	,	,	PUNCT
dpc-2082	133	21	21	21	NUM
dpc-2082	133	22	specimens	specimen	NOUN
dpc-2082	133	23	demonstrated	demonstrate	VERB
dpc-2082	133	24	interrupted	interrupted	ADJ
dpc-2082	133	25	,	,	PUNCT
dpc-2082	133	26	weak	weak	ADJ
dpc-2082	133	27	linear	linear	NOUN
dpc-2082	133	28	or	or	CCONJ
dpc-2082	133	29	granular	granular	ADJ
dpc-2082	133	30	staining	stain	VERB
dpc-2082	133	31	with	with	ADP
dpc-2082	133	32	igm	igm	PROPN
dpc-2082	133	33	,	,	PUNCT
dpc-2082	133	34	igg	igg	PROPN
dpc-2082	133	35	,	,	PUNCT
dpc-2082	133	36	iga	iga	PROPN
dpc-2082	133	37	,	,	PUNCT
dpc-2082	133	38	clq	clq	NOUN
dpc-2082	133	39	and	and	CCONJ
dpc-2082	133	40	c3	c3	PROPN
dpc-2082	133	41	antisera	antisera	PROPN
dpc-2082	134	1	[	[	X
dpc-2082	134	2	18	18	NUM
dpc-2082	134	3	]	]	PUNCT
dpc-2082	134	4	.	.	PUNCT
dpc-2082	135	1	on	on	ADP
dpc-2082	135	2	the	the	DET
dpc-2082	135	3	other	other	ADJ
dpc-2082	135	4	hand	hand	NOUN
dpc-2082	135	5	,	,	PUNCT
dpc-2082	135	6	the	the	DET
dpc-2082	135	7	two	two	NUM
dpc-2082	135	8	other	other	ADJ
dpc-2082	135	9	patients	patient	NOUN
dpc-2082	135	10	with	with	ADP
dpc-2082	135	11	final	final	ADJ
dpc-2082	135	12	diagnoses	diagnosis	NOUN
dpc-2082	135	13	of	of	ADP
dpc-2082	135	14	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	135	15	vasculitis	vasculitis	PROPN
dpc-2082	135	16	and	and	CCONJ
dpc-2082	135	17	vasculitis	vasculitis	PROPN
dpc-2082	135	18	drug	drug	NOUN
dpc-2082	135	19	eruption	eruption	NOUN
dpc-2082	135	20	did	do	AUX
dpc-2082	135	21	not	not	PART
dpc-2082	135	22	show	show	VERB
dpc-2082	135	23	any	any	DET
dpc-2082	135	24	immune	immune	ADJ
dpc-2082	135	25	deposition	deposition	NOUN
dpc-2082	135	26	which	which	PRON
dpc-2082	135	27	might	might	AUX
dpc-2082	135	28	be	be	AUX
dpc-2082	135	29	linked	link	VERB
dpc-2082	135	30	to	to	ADP
dpc-2082	135	31	the	the	DET
dpc-2082	135	32	long	long	ADJ
dpc-2082	135	33	elapsed	elapse	VERB
dpc-2082	135	34	time	time	NOUN
dpc-2082	135	35	between	between	ADP
dpc-2082	135	36	the	the	DET
dpc-2082	135	37	onset	onset	NOUN
dpc-2082	135	38	of	of	ADP
dpc-2082	135	39	rash	rash	NOUN
dpc-2082	135	40	and	and	CCONJ
dpc-2082	135	41	biopsy	biopsy	NOUN
dpc-2082	135	42	(	(	PUNCT
dpc-2082	135	43	14	14	NUM
dpc-2082	135	44	days	day	NOUN
dpc-2082	135	45	)	)	PUNCT
dpc-2082	135	46	for	for	ADP
dpc-2082	135	47	both	both	DET
dpc-2082	135	48	cases	case	NOUN
dpc-2082	135	49	.	.	PUNCT
dpc-2082	136	1	dif	dif	PROPN
dpc-2082	136	2	analysis	analysis	NOUN
dpc-2082	136	3	is	be	AUX
dpc-2082	136	4	suggested	suggest	VERB
dpc-2082	136	5	to	to	PART
dpc-2082	136	6	be	be	AUX
dpc-2082	136	7	performed	perform	VERB
dpc-2082	136	8	within	within	ADP
dpc-2082	136	9	the	the	DET
dpc-2082	136	10	first	first	ADJ
dpc-2082	136	11	24	24	NUM
dpc-2082	136	12	hours	hour	NOUN
dpc-2082	136	13	to	to	PART
dpc-2082	136	14	yield	yield	VERB
dpc-2082	136	15	the	the	DET
dpc-2082	136	16	best	good	ADJ
dpc-2082	136	17	result	result	NOUN
dpc-2082	137	1	[	[	X
dpc-2082	137	2	19	19	NUM
dpc-2082	137	3	]	]	PUNCT
dpc-2082	137	4	.	.	PUNCT
dpc-2082	138	1	immunoreactants	immunoreactant	NOUN
dpc-2082	138	2	can	can	AUX
dpc-2082	138	3	not	not	PART
dpc-2082	138	4	be	be	AUX
dpc-2082	138	5	shown	show	VERB
dpc-2082	138	6	efficiently	efficiently	ADV
dpc-2082	138	7	24	24	NUM
dpc-2082	138	8	-	-	SYM
dpc-2082	138	9	48	48	NUM
dpc-2082	138	10	hours	hour	NOUN
dpc-2082	138	11	after	after	ADP
dpc-2082	138	12	the	the	DET
dpc-2082	138	13	lesion	lesion	NOUN
dpc-2082	138	14	formation	formation	NOUN
dpc-2082	138	15	.	.	PUNCT
dpc-2082	139	1	even	even	ADV
dpc-2082	139	2	though	though	SCONJ
dpc-2082	139	3	our	our	PRON
dpc-2082	139	4	study	study	NOUN
dpc-2082	139	5	has	have	VERB
dpc-2082	139	6	limitations	limitation	NOUN
dpc-2082	139	7	,	,	PUNCT
dpc-2082	139	8	in	in	SCONJ
dpc-2082	139	9	that	that	SCONJ
dpc-2082	139	10	it	it	PRON
dpc-2082	139	11	was	be	AUX
dpc-2082	139	12	a	a	DET
dpc-2082	139	13	retrospective	retrospective	ADJ
dpc-2082	139	14	study	study	NOUN
dpc-2082	139	15	and	and	CCONJ
dpc-2082	139	16	only	only	ADV
dpc-2082	139	17	small	small	ADJ
dpc-2082	139	18	number	number	NOUN
dpc-2082	139	19	of	of	ADP
dpc-2082	139	20	erythrodermic	erythrodermic	ADJ
dpc-2082	139	21	patients	patient	NOUN
dpc-2082	139	22	who	who	PRON
dpc-2082	139	23	had	have	AUX
dpc-2082	139	24	undergone	undergo	VERB
dpc-2082	139	25	both	both	DET
dpc-2082	139	26	histopathological	histopathological	ADJ
dpc-2082	139	27	examination	examination	NOUN
dpc-2082	139	28	and	and	CCONJ
dpc-2082	139	29	dif	dif	ADV
dpc-2082	139	30	analysis	analysis	NOUN
dpc-2082	139	31	were	be	AUX
dpc-2082	139	32	included	include	VERB
dpc-2082	139	33	,	,	PUNCT
dpc-2082	139	34	we	we	PRON
dpc-2082	139	35	would	would	AUX
dpc-2082	139	36	like	like	VERB
dpc-2082	139	37	to	to	PART
dpc-2082	139	38	underline	underline	VERB
dpc-2082	139	39	that	that	DET
dpc-2082	139	40	dif	dif	ADV
dpc-2082	139	41	assay	assay	NOUN
dpc-2082	139	42	may	may	AUX
dpc-2082	139	43	be	be	AUX
dpc-2082	139	44	used	use	VERB
dpc-2082	139	45	as	as	ADP
dpc-2082	139	46	an	an	DET
dpc-2082	139	47	auxiliary	auxiliary	ADJ
dpc-2082	139	48	tool	tool	NOUN
dpc-2082	139	49	in	in	ADP
dpc-2082	139	50	enlightening	enlighten	VERB
dpc-2082	139	51	etiopathogenesis	etiopathogenesis	NOUN
dpc-2082	139	52	of	of	ADP
dpc-2082	139	53	exfoliative	exfoliative	ADJ
dpc-2082	139	54	dermatitis	dermatitis	NOUN
dpc-2082	139	55	.	.	PUNCT
dpc-2082	140	1	references	reference	NOUN
dpc-2082	140	2	1	1	NUM
dpc-2082	140	3	.	.	PUNCT
dpc-2082	140	4	pal	pal	PROPN
dpc-2082	140	5	s	s	PROPN
dpc-2082	140	6	,	,	PUNCT
dpc-2082	140	7	haroon	haroon	PROPN
dpc-2082	140	8	ts	ts	PROPN
dpc-2082	140	9	.	.	PROPN
dpc-2082	140	10	erythroderma	erythroderma	PROPN
dpc-2082	140	11	:	:	PUNCT
dpc-2082	140	12	a	a	DET
dpc-2082	140	13	clinico	clinico	NOUN
dpc-2082	140	14	-	-	PUNCT
dpc-2082	140	15	etiologic	etiologic	ADJ
dpc-2082	140	16	study	study	NOUN
dpc-2082	140	17	of	of	ADP
dpc-2082	140	18	90	90	NUM
dpc-2082	140	19	cases	case	NOUN
dpc-2082	140	20	.	.	PUNCT
dpc-2082	141	1	int	int	NOUN
dpc-2082	141	2	j	j	PROPN
dpc-2082	141	3	dermatol	dermatol	NOUN
dpc-2082	141	4	.	.	PUNCT
dpc-2082	142	1	1998;37(2):104	1998;37(2):104	NUM
dpc-2082	142	2	-	-	PUNCT
dpc-2082	142	3	107	107	NUM
dpc-2082	142	4	.	.	PUNCT
dpc-2082	143	1	doi	doi	NOUN
dpc-2082	143	2	:	:	PUNCT
dpc-2082	143	3	10.1046	10.1046	NUM
dpc-2082	143	4	/	/	SYM
dpc-2082	143	5	j.1365	j.1365	NOUN
dpc-2082	143	6	-	-	PUNCT
dpc-2082	143	7	4362.1998.00228.x	4362.1998.00228.x	NUM
dpc-2082	143	8	.	.	PUNCT
dpc-2082	144	1	pmid	pmid	NOUN
dpc-2082	144	2	:	:	PUNCT
dpc-2082	144	3	9542663	9542663	NUM
dpc-2082	144	4	.	.	PUNCT
dpc-2082	145	1	2	2	X
dpc-2082	145	2	.	.	X
dpc-2082	145	3	cesar	cesar	PROPN
dpc-2082	145	4	a	a	PRON
dpc-2082	145	5	,	,	PUNCT
dpc-2082	145	6	cruz	cruz	PROPN
dpc-2082	145	7	m	m	PROPN
dpc-2082	145	8	,	,	PUNCT
dpc-2082	145	9	mota	mota	PROPN
dpc-2082	145	10	a	a	PRON
dpc-2082	145	11	,	,	PUNCT
dpc-2082	145	12	azevedo	azevedo	PROPN
dpc-2082	145	13	f.	f.	PROPN
dpc-2082	145	14	erythroderma	erythroderma	PROPN
dpc-2082	145	15	.	.	PUNCT
dpc-2082	146	1	a	a	DET
dpc-2082	146	2	clinical	clinical	ADJ
dpc-2082	146	3	and	and	CCONJ
dpc-2082	146	4	etiological	etiological	ADJ
dpc-2082	146	5	study	study	NOUN
dpc-2082	146	6	of	of	ADP
dpc-2082	146	7	103	103	NUM
dpc-2082	146	8	patients	patient	NOUN
dpc-2082	146	9	.	.	PUNCT
dpc-2082	147	1	j	j	PROPN
dpc-2082	147	2	dermatol	dermatol	NOUN
dpc-2082	147	3	case	case	NOUN
dpc-2082	147	4	rep	rep	PROPN
dpc-2082	147	5	.	.	PROPN
dpc-2082	147	6	2016(1);10:1	2016(1);10:1	PROPN
dpc-2082	147	7	-	-	SYM
dpc-2082	147	8	9	9	NUM
dpc-2082	147	9	.	.	PUNCT
dpc-2082	147	10	doi	doi	NOUN
dpc-2082	147	11	:	:	PUNCT
dpc-2082	147	12	10.3315	10.3315	NUM
dpc-2082	147	13	/	/	SYM
dpc-2082	147	14	jdcr.2016.1222	jdcr.2016.1222	NOUN
dpc-2082	147	15	.	.	PUNCT
dpc-2082	148	1	pmid	pmid	NOUN
dpc-2082	148	2	:	:	PUNCT
dpc-2082	148	3	27119000	27119000	NUM
dpc-2082	148	4	.	.	PUNCT
dpc-2082	149	1	pmcid	pmcid	NOUN
dpc-2082	149	2	:	:	PUNCT
dpc-2082	149	3	pmc4844528	pmc4844528	NOUN
dpc-2082	149	4	.	.	PUNCT
dpc-2082	150	1	diagnosis	diagnosis	NOUN
dpc-2082	150	2	of	of	ADP
dpc-2082	150	3	bullous	bullous	ADJ
dpc-2082	150	4	/	/	SYM
dpc-2082	150	5	vesicular	vesicular	ADJ
dpc-2082	150	6	or	or	CCONJ
dpc-2082	150	7	vasculitic	vasculitic	ADJ
dpc-2082	150	8	skin	skin	NOUN
dpc-2082	150	9	diseases	disease	NOUN
dpc-2082	150	10	such	such	ADJ
dpc-2082	150	11	as	as	ADP
dpc-2082	150	12	bullous	bullous	ADJ
dpc-2082	150	13	pemphigoid	pemphigoid	NOUN
dpc-2082	150	14	,	,	PUNCT
dpc-2082	150	15	sjs	sjs	PROPN
dpc-2082	150	16	,	,	PUNCT
dpc-2082	150	17	agep	agep	NOUN
dpc-2082	150	18	,	,	PUNCT
dpc-2082	150	19	fde	fde	PROPN
dpc-2082	150	20	and	and	CCONJ
dpc-2082	150	21	leukocytoclastic	leukocytoclastic	ADJ
dpc-2082	150	22	vasculitis	vasculitis	PROPN
dpc-2082	150	23	etc	etc	X
dpc-2082	150	24	.	.	PUNCT
dpc-2082	151	1	so	so	ADV
dpc-2082	151	2	we	we	PRON
dpc-2082	151	3	most	most	ADV
dpc-2082	151	4	likely	likely	ADV
dpc-2082	151	5	missed	miss	VERB
dpc-2082	151	6	other	other	ADJ
dpc-2082	151	7	causes	cause	NOUN
dpc-2082	151	8	of	of	ADP
dpc-2082	151	9	erythroderma	erythroderma	NOUN
dpc-2082	151	10	for	for	ADP
dpc-2082	151	11	which	which	PRON
dpc-2082	151	12	dif	dif	ADV
dpc-2082	151	13	analysis	analysis	NOUN
dpc-2082	151	14	was	be	AUX
dpc-2082	151	15	not	not	PART
dpc-2082	151	16	performed	perform	VERB
dpc-2082	151	17	in	in	ADP
dpc-2082	151	18	our	our	PRON
dpc-2082	151	19	center	center	NOUN
dpc-2082	151	20	,	,	PUNCT
dpc-2082	151	21	which	which	PRON
dpc-2082	151	22	could	could	AUX
dpc-2082	151	23	be	be	AUX
dpc-2082	151	24	considered	consider	VERB
dpc-2082	151	25	as	as	ADP
dpc-2082	151	26	a	a	DET
dpc-2082	151	27	selection	selection	NOUN
dpc-2082	151	28	bias	bias	NOUN
dpc-2082	151	29	which	which	PRON
dpc-2082	151	30	is	be	AUX
dpc-2082	151	31	the	the	DET
dpc-2082	151	32	limitation	limitation	NOUN
dpc-2082	151	33	of	of	ADP
dpc-2082	151	34	our	our	PRON
dpc-2082	151	35	study	study	NOUN
dpc-2082	151	36	.	.	PUNCT
dpc-2082	152	1	in	in	ADP
dpc-2082	152	2	acde	acde	ADJ
dpc-2082	152	3	category	category	NOUN
dpc-2082	152	4	,	,	PUNCT
dpc-2082	152	5	the	the	DET
dpc-2082	152	6	most	most	ADV
dpc-2082	152	7	common	common	ADJ
dpc-2082	152	8	causes	cause	NOUN
dpc-2082	152	9	of	of	ADP
dpc-2082	152	10	cutaneous	cutaneous	ADJ
dpc-2082	152	11	eruption	eruption	NOUN
dpc-2082	152	12	were	be	AUX
dpc-2082	152	13	antimicrobials	antimicrobial	NOUN
dpc-2082	152	14	followed	follow	VERB
dpc-2082	152	15	by	by	ADP
dpc-2082	152	16	allopurinol	allopurinol	NOUN
dpc-2082	152	17	,	,	PUNCT
dpc-2082	152	18	phenytoin	phenytoin	NOUN
dpc-2082	152	19	,	,	PUNCT
dpc-2082	152	20	hydroxychloroquine	hydroxychloroquine	PROPN
dpc-2082	152	21	,	,	PUNCT
dpc-2082	152	22	intravenous	intravenous	ADJ
dpc-2082	152	23	contrast	contrast	NOUN
dpc-2082	152	24	media	medium	NOUN
dpc-2082	152	25	,	,	PUNCT
dpc-2082	152	26	chemotherapy	chemotherapy	NOUN
dpc-2082	152	27	agents	agent	NOUN
dpc-2082	152	28	and	and	CCONJ
dpc-2082	152	29	others	other	NOUN
dpc-2082	152	30	.	.	PUNCT
dpc-2082	153	1	in	in	ADP
dpc-2082	153	2	concordance	concordance	NOUN
dpc-2082	153	3	with	with	ADP
dpc-2082	153	4	our	our	PRON
dpc-2082	153	5	results	result	NOUN
dpc-2082	153	6	,	,	PUNCT
dpc-2082	153	7	anticonvulsants	anticonvulsant	NOUN
dpc-2082	153	8	,	,	PUNCT
dpc-2082	153	9	beta	beta	NOUN
dpc-2082	153	10	-	-	PUNCT
dpc-2082	153	11	lactams	lactam	NOUN
dpc-2082	153	12	,	,	PUNCT
dpc-2082	153	13	allopurinol	allopurinol	NOUN
dpc-2082	153	14	,	,	PUNCT
dpc-2082	153	15	rifampicin	rifampicin	VERB
dpc-2082	153	16	,	,	PUNCT
dpc-2082	153	17	trimethoprim	trimethoprim	NOUN
dpc-2082	153	18	-	-	PUNCT
dpc-2082	153	19	sulfamethoxazole	sulfamethoxazole	NOUN
dpc-2082	153	20	and	and	CCONJ
dpc-2082	153	21	non	non	ADJ
dpc-2082	153	22	-	-	ADJ
dpc-2082	153	23	steroidal	steroidal	ADJ
dpc-2082	153	24	anti	anti	ADJ
dpc-2082	153	25	-	-	ADJ
dpc-2082	153	26	inflammatory	inflammatory	ADJ
dpc-2082	153	27	drugs	drug	NOUN
dpc-2082	153	28	are	be	AUX
dpc-2082	153	29	reported	report	VERB
dpc-2082	153	30	to	to	PART
dpc-2082	153	31	be	be	AUX
dpc-2082	153	32	the	the	DET
dpc-2082	153	33	leading	lead	VERB
dpc-2082	153	34	causes	cause	NOUN
dpc-2082	153	35	of	of	ADP
dpc-2082	153	36	acquired	acquire	VERB
dpc-2082	153	37	erythroderma	erythroderma	NOUN
dpc-2082	153	38	in	in	ADP
dpc-2082	153	39	multiple	multiple	ADJ
dpc-2082	153	40	studies	study	NOUN
dpc-2082	153	41	[	[	X
dpc-2082	153	42	4,13	4,13	X
dpc-2082	153	43	]	]	PUNCT
dpc-2082	153	44	.	.	PUNCT
dpc-2082	154	1	only	only	ADV
dpc-2082	154	2	one	one	NUM
dpc-2082	154	3	patient	patient	NOUN
dpc-2082	154	4	in	in	ADP
dpc-2082	154	5	the	the	DET
dpc-2082	154	6	acde	acde	PROPN
dpc-2082	154	7	group	group	NOUN
dpc-2082	154	8	with	with	ADP
dpc-2082	154	9	a	a	DET
dpc-2082	154	10	diagnosis	diagnosis	NOUN
dpc-2082	154	11	of	of	ADP
dpc-2082	154	12	mde	mde	PROPN
dpc-2082	154	13	showed	show	VERB
dpc-2082	154	14	deposits	deposit	NOUN
dpc-2082	154	15	of	of	ADP
dpc-2082	154	16	linear	linear	PROPN
dpc-2082	154	17	igm	igm	PROPN
dpc-2082	154	18	,	,	PUNCT
dpc-2082	154	19	granular	granular	ADJ
dpc-2082	154	20	igg	igg	PROPN
dpc-2082	154	21	and	and	CCONJ
dpc-2082	154	22	iga	iga	PROPN
dpc-2082	154	23	deposition	deposition	NOUN
dpc-2082	154	24	at	at	ADP
dpc-2082	154	25	the	the	DET
dpc-2082	154	26	dermo	dermo	NOUN
dpc-2082	154	27	-	-	PUNCT
dpc-2082	154	28	epidermal	epidermal	ADJ
dpc-2082	154	29	junction	junction	NOUN
dpc-2082	154	30	.	.	PUNCT
dpc-2082	155	1	we	we	PRON
dpc-2082	155	2	believe	believe	VERB
dpc-2082	155	3	that	that	SCONJ
dpc-2082	155	4	this	this	DET
dpc-2082	155	5	immunoreactant	immunoreactant	ADJ
dpc-2082	155	6	deposition	deposition	NOUN
dpc-2082	155	7	which	which	PRON
dpc-2082	155	8	was	be	AUX
dpc-2082	155	9	observed	observe	VERB
dpc-2082	155	10	only	only	ADV
dpc-2082	155	11	in	in	ADP
dpc-2082	155	12	one	one	NUM
dpc-2082	155	13	patient	patient	NOUN
dpc-2082	155	14	was	be	AUX
dpc-2082	155	15	most	most	ADV
dpc-2082	155	16	likely	likely	ADJ
dpc-2082	155	17	non	non	ADJ
dpc-2082	155	18	-	-	ADJ
dpc-2082	155	19	specific	specific	ADJ
dpc-2082	155	20	.	.	PUNCT
dpc-2082	155	21	duhra	duhra	PROPN
dpc-2082	155	22	et	et	PROPN
dpc-2082	155	23	al	al	PROPN
dpc-2082	155	24	reported	report	VERB
dpc-2082	155	25	a	a	DET
dpc-2082	155	26	case	case	NOUN
dpc-2082	155	27	of	of	ADP
dpc-2082	155	28	paracetamol	paracetamol	NOUN
dpc-2082	155	29	-	-	PUNCT
dpc-2082	155	30	induced	induce	VERB
dpc-2082	155	31	fixed	fix	VERB
dpc-2082	155	32	drug	drug	NOUN
dpc-2082	155	33	eruption	eruption	NOUN
dpc-2082	155	34	with	with	ADP
dpc-2082	155	35	intercellular	intercellular	ADJ
dpc-2082	155	36	deposition	deposition	NOUN
dpc-2082	155	37	of	of	ADP
dpc-2082	155	38	igg	igg	PROPN
dpc-2082	155	39	and	and	CCONJ
dpc-2082	155	40	c3	c3	PROPN
dpc-2082	155	41	in	in	ADP
dpc-2082	155	42	the	the	DET
dpc-2082	155	43	lesional	lesional	ADJ
dpc-2082	155	44	skin	skin	NOUN
dpc-2082	155	45	and	and	CCONJ
dpc-2082	155	46	suggested	suggest	VERB
dpc-2082	155	47	that	that	SCONJ
dpc-2082	155	48	immunoreactant	immunoreactant	ADJ
dpc-2082	155	49	deposition	deposition	NOUN
dpc-2082	155	50	only	only	ADV
dpc-2082	155	51	in	in	ADP
dpc-2082	155	52	the	the	DET
dpc-2082	155	53	affected	affected	ADJ
dpc-2082	155	54	skin	skin	NOUN
dpc-2082	155	55	might	might	AUX
dpc-2082	155	56	play	play	VERB
dpc-2082	155	57	a	a	DET
dpc-2082	155	58	role	role	NOUN
dpc-2082	155	59	in	in	ADP
dpc-2082	155	60	the	the	DET
dpc-2082	155	61	recurrence	recurrence	NOUN
dpc-2082	155	62	of	of	ADP
dpc-2082	155	63	the	the	DET
dpc-2082	155	64	lesions	lesion	NOUN
dpc-2082	155	65	at	at	ADP
dpc-2082	155	66	the	the	DET
dpc-2082	155	67	same	same	ADJ
dpc-2082	155	68	site	site	NOUN
dpc-2082	155	69	after	after	ADP
dpc-2082	155	70	a	a	DET
dpc-2082	155	71	particular	particular	ADJ
dpc-2082	155	72	drug	drug	NOUN
dpc-2082	155	73	intake	intake	NOUN
dpc-2082	156	1	[	[	X
dpc-2082	156	2	14	14	NUM
dpc-2082	156	3	]	]	PUNCT
dpc-2082	156	4	.	.	PUNCT
dpc-2082	157	1	we	we	PRON
dpc-2082	157	2	want	want	VERB
dpc-2082	157	3	to	to	PART
dpc-2082	157	4	underline	underline	VERB
dpc-2082	157	5	the	the	DET
dpc-2082	157	6	fact	fact	NOUN
dpc-2082	157	7	that	that	SCONJ
dpc-2082	157	8	mde	mde	PROPN
dpc-2082	157	9	is	be	AUX
dpc-2082	157	10	a	a	DET
dpc-2082	157	11	common	common	ADJ
dpc-2082	157	12	cause	cause	NOUN
dpc-2082	157	13	of	of	ADP
dpc-2082	157	14	erythroderma	erythroderma	NOUN
dpc-2082	157	15	and	and	CCONJ
dpc-2082	157	16	negative	negative	ADJ
dpc-2082	157	17	dif	dif	X
dpc-2082	157	18	examination	examination	NOUN
dpc-2082	157	19	favors	favor	VERB
dpc-2082	157	20	the	the	DET
dpc-2082	157	21	diagnosis	diagnosis	NOUN
dpc-2082	157	22	of	of	ADP
dpc-2082	157	23	mde	mde	PROPN
dpc-2082	157	24	,	,	PUNCT
dpc-2082	157	25	when	when	SCONJ
dpc-2082	157	26	absds	absds	NOUN
dpc-2082	157	27	,	,	PUNCT
dpc-2082	157	28	fixed	fix	VERB
dpc-2082	157	29	drug	drug	NOUN
dpc-2082	157	30	eruption	eruption	NOUN
dpc-2082	157	31	and	and	CCONJ
dpc-2082	157	32	drug	drug	NOUN
dpc-2082	157	33	-	-	PUNCT
dpc-2082	157	34	induced	induce	VERB
dpc-2082	157	35	vasculitis	vasculitis	NOUN
dpc-2082	157	36	.	.	PUNCT
dpc-2082	158	1	in	in	ADP
dpc-2082	158	2	addition	addition	NOUN
dpc-2082	158	3	,	,	PUNCT
dpc-2082	158	4	two	two	NUM
dpc-2082	158	5	cases	case	NOUN
dpc-2082	158	6	of	of	ADP
dpc-2082	158	7	ten	ten	NUM
dpc-2082	158	8	were	be	AUX
dpc-2082	158	9	shown	show	VERB
dpc-2082	158	10	to	to	PART
dpc-2082	158	11	exhibit	exhibit	VERB
dpc-2082	158	12	diffuse	diffuse	ADJ
dpc-2082	158	13	homogeneous	homogeneous	ADJ
dpc-2082	158	14	deposits	deposit	NOUN
dpc-2082	158	15	of	of	ADP
dpc-2082	158	16	igm	igm	PROPN
dpc-2082	158	17	,	,	PUNCT
dpc-2082	158	18	iga	iga	PROPN
dpc-2082	158	19	,	,	PUNCT
dpc-2082	158	20	igg	igg	PROPN
dpc-2082	158	21	,	,	PUNCT
dpc-2082	158	22	c3c	c3c	PROPN
dpc-2082	158	23	and	and	CCONJ
dpc-2082	158	24	c1q	c1q	ADP
dpc-2082	158	25	in	in	ADP
dpc-2082	158	26	the	the	DET
dpc-2082	158	27	mid	mid	NOUN
dpc-2082	158	28	-	-	NOUN
dpc-2082	158	29	epidermis	epidermis	NOUN
dpc-2082	158	30	of	of	ADP
dpc-2082	158	31	perilesional	perilesional	ADJ
dpc-2082	158	32	skin	skin	NOUN
dpc-2082	158	33	which	which	PRON
dpc-2082	158	34	was	be	AUX
dpc-2082	158	35	linked	link	VERB
dpc-2082	158	36	to	to	ADP
dpc-2082	158	37	the	the	DET
dpc-2082	158	38	capacity	capacity	NOUN
dpc-2082	158	39	of	of	ADP
dpc-2082	158	40	necrotic	necrotic	ADJ
dpc-2082	158	41	keratinocytes	keratinocyte	NOUN
dpc-2082	158	42	to	to	PART
dpc-2082	158	43	absorb	absorb	VERB
dpc-2082	158	44	immunoreactants	immunoreactant	NOUN
dpc-2082	158	45	[	[	X
dpc-2082	158	46	15	15	NUM
dpc-2082	158	47	]	]	PUNCT
dpc-2082	158	48	.	.	PUNCT
dpc-2082	159	1	diffuse	diffuse	VERB
dpc-2082	159	2	intraepidermal	intraepidermal	ADJ
dpc-2082	159	3	deposition	deposition	NOUN
dpc-2082	159	4	of	of	ADP
dpc-2082	159	5	immune	immune	ADJ
dpc-2082	159	6	deposits	deposit	NOUN
dpc-2082	159	7	was	be	AUX
dpc-2082	159	8	thought	think	VERB
dpc-2082	159	9	to	to	PART
dpc-2082	159	10	favor	favor	VERB
dpc-2082	159	11	the	the	DET
dpc-2082	159	12	early	early	ADJ
dpc-2082	159	13	diagnosis	diagnosis	NOUN
dpc-2082	159	14	of	of	ADP
dpc-2082	159	15	ten	ten	NUM
dpc-2082	159	16	[	[	X
dpc-2082	159	17	15	15	NUM
dpc-2082	159	18	]	]	PUNCT
dpc-2082	159	19	.	.	PUNCT
dpc-2082	160	1	in	in	ADP
dpc-2082	160	2	contrast	contrast	NOUN
dpc-2082	160	3	with	with	ADP
dpc-2082	160	4	this	this	DET
dpc-2082	160	5	report	report	NOUN
dpc-2082	160	6	,	,	PUNCT
dpc-2082	160	7	we	we	PRON
dpc-2082	160	8	did	do	AUX
dpc-2082	160	9	not	not	PART
dpc-2082	160	10	observe	observe	VERB
dpc-2082	160	11	any	any	DET
dpc-2082	160	12	immune	immune	ADJ
dpc-2082	160	13	deposition	deposition	NOUN
dpc-2082	160	14	in	in	ADP
dpc-2082	160	15	4	4	NUM
dpc-2082	160	16	patients	patient	NOUN
dpc-2082	160	17	with	with	ADP
dpc-2082	160	18	a	a	DET
dpc-2082	160	19	final	final	ADJ
dpc-2082	160	20	diagnosis	diagnosis	NOUN
dpc-2082	160	21	of	of	ADP
dpc-2082	160	22	sjs	sjs	PROPN
dpc-2082	160	23	-	-	PUNCT
dpc-2082	160	24	ten	ten	NUM
dpc-2082	160	25	.	.	PUNCT
dpc-2082	161	1	overall	overall	ADJ
dpc-2082	161	2	,	,	PUNCT
dpc-2082	161	3	6	6	NUM
dpc-2082	161	4	(	(	PUNCT
dpc-2082	161	5	19.4	19.4	NUM
dpc-2082	161	6	%	%	NOUN
dpc-2082	161	7	)	)	PUNCT
dpc-2082	161	8	patients	patient	NOUN
dpc-2082	161	9	showed	show	VERB
dpc-2082	161	10	immune	immune	ADJ
dpc-2082	161	11	deposition	deposition	NOUN
dpc-2082	161	12	in	in	ADP
dpc-2082	161	13	dif	dif	ADJ
dpc-2082	161	14	evaluation	evaluation	NOUN
dpc-2082	161	15	.	.	PUNCT
dpc-2082	162	1	all	all	DET
dpc-2082	162	2	3	3	NUM
dpc-2082	162	3	cases	case	NOUN
dpc-2082	162	4	of	of	ADP
dpc-2082	162	5	erythrodermic	erythrodermic	ADJ
dpc-2082	162	6	patients	patient	NOUN
dpc-2082	162	7	diagnosed	diagnose	VERB
dpc-2082	162	8	with	with	ADP
dpc-2082	162	9	absds	absds	NOUN
dpc-2082	162	10	had	have	VERB
dpc-2082	162	11	positive	positive	ADJ
dpc-2082	162	12	immunofluorescence	immunofluorescence	NOUN
dpc-2082	162	13	in	in	ADP
dpc-2082	162	14	dif	dif	X
dpc-2082	162	15	assay	assay	NOUN
dpc-2082	162	16	.	.	PUNCT
dpc-2082	163	1	one	one	NUM
dpc-2082	163	2	patient	patient	NOUN
dpc-2082	163	3	was	be	AUX
dpc-2082	163	4	diagnosed	diagnose	VERB
dpc-2082	163	5	to	to	PART
dpc-2082	163	6	have	have	VERB
dpc-2082	163	7	pemphigus	pemphigus	NOUN
dpc-2082	163	8	foliaceus	foliaceus	NOUN
dpc-2082	163	9	;	;	PUNCT
dpc-2082	163	10	whereas	whereas	SCONJ
dpc-2082	163	11	the	the	DET
dpc-2082	163	12	final	final	ADJ
dpc-2082	163	13	diagnosis	diagnosis	NOUN
dpc-2082	163	14	for	for	ADP
dpc-2082	163	15	the	the	DET
dpc-2082	163	16	2	2	NUM
dpc-2082	163	17	patients	patient	NOUN
dpc-2082	163	18	was	be	AUX
dpc-2082	163	19	bullous	bullous	ADJ
dpc-2082	163	20	pemphigoid	pemphigoid	ADJ
dpc-2082	163	21	.	.	PUNCT
dpc-2082	164	1	one	one	NUM
dpc-2082	164	2	patient	patient	NOUN
dpc-2082	164	3	diagnosed	diagnose	VERB
dpc-2082	164	4	with	with	ADP
dpc-2082	164	5	mde	mde	NOUN
dpc-2082	164	6	and	and	CCONJ
dpc-2082	164	7	two	two	NUM
dpc-2082	164	8	cases	case	NOUN
dpc-2082	164	9	diagnosed	diagnose	VERB
dpc-2082	164	10	with	with	ADP
dpc-2082	164	11	bullous	bullous	ADJ
dpc-2082	164	12	mycosis	mycosis	NOUN
dpc-2082	164	13	fungoides	fungoide	NOUN
dpc-2082	164	14	and	and	CCONJ
dpc-2082	164	15	psoriasiform	psoriasiform	PROPN
dpc-2082	164	16	dermatitis	dermatitis	PROPN
dpc-2082	164	17	,	,	PUNCT
dpc-2082	164	18	respectively	respectively	ADV
dpc-2082	164	19	showed	show	VERB
dpc-2082	164	20	positive	positive	ADJ
dpc-2082	164	21	immunofluorescence	immunofluorescence	NOUN
dpc-2082	164	22	in	in	ADP
dpc-2082	164	23	dif	dif	X
dpc-2082	164	24	assay	assay	NOUN
dpc-2082	164	25	.	.	PUNCT
dpc-2082	165	1	grekin	grekin	PROPN
dpc-2082	165	2	et	et	PROPN
dpc-2082	165	3	al	al	PROPN
dpc-2082	165	4	reported	report	VERB
dpc-2082	165	5	2	2	NUM
dpc-2082	165	6	cases	case	NOUN
dpc-2082	165	7	of	of	ADP
dpc-2082	165	8	erythrodermic	erythrodermic	ADJ
dpc-2082	165	9	psoriasiform	psoriasiform	NOUN
dpc-2082	165	10	pemphigus	pemphigus	PROPN
dpc-2082	165	11	foliaceus	foliaceus	PROPN
dpc-2082	165	12	which	which	PRON
dpc-2082	165	13	showed	show	VERB
dpc-2082	165	14	intercellular	intercellular	ADJ
dpc-2082	165	15	igg	igg	NOUN
dpc-2082	165	16	deposition	deposition	NOUN
dpc-2082	165	17	in	in	ADP
dpc-2082	165	18	dif	dif	X
dpc-2082	165	19	examination	examination	NOUN
dpc-2082	165	20	just	just	ADV
dpc-2082	165	21	like	like	ADP
dpc-2082	165	22	our	our	PRON
dpc-2082	165	23	study	study	NOUN
dpc-2082	165	24	subject	subject	NOUN
dpc-2082	165	25	[	[	X
dpc-2082	165	26	16	16	NUM
dpc-2082	165	27	]	]	PUNCT
dpc-2082	165	28	.	.	PUNCT
dpc-2082	166	1	our	our	PRON
dpc-2082	166	2	patient	patient	NOUN
dpc-2082	166	3	had	have	AUX
dpc-2082	166	4	presented	present	VERB
dpc-2082	166	5	with	with	ADP
dpc-2082	166	6	erythroderma	erythroderma	NOUN
dpc-2082	166	7	accompanied	accompany	VERB
dpc-2082	166	8	by	by	ADP
dpc-2082	166	9	thick	thick	ADJ
dpc-2082	166	10	/	/	SYM
dpc-2082	166	11	adherent	adherent	NOUN
dpc-2082	166	12	scales	scale	NOUN
dpc-2082	166	13	,	,	PUNCT
dpc-2082	166	14	superficial	superficial	ADJ
dpc-2082	166	15	erosions	erosion	NOUN
dpc-2082	166	16	and	and	CCONJ
dpc-2082	166	17	scattered	scatter	VERB
dpc-2082	166	18	hemorrhagic	hemorrhagic	NOUN
dpc-2082	166	19	crusts	crust	NOUN
dpc-2082	166	20	resembling	resemble	VERB
dpc-2082	166	21	seborrheic	seborrheic	ADJ
dpc-2082	166	22	dermatitis	dermatitis	NOUN
dpc-2082	166	23	and	and	CCONJ
dpc-2082	166	24	sjs	sjs	PROPN
dpc-2082	166	25	.	.	PUNCT
dpc-2082	167	1	histopathological	histopathological	ADJ
dpc-2082	167	2	examination	examination	NOUN
dpc-2082	167	3	showed	show	VERB
dpc-2082	167	4	sub	sub	ADJ
dpc-2082	167	5	-	-	ADJ
dpc-2082	167	6	corneal	corneal	ADJ
dpc-2082	167	7	/	/	SYM
dpc-2082	167	8	intra	intra	ADJ
dpc-2082	167	9	-	-	ADJ
dpc-2082	167	10	granular	granular	ADJ
dpc-2082	167	11	blister	blister	NOUN
dpc-2082	167	12	8	8	NUM
dpc-2082	167	13	original	original	ADJ
dpc-2082	167	14	article	article	NOUN
dpc-2082	167	15	|	|	ADV
dpc-2082	167	16	dermatol	dermatol	ADJ
dpc-2082	167	17	pract	pract	NOUN
dpc-2082	167	18	concept	concept	NOUN
dpc-2082	167	19	.	.	PUNCT
dpc-2082	168	1	2022;12(4):e2022160	2022;12(4):e2022160	NUM
dpc-2082	168	2	3	3	NUM
dpc-2082	168	3	.	.	PUNCT
dpc-2082	168	4	miyashiro	miyashiro	PROPN
dpc-2082	168	5	d	d	PROPN
dpc-2082	168	6	,	,	PUNCT
dpc-2082	168	7	sanches	sanches	PROPN
dpc-2082	168	8	ja	ja	PROPN
dpc-2082	168	9	.	.	PROPN
dpc-2082	168	10	erythroderma	erythroderma	PROPN
dpc-2082	168	11	:	:	PUNCT
dpc-2082	168	12	a	a	DET
dpc-2082	168	13	prospective	prospective	ADJ
dpc-2082	168	14	study	study	NOUN
dpc-2082	168	15	of	of	ADP
dpc-2082	168	16	309	309	NUM
dpc-2082	168	17	patients	patient	NOUN
dpc-2082	168	18	followed	follow	VERB
dpc-2082	168	19	for	for	ADP
dpc-2082	168	20	12	12	NUM
dpc-2082	168	21	years	year	NOUN
dpc-2082	168	22	in	in	ADP
dpc-2082	168	23	a	a	DET
dpc-2082	168	24	tertiary	tertiary	ADJ
dpc-2082	168	25	center	center	NOUN
dpc-2082	168	26	.	.	PUNCT
dpc-2082	169	1	sci	sci	PROPN
dpc-2082	169	2	rep	rep	PROPN
dpc-2082	169	3	.	.	PROPN
dpc-2082	169	4	2020;10(1):9774	2020;10(1):9774	NUM
dpc-2082	169	5	.	.	PUNCT
dpc-2082	170	1	doi	doi	NOUN
dpc-2082	170	2	:	:	PUNCT
dpc-2082	170	3	10.1038	10.1038	NUM
dpc-2082	170	4	/	/	SYM
dpc-2082	170	5	s41598	s41598	NOUN
dpc-2082	170	6	-	-	PUNCT
dpc-2082	170	7	020	020	NUM
dpc-2082	170	8	-	-	PUNCT
dpc-2082	170	9	66040	66040	NUM
dpc-2082	170	10	-	-	SYM
dpc-2082	170	11	7	7	NUM
dpc-2082	170	12	.	.	PUNCT
dpc-2082	171	1	pmid	pmid	NOUN
dpc-2082	171	2	:	:	PUNCT
dpc-2082	171	3	32555205	32555205	NUM
dpc-2082	171	4	.	.	PUNCT
dpc-2082	172	1	pmcid	pmcid	ADJ
dpc-2082	172	2	:	:	PUNCT
dpc-2082	172	3	pmc7300014	pmc7300014	VERB
dpc-2082	172	4	.	.	PUNCT
dpc-2082	173	1	4	4	X
dpc-2082	173	2	.	.	X
dpc-2082	173	3	askin	askin	PROPN
dpc-2082	173	4	o	o	PROPN
dpc-2082	173	5	,	,	PUNCT
dpc-2082	173	6	altunkalem	altunkalem	PROPN
dpc-2082	173	7	rn	rn	PROPN
dpc-2082	173	8	,	,	PUNCT
dpc-2082	173	9	uzuncakmak	uzuncakmak	PROPN
dpc-2082	173	10	tk	tk	PROPN
dpc-2082	173	11	,	,	PUNCT
dpc-2082	173	12	toplu	toplu	PROPN
dpc-2082	173	13	fş	fş	PROPN
dpc-2082	173	14	,	,	PUNCT
dpc-2082	173	15	engin	engin	PROPN
dpc-2082	173	16	b.	b.	PROPN
dpc-2082	173	17	erythroderma	erythroderma	PROPN
dpc-2082	173	18	:	:	PUNCT
dpc-2082	173	19	a	a	DET
dpc-2082	173	20	clinicopathological	clinicopathological	ADJ
dpc-2082	173	21	study	study	NOUN
dpc-2082	173	22	of	of	ADP
dpc-2082	173	23	47	47	NUM
dpc-2082	173	24	cases	case	NOUN
dpc-2082	173	25	from	from	ADP
dpc-2082	173	26	2018	2018	NUM
dpc-2082	173	27	to	to	ADP
dpc-2082	173	28	2020	2020	NUM
dpc-2082	173	29	.	.	PUNCT
dpc-2082	174	1	dermatol	dermatol	NOUN
dpc-2082	174	2	ther	ther	ADV
dpc-2082	174	3	.	.	PUNCT
dpc-2082	175	1	2020;33(6):e14342	2020;33(6):e14342	X
dpc-2082	175	2	.	.	PUNCT
dpc-2082	175	3	doi	doi	NOUN
dpc-2082	175	4	:	:	PUNCT
dpc-2082	175	5	10.1111/	10.1111/	NUM
dpc-2082	175	6	dth.14342	dth.14342	PROPN
dpc-2082	175	7	.	.	PUNCT
dpc-2082	176	1	pmid	pmid	NOUN
dpc-2082	176	2	:	:	PUNCT
dpc-2082	176	3	32979015	32979015	NUM
dpc-2082	176	4	.	.	PUNCT
dpc-2082	177	1	5	5	X
dpc-2082	177	2	.	.	X
dpc-2082	177	3	walsh	walsh	PROPN
dpc-2082	177	4	nm	nm	PROPN
dpc-2082	177	5	,	,	PUNCT
dpc-2082	177	6	prokopetz	prokopetz	ADJ
dpc-2082	177	7	r	r	NOUN
dpc-2082	177	8	,	,	PUNCT
dpc-2082	177	9	tron	tron	PROPN
dpc-2082	177	10	va	va	PROPN
dpc-2082	177	11	,	,	PUNCT
dpc-2082	177	12	et	et	PROPN
dpc-2082	177	13	al	al	PROPN
dpc-2082	177	14	.	.	PROPN
dpc-2082	177	15	histopathology	histopathology	NOUN
dpc-2082	177	16	in	in	ADP
dpc-2082	177	17	erythroderma	erythroderma	PROPN
dpc-2082	177	18	:	:	PUNCT
dpc-2082	177	19	review	review	NOUN
dpc-2082	177	20	of	of	ADP
dpc-2082	177	21	a	a	DET
dpc-2082	177	22	series	series	NOUN
dpc-2082	177	23	of	of	ADP
dpc-2082	177	24	cases	case	NOUN
dpc-2082	177	25	by	by	ADP
dpc-2082	177	26	multiple	multiple	ADJ
dpc-2082	177	27	observers	observer	NOUN
dpc-2082	177	28	.	.	PUNCT
dpc-2082	178	1	j	j	PROPN
dpc-2082	178	2	cutan	cutan	PROPN
dpc-2082	178	3	pathol	pathol	NOUN
dpc-2082	178	4	.	.	PUNCT
dpc-2082	179	1	1994;21(5):419	1994;21(5):419	NUM
dpc-2082	179	2	-	-	SYM
dpc-2082	179	3	423	423	NUM
dpc-2082	179	4	.	.	PUNCT
dpc-2082	180	1	doi	doi	NOUN
dpc-2082	180	2	:	:	PUNCT
dpc-2082	180	3	10.1111	10.1111	NUM
dpc-2082	180	4	/	/	SYM
dpc-2082	180	5	j.1600	j.1600	NOUN
dpc-2082	180	6	-0560.1994.tb00283.x	-0560.1994.tb00283.x	NOUN
dpc-2082	180	7	.	.	PUNCT
dpc-2082	181	1	pmid	pmid	NOUN
dpc-2082	181	2	:	:	PUNCT
dpc-2082	181	3	7868754	7868754	NUM
dpc-2082	181	4	.	.	PUNCT
dpc-2082	182	1	6	6	X
dpc-2082	182	2	.	.	X
dpc-2082	182	3	rothe	rothe	PROPN
dpc-2082	182	4	mj	mj	PROPN
dpc-2082	182	5	,	,	PUNCT
dpc-2082	182	6	bernstein	bernstein	PROPN
dpc-2082	182	7	ml	ml	PROPN
dpc-2082	182	8	,	,	PUNCT
dpc-2082	182	9	grant	grant	NOUN
dpc-2082	182	10	-	-	PUNCT
dpc-2082	182	11	kels	kel	NOUN
dpc-2082	182	12	jm	jm	PROPN
dpc-2082	182	13	.	.	PROPN
dpc-2082	182	14	life	life	NOUN
dpc-2082	182	15	-	-	PUNCT
dpc-2082	182	16	threatening	threaten	VERB
dpc-2082	182	17	erythroderma	erythroderma	NOUN
dpc-2082	182	18	:	:	PUNCT
dpc-2082	182	19	diagnosing	diagnose	VERB
dpc-2082	182	20	and	and	CCONJ
dpc-2082	182	21	treating	treat	VERB
dpc-2082	182	22	the	the	DET
dpc-2082	182	23	“	"	PUNCT
dpc-2082	182	24	red	red	ADJ
dpc-2082	182	25	man	man	NOUN
dpc-2082	182	26	”	"	PUNCT
dpc-2082	182	27	.	.	PUNCT
dpc-2082	183	1	clin	clin	PROPN
dpc-2082	183	2	dermatol	dermatol	NOUN
dpc-2082	183	3	.	.	PUNCT
dpc-2082	184	1	2005;23(2):206	2005;23(2):206	NUM
dpc-2082	184	2	-	-	SYM
dpc-2082	184	3	217	217	NUM
dpc-2082	184	4	.	.	PUNCT
dpc-2082	185	1	doi	doi	NOUN
dpc-2082	185	2	:	:	PUNCT
dpc-2082	185	3	10.1016	10.1016	NUM
dpc-2082	185	4	/	/	SYM
dpc-2082	185	5	j.	j.	PROPN
dpc-2082	185	6	clindermatol.2004.06.018	clindermatol.2004.06.018	PROPN
dpc-2082	185	7	.	.	PUNCT
dpc-2082	186	1	pmid	pmid	NOUN
dpc-2082	186	2	:	:	PUNCT
dpc-2082	186	3	15802214	15802214	NUM
dpc-2082	186	4	.	.	PUNCT
dpc-2082	187	1	7	7	X
dpc-2082	187	2	.	.	X
dpc-2082	187	3	kim	kim	PROPN
dpc-2082	187	4	rh	rh	PROPN
dpc-2082	187	5	,	,	PUNCT
dpc-2082	187	6	brinster	brinster	PROPN
dpc-2082	187	7	nk	nk	PROPN
dpc-2082	187	8	.	.	PROPN
dpc-2082	187	9	practical	practical	ADJ
dpc-2082	187	10	direct	direct	ADJ
dpc-2082	187	11	immunofluorescence	immunofluorescence	NOUN
dpc-2082	187	12	.	.	PUNCT
dpc-2082	187	13	am	be	AUX
dpc-2082	187	14	j	j	PROPN
dpc-2082	187	15	dermatopathol	dermatopathol	NOUN
dpc-2082	187	16	.	.	PUNCT
dpc-2082	188	1	2020;42(2):75	2020;42(2):75	NUM
dpc-2082	188	2	-	-	PUNCT
dpc-2082	188	3	85	85	NUM
dpc-2082	188	4	.	.	PUNCT
dpc-2082	189	1	doi	doi	NOUN
dpc-2082	189	2	:	:	PUNCT
dpc-2082	189	3	10.1097/	10.1097/	NUM
dpc-2082	189	4	dad.0000000000001516	dad.0000000000001516	NUM
dpc-2082	189	5	.	.	PUNCT
dpc-2082	190	1	pmid	pmid	NOUN
dpc-2082	190	2	:	:	PUNCT
dpc-2082	190	3	31990699	31990699	NUM
dpc-2082	190	4	.	.	PUNCT
dpc-2082	191	1	8	8	NUM
dpc-2082	191	2	.	.	PUNCT
dpc-2082	191	3	buch	buch	PROPN
dpc-2082	191	4	ac	ac	PROPN
dpc-2082	191	5	,	,	PUNCT
dpc-2082	191	6	kumar	kumar	PROPN
dpc-2082	191	7	h	h	PROPN
dpc-2082	191	8	,	,	PUNCT
dpc-2082	191	9	panicker	panicker	PROPN
dpc-2082	191	10	n	n	CCONJ
dpc-2082	191	11	,	,	PUNCT
dpc-2082	191	12	misal	misal	PROPN
dpc-2082	191	13	s	s	PROPN
dpc-2082	191	14	,	,	PUNCT
dpc-2082	191	15	sharma	sharma	PROPN
dpc-2082	191	16	y	y	PROPN
dpc-2082	191	17	,	,	PUNCT
dpc-2082	191	18	gore	gore	PROPN
dpc-2082	191	19	cr	cr	PROPN
dpc-2082	191	20	.	.	PUNCT
dpc-2082	192	1	a	a	DET
dpc-2082	192	2	cross	cross	ADJ
dpc-2082	192	3	-	-	ADJ
dpc-2082	192	4	sectional	sectional	ADJ
dpc-2082	192	5	study	study	NOUN
dpc-2082	192	6	of	of	ADP
dpc-2082	192	7	direct	direct	ADJ
dpc-2082	192	8	immunofluorescence	immunofluorescence	NOUN
dpc-2082	192	9	in	in	ADP
dpc-2082	192	10	the	the	DET
dpc-2082	192	11	diagnosis	diagnosis	NOUN
dpc-2082	192	12	of	of	ADP
dpc-2082	192	13	immunobullous	immunobullous	ADJ
dpc-2082	192	14	dermatoses	dermatosis	NOUN
dpc-2082	192	15	.	.	PUNCT
dpc-2082	193	1	indian	indian	PROPN
dpc-2082	193	2	j	j	PROPN
dpc-2082	193	3	dermatol	dermatol	NOUN
dpc-2082	193	4	.	.	PUNCT
dpc-2082	194	1	2014;59(4):364	2014;59(4):364	NUM
dpc-2082	194	2	-	-	PUNCT
dpc-2082	194	3	368	368	NUM
dpc-2082	194	4	.	.	PUNCT
dpc-2082	195	1	doi	doi	NOUN
dpc-2082	195	2	:	:	PUNCT
dpc-2082	195	3	10.4103/0019	10.4103/0019	NUM
dpc-2082	195	4	-	-	SYM
dpc-2082	195	5	5154.135488	5154.135488	NUM
dpc-2082	195	6	.	.	PUNCT
dpc-2082	196	1	pmid	pmid	NOUN
dpc-2082	196	2	:	:	PUNCT
dpc-2082	196	3	25071256	25071256	NUM
dpc-2082	196	4	.	.	PUNCT
dpc-2082	197	1	pmcid	pmcid	NOUN
dpc-2082	197	2	:	:	PUNCT
dpc-2082	197	3	pmc4103273	pmc4103273	NOUN
dpc-2082	197	4	.	.	PUNCT
dpc-2082	198	1	9	9	X
dpc-2082	198	2	.	.	X
dpc-2082	198	3	lath	lath	PROPN
dpc-2082	198	4	k	k	PROPN
dpc-2082	198	5	,	,	PUNCT
dpc-2082	198	6	chatterjee	chatterjee	PROPN
dpc-2082	198	7	d	d	PROPN
dpc-2082	198	8	,	,	PUNCT
dpc-2082	198	9	saikia	saikia	PROPN
dpc-2082	198	10	un	un	PROPN
dpc-2082	198	11	,	,	PUNCT
dpc-2082	198	12	et	et	PROPN
dpc-2082	198	13	al	al	PROPN
dpc-2082	198	14	.	.	PUNCT
dpc-2082	198	15	role	role	NOUN
dpc-2082	198	16	of	of	ADP
dpc-2082	198	17	direct	direct	ADJ
dpc-2082	198	18	immunofluorescence	immunofluorescence	NOUN
dpc-2082	198	19	in	in	ADP
dpc-2082	198	20	cutaneous	cutaneous	ADJ
dpc-2082	198	21	small	small	ADJ
dpc-2082	198	22	-	-	PUNCT
dpc-2082	198	23	vessel	vessel	NOUN
dpc-2082	198	24	vasculitis	vasculitis	NOUN
dpc-2082	198	25	:	:	PUNCT
dpc-2082	198	26	experience	experience	NOUN
dpc-2082	198	27	from	from	ADP
dpc-2082	198	28	a	a	DET
dpc-2082	198	29	tertiary	tertiary	ADJ
dpc-2082	198	30	center	center	NOUN
dpc-2082	198	31	.	.	PUNCT
dpc-2082	199	1	am	be	AUX
dpc-2082	199	2	j	j	PROPN
dpc-2082	199	3	dermatopathol	dermatopathol	NOUN
dpc-2082	199	4	.	.	PUNCT
dpc-2082	200	1	2018;40(9):661	2018;40(9):661	NUM
dpc-2082	200	2	-	-	PUNCT
dpc-2082	200	3	666	666	NUM
dpc-2082	200	4	.	.	PUNCT
dpc-2082	200	5	doi	doi	NOUN
dpc-2082	200	6	:	:	PUNCT
dpc-2082	200	7	10.1097	10.1097	NUM
dpc-2082	200	8	/	/	SYM
dpc-2082	200	9	dad.0000000000001170	dad.0000000000001170	NUM
dpc-2082	200	10	.	.	PUNCT
dpc-2082	201	1	pmid	pmid	NOUN
dpc-2082	201	2	:	:	PUNCT
dpc-2082	201	3	29672364	29672364	NUM
dpc-2082	201	4	.	.	PUNCT
dpc-2082	202	1	10	10	NUM
dpc-2082	202	2	.	.	PUNCT
dpc-2082	203	1	khaled	khaled	PROPN
dpc-2082	203	2	a	a	PRON
dpc-2082	203	3	,	,	PUNCT
dpc-2082	203	4	sellami	sellami	VERB
dpc-2082	203	5	a	a	PRON
dpc-2082	203	6	,	,	PUNCT
dpc-2082	203	7	fazaa	fazaa	NOUN
dpc-2082	203	8	b	b	PROPN
dpc-2082	203	9	,	,	PUNCT
dpc-2082	203	10	kharfi	kharfi	NOUN
dpc-2082	203	11	m	m	PROPN
dpc-2082	203	12	,	,	PUNCT
dpc-2082	203	13	zeglaoui	zeglaoui	NOUN
dpc-2082	203	14	f	f	X
dpc-2082	203	15	,	,	PUNCT
dpc-2082	203	16	kamoun	kamoun	PROPN
dpc-2082	203	17	mr	mr	PROPN
dpc-2082	203	18	.	.	PROPN
dpc-2082	203	19	acquired	acquire	VERB
dpc-2082	203	20	erythroderma	erythroderma	NOUN
dpc-2082	203	21	in	in	ADP
dpc-2082	203	22	adults	adult	NOUN
dpc-2082	203	23	:	:	PUNCT
dpc-2082	203	24	a	a	DET
dpc-2082	203	25	clinical	clinical	ADJ
dpc-2082	203	26	and	and	CCONJ
dpc-2082	203	27	prognostic	prognostic	ADJ
dpc-2082	203	28	study	study	NOUN
dpc-2082	203	29	.	.	PUNCT
dpc-2082	204	1	j	j	PROPN
dpc-2082	204	2	eur	eur	PROPN
dpc-2082	204	3	acad	acad	PROPN
dpc-2082	204	4	dermatol	dermatol	NOUN
dpc-2082	204	5	venereol	venereol	NOUN
dpc-2082	204	6	.	.	PUNCT
dpc-2082	205	1	2010;24(7):781	2010;24(7):781	NUM
dpc-2082	205	2	-	-	SYM
dpc-2082	205	3	788	788	NUM
dpc-2082	205	4	.	.	PUNCT
dpc-2082	206	1	doi	doi	NOUN
dpc-2082	206	2	:	:	PUNCT
dpc-2082	206	3	10.1111	10.1111	NUM
dpc-2082	206	4	/	/	SYM
dpc-2082	206	5	j.1468	j.1468	NOUN
dpc-2082	206	6	-	-	PUNCT
dpc-2082	206	7	3083.2009.03526.x	3083.2009.03526.x	NUM
dpc-2082	206	8	.	.	PUNCT
dpc-2082	207	1	pmid	pmid	NOUN
dpc-2082	207	2	:	:	PUNCT
dpc-2082	207	3	20028449	20028449	NUM
dpc-2082	207	4	.	.	PUNCT
dpc-2082	208	1	11	11	NUM
dpc-2082	208	2	.	.	PUNCT
dpc-2082	209	1	li	li	PROPN
dpc-2082	209	2	j	j	PROPN
dpc-2082	209	3	,	,	PUNCT
dpc-2082	209	4	zheng	zheng	PROPN
dpc-2082	209	5	hy	hy	PROPN
dpc-2082	209	6	.	.	PROPN
dpc-2082	209	7	erythroderma	erythroderma	PROPN
dpc-2082	209	8	:	:	PUNCT
dpc-2082	209	9	a	a	DET
dpc-2082	209	10	clinical	clinical	ADJ
dpc-2082	209	11	and	and	CCONJ
dpc-2082	209	12	prognostic	prognostic	ADJ
dpc-2082	209	13	study	study	NOUN
dpc-2082	209	14	.	.	PUNCT
dpc-2082	210	1	dermatology	dermatology	NOUN
dpc-2082	210	2	2012;225(2):154	2012;225(2):154	PROPN
dpc-2082	210	3	-	-	SYM
dpc-2082	210	4	162	162	NUM
dpc-2082	210	5	.	.	PUNCT
dpc-2082	211	1	doi	doi	NOUN
dpc-2082	211	2	:	:	PUNCT
dpc-2082	211	3	10.1159/000342365	10.1159/000342365	NUM
dpc-2082	211	4	.	.	PUNCT
dpc-2082	212	1	pmid	pmid	NOUN
dpc-2082	212	2	:	:	PUNCT
dpc-2082	212	3	23037884	23037884	NUM
dpc-2082	212	4	.	.	PUNCT
dpc-2082	213	1	12	12	NUM
dpc-2082	213	2	.	.	PUNCT
dpc-2082	214	1	yuan	yuan	NOUN
dpc-2082	214	2	xy	xy	PROPN
dpc-2082	214	3	,	,	PUNCT
dpc-2082	214	4	guo	guo	PROPN
dpc-2082	214	5	jy	jy	PROPN
dpc-2082	214	6	,	,	PUNCT
dpc-2082	214	7	dang	dang	INTJ
dpc-2082	214	8	yp	yp	PROPN
dpc-2082	214	9	,	,	PUNCT
dpc-2082	214	10	qiao	qiao	PROPN
dpc-2082	214	11	l	l	PROPN
dpc-2082	214	12	,	,	PUNCT
dpc-2082	214	13	liu	liu	PROPN
dpc-2082	214	14	w.	w.	PROPN
dpc-2082	214	15	erythroderma	erythroderma	PROPN
dpc-2082	214	16	:	:	PUNCT
dpc-2082	214	17	a	a	DET
dpc-2082	214	18	clinical	clinical	ADJ
dpc-2082	214	19	-	-	PUNCT
dpc-2082	214	20	etiological	etiological	ADJ
dpc-2082	214	21	study	study	NOUN
dpc-2082	214	22	of	of	ADP
dpc-2082	214	23	82	82	NUM
dpc-2082	214	24	cases	case	NOUN
dpc-2082	214	25	.	.	PUNCT
dpc-2082	215	1	eur	eur	PROPN
dpc-2082	215	2	j	j	PROPN
dpc-2082	215	3	dermatol	dermatol	NOUN
dpc-2082	215	4	2010;20(3):373	2010;20(3):373	PROPN
dpc-2082	215	5	-	-	SYM
dpc-2082	215	6	377	377	NUM
dpc-2082	215	7	.	.	PUNCT
dpc-2082	216	1	doi	doi	NOUN
dpc-2082	216	2	:	:	PUNCT
dpc-2082	216	3	10.1684	10.1684	NUM
dpc-2082	216	4	/	/	SYM
dpc-2082	216	5	ejd.2010.0943	ejd.2010.0943	NOUN
dpc-2082	216	6	.	.	PUNCT
dpc-2082	217	1	pmid	pmid	NOUN
dpc-2082	217	2	:	:	PUNCT
dpc-2082	217	3	20400388	20400388	NUM
dpc-2082	217	4	.	.	PUNCT
dpc-2082	218	1	13	13	NUM
dpc-2082	218	2	.	.	X
dpc-2082	218	3	sigurdsson	sigurdsson	PROPN
dpc-2082	218	4	v	v	PROPN
dpc-2082	218	5	,	,	PUNCT
dpc-2082	218	6	toonstra	toonstra	PROPN
dpc-2082	218	7	j	j	PROPN
dpc-2082	218	8	,	,	PUNCT
dpc-2082	218	9	hezemans	hezemans	PROPN
dpc-2082	218	10	-	-	NOUN
dpc-2082	218	11	boer	boer	PROPN
dpc-2082	218	12	m	m	PROPN
dpc-2082	218	13	,	,	PUNCT
dpc-2082	218	14	van	van	PROPN
dpc-2082	218	15	vloten	vloten	VERB
dpc-2082	218	16	wa	wa	PROPN
dpc-2082	218	17	.	.	PROPN
dpc-2082	218	18	erythroderma	erythroderma	PROPN
dpc-2082	218	19	.	.	PUNCT
dpc-2082	219	1	a	a	DET
dpc-2082	219	2	clinical	clinical	ADJ
dpc-2082	219	3	and	and	CCONJ
dpc-2082	219	4	follow	follow	VERB
dpc-2082	219	5	-	-	PUNCT
dpc-2082	219	6	up	up	ADP
dpc-2082	219	7	study	study	NOUN
dpc-2082	219	8	of	of	ADP
dpc-2082	219	9	102	102	NUM
dpc-2082	219	10	patients	patient	NOUN
dpc-2082	219	11	,	,	PUNCT
dpc-2082	219	12	with	with	ADP
dpc-2082	219	13	special	special	ADJ
dpc-2082	219	14	emphasis	emphasis	NOUN
dpc-2082	219	15	on	on	ADP
dpc-2082	219	16	survival	survival	NOUN
dpc-2082	219	17	.	.	PUNCT
dpc-2082	220	1	j	j	PROPN
dpc-2082	220	2	am	be	AUX
dpc-2082	220	3	acad	acad	ADJ
dpc-2082	220	4	dermatol	dermatol	NOUN
dpc-2082	220	5	.	.	PUNCT
dpc-2082	221	1	1996;35(1):53	1996;35(1):53	NUM
dpc-2082	221	2	-	-	SYM
dpc-2082	221	3	57	57	NUM
dpc-2082	221	4	.	.	PUNCT
dpc-2082	222	1	doi	doi	NOUN
dpc-2082	222	2	:	:	PUNCT
dpc-2082	222	3	10.1016	10.1016	NUM
dpc-2082	222	4	/	/	SYM
dpc-2082	222	5	s0190	s0190	VERB
dpc-2082	222	6	-	-	PUNCT
dpc-2082	222	7	9622(96)90496	9622(96)90496	NOUN
dpc-2082	222	8	-	-	PUNCT
dpc-2082	222	9	x.	x.	NOUN
dpc-2082	222	10	pmid	pmid	PROPN
dpc-2082	222	11	:	:	PUNCT
dpc-2082	222	12	8682964	8682964	NUM
dpc-2082	222	13	.	.	PUNCT
dpc-2082	223	1	14	14	NUM
dpc-2082	223	2	.	.	PUNCT
dpc-2082	224	1	duhra	duhra	PROPN
dpc-2082	224	2	p	p	NOUN
dpc-2082	224	3	,	,	PUNCT
dpc-2082	224	4	porter	porter	NOUN
dpc-2082	224	5	di	di	PROPN
dpc-2082	224	6	.	.	PROPN
dpc-2082	224	7	paracetamol	paracetamol	NOUN
dpc-2082	224	8	-	-	PUNCT
dpc-2082	224	9	induced	induce	VERB
dpc-2082	224	10	fixed	fix	VERB
dpc-2082	224	11	drug	drug	NOUN
dpc-2082	224	12	eruption	eruption	NOUN
dpc-2082	224	13	with	with	ADP
dpc-2082	224	14	positive	positive	ADJ
dpc-2082	224	15	immunofluorescence	immunofluorescence	NOUN
dpc-2082	224	16	findings	finding	NOUN
dpc-2082	224	17	.	.	PUNCT
dpc-2082	225	1	clin	clin	PROPN
dpc-2082	225	2	exp	exp	NOUN
dpc-2082	225	3	dermatol	dermatol	NOUN
dpc-2082	225	4	.	.	PUNCT
dpc-2082	226	1	1990;15(4):293	1990;15(4):293	NUM
dpc-2082	226	2	-	-	SYM
dpc-2082	226	3	295	295	NUM
dpc-2082	226	4	.	.	PUNCT
dpc-2082	227	1	doi	doi	NOUN
dpc-2082	227	2	:	:	PUNCT
dpc-2082	227	3	10.1111	10.1111	NUM
dpc-2082	227	4	/	/	SYM
dpc-2082	227	5	j.1365	j.1365	NOUN
dpc-2082	227	6	-	-	PUNCT
dpc-2082	227	7	2230.1990	2230.1990	NOUN
dpc-2082	227	8	.	.	PUNCT
dpc-2082	227	9	tb02093.x	tb02093.x	NOUN
dpc-2082	227	10	.	.	PUNCT
dpc-2082	228	1	pmid	pmid	NOUN
dpc-2082	228	2	:	:	PUNCT
dpc-2082	228	3	2145100	2145100	NUM
dpc-2082	228	4	.	.	PUNCT
dpc-2082	229	1	15	15	NUM
dpc-2082	229	2	.	.	PUNCT
dpc-2082	229	3	king	king	PROPN
dpc-2082	229	4	t	t	PROPN
dpc-2082	229	5	,	,	PUNCT
dpc-2082	229	6	helm	helm	PROPN
dpc-2082	229	7	tn	tn	PROPN
dpc-2082	229	8	,	,	PUNCT
dpc-2082	229	9	valenzuela	valenzuela	PROPN
dpc-2082	229	10	r	r	PROPN
dpc-2082	229	11	,	,	PUNCT
dpc-2082	229	12	bergfeld	bergfeld	ADJ
dpc-2082	229	13	wf	wf	PROPN
dpc-2082	229	14	.	.	PUNCT
dpc-2082	230	1	diffuse	diffuse	VERB
dpc-2082	230	2	intraepidermal	intraepidermal	ADJ
dpc-2082	230	3	deposition	deposition	NOUN
dpc-2082	230	4	of	of	ADP
dpc-2082	230	5	immunoreactants	immunoreactant	NOUN
dpc-2082	230	6	on	on	ADP
dpc-2082	230	7	direct	direct	ADJ
dpc-2082	230	8	immunofluorescence	immunofluorescence	NOUN
dpc-2082	230	9	:	:	PUNCT
dpc-2082	230	10	a	a	DET
dpc-2082	230	11	clue	clue	NOUN
dpc-2082	230	12	to	to	ADP
dpc-2082	230	13	the	the	DET
dpc-2082	230	14	early	early	ADJ
dpc-2082	230	15	diagnosis	diagnosis	NOUN
dpc-2082	230	16	of	of	ADP
dpc-2082	230	17	epidermal	epidermal	ADJ
dpc-2082	230	18	necrolysis	necrolysis	NOUN
dpc-2082	230	19	.	.	PUNCT
dpc-2082	231	1	int	int	PROPN
dpc-2082	231	2	j	j	PROPN
dpc-2082	231	3	dermatol	dermatol	NOUN
dpc-2082	231	4	.	.	PUNCT
dpc-2082	232	1	1994;33(9):634	1994;33(9):634	PROPN
dpc-2082	232	2	-	-	PUNCT
dpc-2082	232	3	636	636	NUM
dpc-2082	232	4	.	.	PUNCT
dpc-2082	233	1	doi	doi	NOUN
dpc-2082	233	2	:	:	PUNCT
dpc-2082	233	3	10.1111	10.1111	NUM
dpc-2082	233	4	/	/	SYM
dpc-2082	233	5	j.1365	j.1365	NOUN
dpc-2082	233	6	-4362.1994.tb02922.x	-4362.1994.tb02922.x	NOUN
dpc-2082	233	7	.	.	PUNCT
dpc-2082	234	1	pmid	pmid	NOUN
dpc-2082	234	2	:	:	PUNCT
dpc-2082	234	3	8002159	8002159	NUM
dpc-2082	234	4	.	.	PUNCT
dpc-2082	235	1	16	16	NUM
dpc-2082	235	2	.	.	X
dpc-2082	235	3	grekin	grekin	PROPN
dpc-2082	235	4	sj	sj	PROPN
dpc-2082	235	5	,	,	PUNCT
dpc-2082	235	6	fox	fox	PROPN
dpc-2082	235	7	mc	mc	PROPN
dpc-2082	235	8	,	,	PUNCT
dpc-2082	235	9	gudjonsson	gudjonsson	PROPN
dpc-2082	235	10	je	je	PROPN
dpc-2082	235	11	,	,	PUNCT
dpc-2082	235	12	fullen	fullen	PROPN
dpc-2082	235	13	dr	dr	PROPN
dpc-2082	235	14	.	.	PROPN
dpc-2082	235	15	psoriasiform	psoriasiform	PROPN
dpc-2082	235	16	pemphigus	pemphigus	PROPN
dpc-2082	235	17	foliaceus	foliaceus	PROPN
dpc-2082	235	18	:	:	PUNCT
dpc-2082	235	19	a	a	DET
dpc-2082	235	20	report	report	NOUN
dpc-2082	235	21	of	of	ADP
dpc-2082	235	22	two	two	NUM
dpc-2082	235	23	cases	case	NOUN
dpc-2082	235	24	.	.	PUNCT
dpc-2082	236	1	j	j	PROPN
dpc-2082	236	2	cutan	cutan	PROPN
dpc-2082	236	3	pathol	pathol	PROPN
dpc-2082	236	4	.	.	PUNCT
dpc-2082	237	1	2012;39(5):549	2012;39(5):549	NUM
dpc-2082	237	2	-	-	PUNCT
dpc-2082	237	3	553	553	NUM
dpc-2082	237	4	.	.	PUNCT
dpc-2082	238	1	doi	doi	NOUN
dpc-2082	238	2	:	:	PUNCT
dpc-2082	238	3	10.1111	10.1111	NUM
dpc-2082	238	4	/	/	SYM
dpc-2082	238	5	j.1600	j.1600	NOUN
dpc-2082	238	6	-	-	PUNCT
dpc-2082	238	7	0560.2012.01866.x	0560.2012.01866.x	PROPN
dpc-2082	238	8	.	.	PUNCT
dpc-2082	239	1	pmid	pmid	NOUN
dpc-2082	239	2	:	:	PUNCT
dpc-2082	239	3	22449394	22449394	NUM
dpc-2082	239	4	.	.	PUNCT
dpc-2082	240	1	17	17	NUM
dpc-2082	240	2	.	.	PUNCT
dpc-2082	240	3	joly	joly	PROPN
dpc-2082	240	4	p	p	PROPN
dpc-2082	240	5	,	,	PUNCT
dpc-2082	240	6	tanasescu	tanasescu	NOUN
dpc-2082	240	7	s	s	PROPN
dpc-2082	240	8	,	,	PUNCT
dpc-2082	240	9	wolkenstein	wolkenstein	NOUN
dpc-2082	240	10	p	p	NOUN
dpc-2082	240	11	,	,	PUNCT
dpc-2082	240	12	et	et	PROPN
dpc-2082	240	13	al	al	PROPN
dpc-2082	240	14	.	.	PUNCT
dpc-2082	241	1	lichenoid	lichenoid	PROPN
dpc-2082	241	2	erythrodermic	erythrodermic	ADJ
dpc-2082	241	3	bullous	bullous	ADJ
dpc-2082	241	4	pemphigoid	pemphigoid	NOUN
dpc-2082	241	5	of	of	ADP
dpc-2082	241	6	the	the	DET
dpc-2082	241	7	african	african	ADJ
dpc-2082	241	8	patient	patient	NOUN
dpc-2082	241	9	.	.	PUNCT
dpc-2082	242	1	j	j	PROPN
dpc-2082	242	2	am	be	AUX
dpc-2082	242	3	acad	acad	ADJ
dpc-2082	242	4	dermatol	dermatol	NOUN
dpc-2082	242	5	1998;39(5	1998;39(5	NUM
dpc-2082	242	6	pt	pt	NOUN
dpc-2082	242	7	1):691	1):691	NOUN
dpc-2082	242	8	-	-	PUNCT
dpc-2082	242	9	697	697	NUM
dpc-2082	242	10	.	.	PUNCT
dpc-2082	243	1	doi	doi	NOUN
dpc-2082	243	2	:	:	PUNCT
dpc-2082	243	3	10.1016	10.1016	NUM
dpc-2082	243	4	/	/	SYM
dpc-2082	243	5	s0190	s0190	VERB
dpc-2082	243	6	-	-	PUNCT
dpc-2082	243	7	9622(98)70040	9622(98)70040	NUM
dpc-2082	243	8	-	-	PUNCT
dpc-2082	243	9	4	4	NUM
dpc-2082	243	10	.	.	PUNCT
dpc-2082	244	1	pmid	pmid	NOUN
dpc-2082	244	2	:	:	PUNCT
dpc-2082	244	3	9810884	9810884	NUM
dpc-2082	244	4	.	.	PUNCT
dpc-2082	245	1	18	18	NUM
dpc-2082	245	2	.	.	PUNCT
dpc-2082	246	1	leibold	leibold	PROPN
dpc-2082	246	2	am	am	NOUN
dpc-2082	246	3	,	,	PUNCT
dpc-2082	246	4	bennion	bennion	NOUN
dpc-2082	246	5	s	s	PART
dpc-2082	246	6	,	,	PUNCT
dpc-2082	246	7	david	david	PROPN
dpc-2082	246	8	-	-	PUNCT
dpc-2082	246	9	bajar	bajar	PROPN
dpc-2082	246	10	k	k	PROPN
dpc-2082	246	11	,	,	PUNCT
dpc-2082	246	12	schleve	schleve	PROPN
dpc-2082	246	13	mj	mj	PROPN
dpc-2082	246	14	.	.	PROPN
dpc-2082	246	15	occurrence	occurrence	NOUN
dpc-2082	246	16	of	of	ADP
dpc-2082	246	17	positive	positive	ADJ
dpc-2082	246	18	immunofluorescence	immunofluorescence	NOUN
dpc-2082	246	19	in	in	ADP
dpc-2082	246	20	the	the	DET
dpc-2082	246	21	dermo	dermo	NOUN
dpc-2082	246	22	-	-	PUNCT
dpc-2082	246	23	epidermal	epidermal	ADJ
dpc-2082	246	24	junction	junction	NOUN
dpc-2082	246	25	of	of	ADP
dpc-2082	246	26	sun	sun	NOUN
dpc-2082	246	27	-	-	PUNCT
dpc-2082	246	28	exposed	expose	VERB
dpc-2082	246	29	skin	skin	NOUN
dpc-2082	246	30	of	of	ADP
dpc-2082	246	31	normal	normal	ADJ
dpc-2082	246	32	adults	adult	NOUN
dpc-2082	246	33	.	.	PUNCT
dpc-2082	247	1	j	j	PROPN
dpc-2082	247	2	cutan	cutan	PROPN
dpc-2082	247	3	pathol	pathol	NOUN
dpc-2082	247	4	.	.	PUNCT
dpc-2082	248	1	1994;21(3):200	1994;21(3):200	NUM
dpc-2082	248	2	-	-	PUNCT
dpc-2082	248	3	206	206	NUM
dpc-2082	248	4	.	.	PUNCT
dpc-2082	249	1	doi	doi	NOUN
dpc-2082	249	2	:	:	PUNCT
dpc-2082	249	3	10.1111	10.1111	NUM
dpc-2082	249	4	/	/	SYM
dpc-2082	249	5	j.1600	j.1600	NOUN
dpc-2082	249	6	-	-	PUNCT
dpc-2082	249	7	0560.1994	0560.1994	PROPN
dpc-2082	249	8	.	.	PUNCT
dpc-2082	250	1	tb00261.x	tb00261.x	NOUN
dpc-2082	250	2	.	.	PUNCT
dpc-2082	251	1	pmid	pmid	NOUN
dpc-2082	251	2	:	:	PUNCT
dpc-2082	251	3	7962822	7962822	NUM
dpc-2082	251	4	.	.	PUNCT
dpc-2082	252	1	19	19	NUM
dpc-2082	252	2	.	.	X
dpc-2082	253	1	palit	palit	PROPN
dpc-2082	253	2	a	a	DET
dpc-2082	253	3	,	,	PUNCT
dpc-2082	253	4	inamadar	inamadar	PROPN
dpc-2082	253	5	ac	ac	PROPN
dpc-2082	253	6	.	.	PUNCT
dpc-2082	254	1	vasculitis	vasculitis	PROPN
dpc-2082	254	2	:	:	PUNCT
dpc-2082	254	3	approach	approach	NOUN
dpc-2082	254	4	to	to	ADP
dpc-2082	254	5	diagnosis	diagnosis	NOUN
dpc-2082	254	6	and	and	CCONJ
dpc-2082	254	7	therapy	therapy	NOUN
dpc-2082	254	8	.	.	PUNCT
dpc-2082	255	1	indian	indian	PROPN
dpc-2082	255	2	j	j	PROPN
dpc-2082	255	3	dermatol	dermatol	PROPN
dpc-2082	255	4	venereol	venereol	ADJ
dpc-2082	255	5	leprol	leprol	NOUN
dpc-2082	255	6	.	.	PUNCT
dpc-2082	256	1	2006;72(5):334	2006;72(5):334	NUM
dpc-2082	256	2	-	-	PUNCT
dpc-2082	256	3	345	345	NUM
dpc-2082	256	4	.	.	PUNCT
dpc-2082	257	1	doi	doi	NOUN
dpc-2082	257	2	:	:	PUNCT
dpc-2082	257	3	10.4103/0378	10.4103/0378	NUM
dpc-2082	257	4	-	-	PUNCT
dpc-2082	257	5	6323.27748	6323.27748	NOUN
dpc-2082	257	6	.	.	PUNCT
dpc-2082	258	1	pmid	pmid	NOUN
dpc-2082	258	2	:	:	PUNCT
dpc-2082	258	3	17050926	17050926	NUM
dpc-2082	258	4	.	.	PUNCT